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A b s t r a c t
Prolyl Ohgopeptidase (PO) was purified from human saliva and partially characterised The techniques 
employed during purification were Phenyl Sepharose Hydrophobic Interaction and Anion Exchange 
Chromatography, where the peptidase could be isolated from this low protein source
The enzyme was shown to have a monomeric molecular weight o f81,000 Da, which was also believed to be 
the native molecular weight DTT had a considerable enhancing effect on PO activity, suggesting the 
presence o f thiol groups as part o f cysteine residues at or near the enzyme’s active site A preference was 
shown for neutral p H ’s with an optimum at pH 7 5 in potassium phophate buffer
The peptidase’s activity proved to be quite unstable at physiological temperature, even when stabilising 
agents were included Similarly significant enzyme activity was lost at frozen storage conditions Therefore it 
is probable that PO is secreted into saliva in an inherently unstable form
Dipeptidyl Peptidase IV (DPPIV) was purified to homogeneity from bovine serum The chromatographic 
techniques used were Phenyl Sepharose Hydrophobic Interaction, Sephacryl S300 Gel Filtration, Anion 
Exchange and G100 Gel Filtration, producing an overall purification factor o f 257
SDS PAGE resulted in a monomeric weight of 70,740 Da while Size Exclusion Chromatography generated 
an average native molecular weight determination o f 302 000 Da Therefore it is proposed that the enzyme 
was a tetramer A glycoprotein stain o f a SDS PAGE gel suggests that DPPIV is glycosylated\ which adds to 
the estimated molecular weight
DPPIV remains active over a broad pH range with a preference for neutral pH, while the isoelectric point 
was estimated at 4 7 Although the enzyme is generally classified as a serine protease, it was not inhibited by 
any serine protease inhibitors The enzyme was inhibited by the phenanthrolmes, which are metallo-protease 
inhibitors but remained unaffected by the metal chelators Therefore is not believed that DPPIV is a metallo 
protease but its activity could be reduced due to enzyme surface binding This was confirmed by the minimal 
effect metal ions had on activity
Substrate Specificity o f DPPIV via HPLC proved that DPPTV is capable o f sequential cleavage of fi- 
Casomorphin, Substance P and Enterostatin Analogues o f C-Reactive Protein (CRP), Insulin-like Growth
III
Factor (IGF) and Neuropeptide Y were also shown to be susceptible to DPPTV cleavage The peptidase 
cleaved the standard DPPTV substrate, Gly-Pro-MCA with a Km o f 38 4fjM, while Lys-Pro-MCA was 
hydrolysed with a KM value o f 103
DPPTV was specifically inhibited by both Diprotm A and B, where the mode o f inhibition was observed to be 
non-competitive, generating K, ’s o f 1 4x10 4M for both inhibitors Ile-Thiazohdide and Ile-Pyrrohdide both 
inhibited DPPTV competitively with estimated inhibition constants o f 3 7x10 ?M  and 7 5x10 7M  determined 
respectively Inhibition studies o f two prohne containing peptides, /3-Casomorphm and Substance P, 
generated two different modes o f inhibition for the two peptides fi-Casomorphin inhibited competitively with 
an average K, o f 1 1x1 O'4M, while Substance P inhibited un-competitively generating an inhibition constant 
o f5 5x10 4M
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General Abbreviations
vj; Indicates the peptide bond has been modified by the group in parenthesis immediately
following
pNa p-naphthylamide
(NH4)2S04 Ammonium sulphate
2-NNAp p-naphthylamide
AP Amyloid p-protein
A2so Absorbance at 280nm
AA Amino acid
ACN Acetomtnle
AD Alzheimer’s disease
ADH Alcohol dehydrogenase
AEBSF 4-(2-aminoethyl)-benzenesulfonyl fluonde
AMC 7-amido Methyl Coumann
APMSF 4-amidmo-phenyl methane-sulphonyl fluonde
APP Amyloid Precursor Protein
AVP Argimne vasopressin
BCA Bicmchomnic Acid
Bisacryl Bisacrylamide
BSA Bovine serum albumin
Bz Benzoyl
Ca Calcium
CAPS 3 [cyclohexylamino] -1 -propanesulphomc acid
Cd Cadmium
cDNA copy Deoxyribonucleic acid
CDTA 1,2-cyclo hexanediaminetetraaectic acid
Cl Chloride ion
CMK Chloromethylketone
CN 2-mtnle
CNS Central Nervous System
Co Cobalt
Cone Concentration
CPC Calcium cellulose phosphate
V
Cpp N-[ 1 -(RS)-carboxyl-3 -phenylpropyl]
Cu Copper
Da Daltons
DEAE Diethylaminoethyl
DFP Dnsopropyl fluorophosphate
Dip A Diprotin A
Dip B Diprotin B
DMF Dimethylformamide
DMSO Dimethylsulphoxide
DNP 2,4-dinitrophenyl-
DPP I Dipeptidyl Aminopeptidase I
DPPn Dipeptidyl Aminopeptidase II
DPP III Dipeptidyl Aminopeptidase III
DPP IV Dipeptidyl Aminopeptidase IV
DPPX Dipeptidyl Aminopeptidase X
DTNB 5,5-dithio-bis2-mtrobenzoic acid
DTT Dithiothreitol
DXN Dioxane
ed Editors
EDTA Ethylenediaminetetra acetic acid
EGTA [Ethylenebis (oxyethylenemtnlo)] tetraacetic acid
EH Eadie-Hofstee
EtOH Ethanol
Fmoc- 9-fluorenylmethyloxycarbonyl
FPLC Fast protein liquid chromatography
FXGLM-NH2 Phe-Xaa-Gly-Leu-Met-amide
GPL
H
HC1
HEPES
HEXXH
Hg
HIC
HIV-1
HPLC
VI
Gly-Pro-Leu 
Homogenate 
Hydrochlonc acid
N-[2-Hydroxyethyl]piperazine-N’ -[2-ethanesulfomc acid]
His-Glu-Xaa-Xaa-His
Mercury
Hydrophobic interactions chromatography 
Human Immunodeficiency Virus 1 
High performance liquid chromatography
HRP
HW
I
IC50
IEF
JTP-4819
K2HP04
KCl
KH2P04
K,
KI
Km
LB
LHRH
Log
MW
Mca
MCA
MeOH
Meq
MES
Mg
MM
Mn
mRNA
Na
NaCl
NaOH
ND
NEM
Ni
OH
P
Horse radish peroxidase
Hanes-Woolf
Iodine
Concentration at which enzyme is 50% inhibited 
Isoelectric focusing
(S)-2-[[(S)-2-(hydroxyacetyl)-l-pyrrolidinyI]carbonyl]-N-[phenylmethyl]-l-
pyrrolidinecar-boxamide
Potassium phosphate base
Potassium chloride
Potassium phosphate acid
Inhibition constant
Potassium iodide
Michaelis constant
Lineweaver-Burk
Lutemising hormone-releasing hormone 
Logarithm 
Molecular weight 
(7-methoxy-coumann-4-yl) acetyl 
7-ami no-4-methyl coumann 
Methanol
7-amino-4-methyI-2-quinoline
2-[N-Morphohno]ethane-sulphomc acid
Magnesium
Michaelis-Menten
Manganese
Messenger ribonucleic acid 
Sodium
Sodium chloride 
Sodium hydroxide 
Not determined 
N-ethyl maleimide 
Nickel 
Hydroxy- 
Pellet
Substrate subsite located n positions from the scissile bond on the N-terminal side 
Substrate subsite located n positions from the scissile bond on the C-terminal side
VII
pAb p-aminobenzoate
PAGE Polyacrylamide gel electrophoresis
PBE Polybuffer exchanger
PCMB /?-chloromercunbenzoate
PE Perkin Elmer
PEG Polyethylene glycol
pH log of the reciprocal of the hydrogen ion concentration
pi Isoelectric point
pKa Negative log of the equilibrium constant for an acid
PMSF Phenylmethylsulphonylfluonde
PO Prolyl oligopeptidase
PPCE Post Prolm Cleaving Enzyme
PS Phenyl sepharose
PVDF Polyvinylidene difluonde
Pyrr Pyrrolidide
Pz Phenylazobenzyloxycarbonyl-Pro-Leu-Gly-Pro-D-Arg
Q Quaternary
R2 Regression coefficient
RCO Acyl
Rf Relative mobility
RP Reverse phase
Rpm Revolutions per minute
S Sulphur
SI First supernatant
S2 Second supernatant
S9 Prolyl oligopeptidase family of senne proteases
SD Standard Deviation
SDS Sodium dodecyl sulphate (Lauryl sulphate)
SE Standard error
SEC Size exclusion chromatography
SEM Standard Error Mean
SH Thiol group
Sn Enzyme subsite positioned n places from the active site
s„* Enzyme subsite positioned n places from the active site
S04 Sulphate
vin
s-s
Suc-
TEMED
TFA
Thia
TLCK
TRH
Tns
UV
v/v
Ve
V0
w rt
Xaa
Yaa
Z-
Zaa
ZIP
Zn
ZnCl
ZPP
ZTTA
A
Da
g
hr
k
L
m
M
nun
N
sec
Disulphide Bndges 
Succinyl-
N, N, N, N’-tetramethyl elhylenediamine
Tnfluoroacetic acid
Thiazolidide
Tosyl-L-lysyichloromethane
Thyrotropin-releasing hormone
Tns (hydroxymethyl) amino methane
Ultraviolet
Volume per volume
Elution volume
Void volume
With respect to
Any amino acid
Any amino acid
jV-benzy I oxy carbonyl
Any amino acid
Z-Pro-Prolmal insensitive Z-Gly-Pro-MCA degrading peptidase 
Zinc
Zinc chlonde
Z-Pro-Prolmal
Z-Thiopro-thioprolinal
UNITS
Amp
Dalton
Gram
Hour
Kilo
Litre
Metre
Molar
Minute
Normal
Second
IX
Pr e f ix e s
c centi (1x10 2)
m milli (1x103)
H micro (1x106)
n nano (1x10 9)
P pico (1x10 ,2)
A m i n o  A c i d  A b b r e v i a t i o n s
Ala A Alanine
Arg R Arginine
Asn D Asparagine
Asp N Aspartic acid
Cys C Cysteme
Gin Q Glutamine
Glu E Glutamic acid
Gly G Glycine
His H Histidine
Hyp Hydroxyproline
lie I Isoleucme
Leu L Leucine
Lys K Lysme
Met M Methionine
Phe F Phenylalanine
Pro P Prolme
Ser S Senne
Thr T Threonine
Trp W Tryptophan
Tyr Y Tyrosine
Val V Valine
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1 . 0 .  I n t r o d u c t i o n
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1.0. I n tr o d u c t io n
In mammalian systems, proteins play a crucial role in the life, death and general functionality 
of cells Protein-Receptor interactions produce specific signals, instructing the fate of the cell 
Similarly, the signal in the guise of endocrine molecules such as hormones, are proteins often 
with specific function This function can be altered by the effect of proteolytic cleavage, 
which is the most frequent and important enzymatic modification of proteins The resultant 
cleavage product can have a different, possibly more potent physiological effect, illustrating 
the powerful influence and necessity of enzymatic processes
Proteases can roughly be divided into exopeptidases and endopeptidases The specificities of 
exopeptidases often allow a high degree of synergism with endopeptidases, as well as with 
one another (McDonald and Barrett, 1986) The specificities may have evolved as part of a 
proteolytic mechanism that provides for the efficient retrieval of essential amino acids from 
dietary proteins and from intracellular proteins that are degraded as part of the dynamic 
process of protein turnover This is achieved by hydrolysing peptide chains from either the 
amino or carboxyl terminals of the peptide Initially proteases were classified according to 
their molecular size, charge or substrate specificity A more rational system is now used, 
based on a comparison of active sites, mechanism of action and three-dimensional structure 
Four mechanistic classes are recognised by the International Union of Biochemistry These 
include senne and cysteine proteases (those that form covalent enzyme complexes) and 
aspartic and metallo-proteases (those that do not form covalent enzyme complexes) (Benynon 
and Bond, 1989)
Proteolytic enzymes dependent on a senne residue for catalytic activity are widespread and 
very numerous Senne peptidases are found in viruses, bactena and eukaryotes and they 
include exopeptidases, endopeptidases and oligopeptidases Over 20 families of senne 
proteases have been recognised (Rawlings, 1994) Mainly based on the three-dimensional 
structure, most of these families can be grouped together into approximately 6 clans that may 
well have common ancestors It is speculated there are at least four separate evolutionary 
ongins of senne peptidases However there are similanties in the reaction mechanisms of 
several of the peptidases even with different evolutionary ongins They have a common 
‘catalytic tnad’ of three ammo acids Senne (nucleophile), aspartic acid (electrophile) and 
histidine (base) The geometnc onentations of these amino acids may vary slightly between
1 1  P r o t e o l y t ic  E n z y m e s
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families, despite the fact that the protein folds are very different It is this parameter that can 
often create a proteins individual functionality (See TABLE 1 1 )
Clan Family Representative Enzyme
SA SI Chymotrypsin
SA S5 Lysyl Endopeptidase
SB S8 Subtihsm
SC S9 Prolyl Oligopeptidase
SC S10 Carboxypeptidase C
* S15 Lactococcus X-Pro-peptidase
* S28 Lysosomal Pro-X Carboxypeptidase
SE Sll Eschenchia D-Ala-D-Ala peptidase A
SF S26 Leader Peptidase
SG S25 Multicatalytic endopeptidase complex
Ta b l e  1 1  C l a n s  a n d  F a m il ie s  of  so m e  Se r in e  Pe pt id a ses
* Represents Peptidases that are roughly grouped into the SC clan eventhough the catalytic 
residues have not been fully established
Dipeptidyl Peptidases (DPP) are a group of enzymes that have not been grouped due to their 
catalytic similarity, molecular size nor charge It is probable that the proteases have very little 
evolutionary link whatsoever They are grouped due to their ability to hydrolyse dipeptides 
from the N-terminus of peptides Therefore they are exopeptidases and may play a significant 
role in protein metabolism and their general turnover as mentioned earlier It is possible too 
that they could be involved in the less reported process of peptide synthesis Proteases are 
classified by their biological function as hydrolases, however as catalysts they must also be 
able to catalyse the reverse reaction, such as the formation of a peptide bond Nevertheless, 
the four characterised DPPs are quite diverse DPPI is a broad acidic, cysteine proteinase, 
DPPIII is generally recognised as a metalloprotease, while DPPII and IV resemble the 
greatest similarity, both classified as senne proteases and have almost identical unique 
substrate specificities The only significant difference between both enzymes is their pH 
optimums, with DPPII enjoying acidic pH conditions while DPPIV favours more neutral pH 
As a consequence, most of the research on the dipeptidyl peptidases have focused on both 
DPPII and IV This work has grouped both proteases in the ‘unclassicaP senne protease SC 
clan, as part of the Prolyl Oligopeptidase family (See TABLE 1 1)
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Other dipeptidyl peptidases have been discovered but await thorough characterisation and 
eventual classification Most have been compared to DPPIV, in an attempt to ascertain a 
significant enzymatic difference and thus a possible novel, undiscovered protease
3
1 2 D ip e p t id y l  P e p t id a s e  I
1 2  1 Introduction
Dipeptidyl Peptidase I (EC 3 4 14 1) is a lysosomal cysteine protease capable of sequentially 
cleaving dipeptides from the ammo terminus of suitable substrates The peptidase was first 
discovered in Porcine kidney (Gutman & Fruton, 1948) having chymotrypsin-like activity 
which was termed Cathepsin C (Tallan et a l , 1952) The enzyme was named dipeptidyl 
transferase (Metnone et a l , 1966) and later renamed dipeptidyl aminopeptidase I (DPPI) 
by McDonald et a l , 1969a in recognition of its exopeptidase activity The enzyme is 
predominantly found in cytotoxic T-cells, mast cells and myelomonocytic cells (Wolters et 
a l , 1998)
1 2  2 D istribution
DPPI is widely distributed in mammalian tissues, spleen and kidney being rich sources 
(Kunbayashi, et a l, 1993, Kominami et a l, 1992) Recent work has demonstrated a high 
level of DPPI expression in bone marrow and bone marrow-derived cells These include 
myeloid cells such as mast cells (Wolters et al, 1998) and lymphocytes with cytolytic 
potential Brown et a l , 1993) Within these cells, DPPI plays a requisite role in the post- 
translational processing and activation of granule serine proteases by removal of the 
activation dipeptide Thus converting the pro-enzyme to the active mature enzyme In blood it 
is predicted that DPPI activates thrombin cleaved urokinase-type plasminogen activator 
(Nauland & Rijken, 1994)
1 2  3 P hysiological Im portance
The main function of DPPI is protein degradation in the lysosome Similarly it has been found 
to activate neuraminidase and platelet factor XIII, highlighting its involvement in the 
regulation of the plasminogen-plasmin system Maintenance of cell growth has been reported 
as another possible DPPI function
Smyth et a l, 1995, describes the common tissue expression of senne proteases and DPPI, 
their intracellular compartmentalisation and co-localisation, and the enzymatic characteristics 
of DPPI These findings clearly suggests the enzyme is a potential candidate for the 
processing and activation of granzyme B Granzyme B is a neutral senne protease found in 
cytotoxic lymphocytes It is cntically involved in delivering the rapid apoptotic signal to 
susceptible target cells Active recombinant human granzyme B (hGrzB) was expressed in 
mammalian COS cells which was able to hydrolyse BOC-Ala-Ala-Asp-SBZL, which is
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termed the Asp’ase assay However unmodified hGrzB was inactive until DPPI was added 
The inactive hGrzB differs from the active form only by the presence of an amino-terminal 
prodipeptide Thus, it is believed that the proteolytic processing of the prodipeptide and 
subsequent activation of the enzyme is carried out by DPPI Pham et a l , 1998 found that at 
pH 5 0, bovine DPPI efficiently activated recombinant pro-GrzB DPPI had no effect on the 
Asp’ase assay nor did it affect the activity of mature rGrzB, suggesting that once the 
prodipeptide is removed, mature GrzB is resistant to further proteolytic cleavage by DPPI 
Kummer et a l , 1996, and Mabee et a l , 1998, report the activation of Granzyme A, another 
senne proteinase present m the granules of cytotoxic T lymphocytes and natural killer cells 
Like GrzB, GrzA is synthesised as an mactive proenzyme with an amino-terminal 
prodipeptide, which is processed during transport to the cytotoxic granules, where it is stored 
as an active protease DPPI’s involvement in cytotoxic lymphocytes and cells of myeloid 
origin is highlighted by the fact that human natural killer (NK) lymphocytes have 
approximately 20 times the DPPI activity as fibroblasts or B cells This could also indicate 
that DPPI has a more specific role in immune effector or inflammatory cells, a subset of bone 
marrow derived cells
Rao et a l , 1997 discovered that high levels of DPPI were expressed in polymorphonuclear 
leukocytes (PMNL) and alveolar macrophages and their precursor cells Treatment of 
lymphocytes with interleukin-2 (IL-2) resulted in a significant increase in DPPI mRNA 
levels, suggesting that the gene is subjected to transcriptional regulation
Dipeptidyl Peptidase I is also reported to activate chymase, a serine protease with 
chymotrypsin-like substrate specificity which is synthesised and stored in the secretoiy 
granules of mast cells Chymase is released m response to allergens to defend against 
helminthic parasites, cardiovascular disease and chronic inflammatory disease (McEuen et a l ,
1998) Treatment with DPPI on recombinant prochymase resulted in enzymatically active 
chymase Tryptase is also synthesised as an mactive zymogen and then activated by removal 
of the NH2-terminal dipeptide by DPPI
Wolters et a l , 1998, postulated that mast cell-DPPI (MC-DPPI) may have an extracellular 
role by degrading neuropeptides, cytokines or extracellular matnx proteins As a 
consequence, the enzyme may influence cellular functions or matnx remodelling In addition, 
MC-DPPI may be regulated by inflammatory mediators As mast cells have a role in allergic 
and inflammatory diseases, inflammatory mediators may alter quantities in MC-DPPI and 
influence its role in these diseases
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Dolenc et a l , 1995, report that DPPI serum levels are highest in hepatic diseases, followed by 
penpheral artenal disease, thromboembolism, myocardial infarction, diabetes mellitus and 
prostatic hypertrophy In addition, it has been suggested that DPPI is also involved in several 
pathological events, such as Duchenne muscular dystrophy and basal cell carcmomas 
Krepela e t a l , 1996, found that the mean specific activity of DPPI was higher m human 
squamous cell lung carcmoma (SQCLC) than in normal lung suggesting possible involvement 
of the DPPI enzyme
1 2  4 A ssay
DPPI preferentially cleaves dipeptides from the unsubstituted N-termini of polypeptide 
substrates with broad specificity Most common assay substrates are derivatives of Gly-Phe-, 
Gly-Arg or Ala-Ala- dipeptides (McDonald & Schwabe, 1977, Kirschke et a l , 1995, Wolters 
et a l , 1998) Having unblocked N-termini, the substrates are susceptible to aminopeptidase 
activity and therefore may not be regarded as specific for the peptidase Although widely 
classified as an exopeptidase, DPPI was shown to have an affinity for cleavage of Z-Phe-Arg, 
Pro-Phe-Arg and Suc-Leu-Leu-Val-Tyr-MCA (Kunbayashi et a l , 1993) under optimal 
conditions, highlighting a possible secondary endopeptidase activity
1 2  5 P urification
DPPI has been punfied from many species, such as human, rat, bovine, porcine and goat as 
well as mammalian cells The enzymes molecular size and net charge appear to be the two 
mam properties exploited while purifying the DPPI enzyme One of the first documented 
purification of DPPI was by Mycek m 1970 from bovine spleen, employing Ammonium 
Sulphate precipitation and Sephadex G-200, DEAE Cellulose and the cation exchanger CM- 
Cellulose chromatography, resulting in an overall 92 5-fold increase in punty Horn et a l , 
2000 also utilised this procedure when purifying from bovine spleen
Kunbayashi et a l , 1993, also punfied DPPI from bovine spleen in an attempt to determine 
the enzyme’s endopeptidase potential A G3000SW gel filtration resin was used as well as a 
DEAE-Toyopearl 650M anion exchanger However it is not reported whether the enzyme was 
punfied to homogeneity nor is a punfication factor given
Ishidoh et a l , 1991 punfied Cathepsin C from rat liver usmg a combination of Ammonium 
Sulphate salt precipitation, Ion Exchange, Gel Filtration and Hydroxyapatite chromatography 
Although the percentage yield was quite low at 5%, a punfication factor of 1580 was 
generated resulting in lmg of pure Cathepsin C
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Wolter et a l , 1998 purified DPPI to homogeneity from dog C2 mastocytoma cells The 
enzymes glycosylation properties were exploited to bind to a lentil column The subsequent 
pooled fraction was further purified via a Superose 6 gel filtration column connected to a 
Superose 12 column and finally applied to a Mono-Q amon exchange column The procedure 
employed generated a 30-fold increase in punty
Although this is not an exhaustive list of DPPI purification, it provides an ample survey of 
some of the techniques employed
1.2 6 B iochem ical C haracteristics
DPPI exists as a 200kDa oligomer Depending on the species, the cDNA generally encode a 
protein of three functional domains, a signal peptide, an unusually long pro-peptide and the 
mature region DPPI is initially synthesised as a single-chain 55kDa pre-proenzyme and is 
converted rapidly to a two-cham form of the mature enzyme Many reports have conflicting 
evidence on the subunit composition Most regard DPPI as a tetramer, each subunit composed 
of three different polypeptide chains, a heavy chain, a light chain and a propeptide part 
However bovine DPPI was found to be composed of eight subunits in the form of two 
tetramers with two different types of subunits (Metnone et a l , 1970)
The enzyme is generally characterised as a glycoprotein Four potential glycosylation sites 
were found in rat DPPI (Ishidoh et a l , 1991), three located in the propeptide region and one 
in the mature enzyme region
The pi of the mature protein ranges from 5 0 to 6 0 It has a broad acidic pH optimum of 
between 4 5 and 7 0 (McGuire, et a l , 1992) This pH range correlates well to that of Wada et 
a l, in 1992 who evaluated that Cathepsin C is located in lysosomes which exist in an acidic 
medium Doienc et a l , 1995, report a pH optimum of 6 0 for their lysosomal proteinase but 
believe it is extremely unstable at neutral pH Wolters et a l , 1998, found activity of mast cell 
DPPI over a broad pH range from 6 0-7 5, which agrees with the conditions required for the 
enzymes ability to activate other mast cell proteases, tryptase and chymase This may occur in 
either the Golgi apparatus or m secretory granules, which are both acidic organelles
1 2  7 C atalytic C lassification  and M echanism  o f A ction
DPPI is universally classified as a lysosomal cysteine peptidase of the papam family Nikawa 
e t a l , 1992 highlighted the enzyme to be inhibited by E-64 and leupeptin, two typical thiol
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blocking reagents Similarly, Green and Shaw, 1981, reported specific inactivation by Gly- 
Phe-diazomethyl ketone, another thiol blocking reagent The enzyme was also inhibited by rat 
stefin A and chicken cystatin, two protein inhibitors of cysteine peptidases
Ishidoh et a l , 1991, deduced that the mouse DPPI sequence contains a distinctive tyrosine 
adjacent to the active site cysteine This tyrosine residue appears to be unique m the papain 
family, of which DPPI is a member, whereby tryptophan usually occupies the position 
adjacent to the active site residue This suggests that the tyrosine motif may play a role in the 
specificity of DPPI In addition, while other cysteine proteases contain an Asn, Gin, Lys or 
Gly residue at position 64, mouse and rat DPPI contain Asp and human DPPI contain Glu at 
this position It is possible that these acidic side-chains may directly interact with the amino- 
terminus of the substrate and contribute to the substrate specificity of the enzyme and the 
requirement for the substrate to have an unblocked amino-terminus All three species encode 
an lie at position 205, which may reside in the cleft that interacts with the P2 amino acid side 
chain of the substrate This could explain the exclusion of peptides with P2 Arg and Lys 
residues as potential DPPI substrates
As the enzyme has four catalytically active subunits, it is a good candidate for allostenc 
regulation (Nikawa, et a l, 1992) Dolenc et al, 1995, report for human DPPI that binding of 
the first substrate molecule to any of the four binding sites has little effect on the affinity for 
the second substrate molecule However increasing the substrate concentration enables the 
enzyme to bind additional substrate molecules The binding of the second molecule reduces 
the catalytic activity of the first site and dramatically decreases the binding affinity for the 
third substrate molecule, exhibiting a large negative co-operativity effect
Cigic and Pam, 1999, discovered that human kidney DPPI is activated by chlonde (Cl) ions 
This activation seemed to be specific and pH dependent The ions involvement in substrate 
binding was confirmed by the decrease in the Michealis-Menton constant, KM upon substrate 
hydrolysis without any significant change in Vmax Lower KM’s for the hydrolysis of simple 
amide substrates show that S sites are involved in catalysis The ion appears to bind close to 
the S2 site while S sites do not seem to have any involvement
However Nagler et a l , 1999, report that DPPI is able to hydrolyse substrates through the
exopeptidase route even in the absence of preferred interactions in the S2 and SI subsites
This is due to specific structural elements in DPPI which serve as an anchor for the C- or N-
terminus of the substrate, allowing a favourable enzyme-substrate interaction independently
of the P2-P1 sequence Therefore the nature of the residue at position P2 of a substrate, which
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is usually the main factor determining the specificity of cysteine proteases of the papam 
family, does not have the same contribution towards exopeptidase activity
Kunbayashi et a l , 1993, report DPPI’s unique endopeptidase ability Cleavage of Z-Phe-Arg- 
MCA, Pro-Phe-Arg-MCA and Suc-Leu-Leu-Val-Tyr-MCA by DPPI required sulphydryl 
reagents and halide ions The enzyme seems to favour less bulky residues such as Gly, Ala, 
Ser and acetyl groups at the S3 or S4 positions The binding pockets at these sites may be 
small or absent due to stenc hindrance in the enzyme structure, excluding the binding of 
peptides to these positions, so that the function of cathepsin C is largely as a dipeptidyl 
aminopeptidase and rarely as an endopeptidase Similarly it is apparent that a binding mode 
other than electrostatic between the enzyme and substrate is important for endopeptidase 
activity, whereas the electrostatic binding energy generated from the free a-amino group of 
the substrate is important for DAP activity
In general, DPPI can hydrolyse most NH2 -  terminal dipeptides expect those with PI or PI 
prolme or an N-termmal Arg or Lys Another catalytic restriction exists when the N-terminus 
is hidden by a conformational change in the target protein
1 2  8 Inhib itors
As previously described, DPPI is classified as a cysteine protease As a consequence, thiol 
blocking agents or inhibitors, E64 and leupeptin have a potent effect on the enzymes 
catalysis, although at tunes very weakly Similarly, Smyth et a l , 1994, report the inhibition of 
the activation of Granzyme B by DPPI via NEM, another thiol protease inhibitor Complete 
inhibition was attained at ImM while \[iM NEM achieved approximately 20% inhibition
DPPI activity can be selectively inhibited by Gly-Phe-CHN2, a peptidyl diazomethane that 
readily penetrates cells and irreversibly inhibits DPPI while not directly impairing the 
function of other granule thiol or senne proteases (McGuire, et a l , 1993) Pham et a l , 1998, 
also inhibited the activation of recombinant munne Granzyme B by DPPI with Gly-Phe- 
CHN2 Although the mechanism of inhibition is not well documented, it may be speculated 
that Gly-Phe-CHN2 could act as a competitive inhibitor
Cigic and Pam, 1999, discovered that DPPI was competitively inhibited by the guamdinium 
ion (Gdm+) which binds to the S sites (see Fig 11) They postulated two main findings as a 
consequence, (i) Gdm+ binds to the enzyme only in the presence of Cl and (n) it exerts an 
opposite effect to Cl on the rate of irreversible inhibition of DPPI It is possible that bound
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Cl forms an essential part of the binding site for Gdm+, creating a favourable electrostatic 
interaction which supplements the hydrogen bonding of the inhibitor to neighbouring residues 
in the S site
Hepain and histamine have also been shown to have an inhibitory effect on DPPI, with the 
latter generatmg an IC50 of 2mM (M°Euen et a l, 1998) Wolters et a l, 1998, investigated the 
inhibition of Ala-Ala-p-nitroamlide hydrolysis by mast cell DPPI They discovered that ImM 
Iodoacetic acid had a 100% inhibitory effect, while 50|ag/ml Cystatin inhibited hydrolysis by 
93% Cystatms are naturally occumng inhibitors of cysteine proteases They inhibit by 
forming tight, reversible complexes with the target enzyme
Horn et a l , 2000, mvestigated the inhibition qualities of the N-terminal cluster of L-argmine 
residues The inhibitory potency of oligoarginmes increases with the elongation of the peptide 
chain, reaching a maximum for octyl-argmine The oligoarginmes competitively interact with 
the active site of DPPI, resulting in K,’s in the region of 1x10 5M
Korver et a l, 2001 recently developed dipeptide Vmyl Sulfones for intracellular DPPI 
inhibition Vinyl Sulfone (VS) compounds are irreversible inhibitors of several cysteine 
proteases and do not react with senne proteases The sulphur of the active site cysteine 
residue of the protease forms a covalent bond with the double bond portion of the VS Leu- 
Phe-VS-CH3 inactivated DPPI m spleemc T-cells with an IC50 of approximately 5\xM The 
inhibitor proved non-toxic with a half-life of 97min at pH 7 5 (extracellular medium) and 
1302min at pH 5 5 (the intracellular environment of DPPI) The inhibitor showed no cross 
reactivity on granzyme nor chymase activity Therefore it appears that this Vmyl Sulfone 
compound may be suitable for investigation of the influence of DPPI m cellular processes 
The inhibitor is highly reactive, non-toxic and able to cross plasma and granule membranes to 
selectively inhibit intracellular DPPI
i j c u t  u c  y  J - c n 3
F ig u r e  i . i  d ip e p t id y l  P e pt id a se  I  in h ib it o r s
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1 3 D ip e p t id y l  P e p t id a s e  n
1 3  1 Introduction
The senne protease dipeptidyl peptidase II (EC 3 4 14 2) was originally discovered from the 
purification of dipeptidyl peptidase I from bovine pituitary glands and was initially referred to 
as dipeptidyl arylamidase II (McDonald et a l , 1968a) The purified enzyme was 
characterised using peptide substrates and its name was changed to dipeptidyl 
ammopeptidase II or DAP II (McDonald et a l, 1968b) The name dipeptidyl peptidase II 
(DPP II) was recommended when the enzyme was included as the second member of the 
dipeptidylpeptide hydrolase subclass (3 4 14 ) The enzyme is generally classified as a senne 
protease with an acidic pH optimum
1 3  2 D istribution
Dipeptidyl Peptidase II is expressed in many tissues, most commonly lysosomes Although 
species variations occur, the highest levels in the rat occur m the thyroid gland where it is 
localised to the secretory epithelial cell lysosomes of the thyroid follicles (McDonald et a l , 
1971) DPPII has been detected cytohistochemically in rat pentoneal and alveolar mast cells 
and macrophages The enzyme is exclusively found in granules or lysosomes in both cell 
types However distnbution seems to be restncted to a subtype of mast-cell granules 
(Struckhoff and Heymann, 1986)
Astrocytic glial cells in pnmary culture from neonatal rat bram express prominent DPPII 
activity levels (Stevens et a l , 1987), as well as histologically in rat bram neurons Mentlein 
and Struckhoff in 1989, punfied two enzymes, a soluble and membrane bound form from rat 
bram homogenate which they named DPPII-S and DPPII-M respectively Both enzymes have 
a pH optimum of 5 5 for the hydrolysis of Gly-Pro and Arg-Pro-mtroamlidides Fukasama et 
a l , 1983 isolated DPPII from rat kidney, suggesting a possible source of ongin as DPPII is 
normally present in both T and B lymphocytes
As well as rat, both mouse and guinea pig were shown to have a wide tissue distnbution of 
DPPII The epididymis of the guinea pig was a particularly nch source Similarly, DPPII has 
been localised histochemically to the acrosomes of guinea pig washed sperm (McDonald et 
a l, 1987) Huang et a l, 1996 isolated DPPII from porcine seminal plasma where it co-exists 
with DPPIV Vanha-Perttula, 1984, report that human seminal plasma DPPII activity occurs 
in both soluble and membrane-bound forms Therefore it is possible that DPPII in seminal 
plasma is derived from the epididymis and seminal plasma
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Despite initially being reported as DPPIV, Eisenhauer and McDonald, 1986 discovered a 
novel DPPII from porcine ovary due to its marked ability to hydrolyse prolyl bonds and its 
optimum activity at pH 5 5 Sentandreu and Toldra, 2001, report the first purification of 
DPPII from porcine skeletal muscle, although it is not particularly abundant there While 
DPPII was initially discovered in bovine pituitary glands it has also been prepared from 
bovine connective tissue (McDonald and Schwabe, 1977)
1 3  3 P hysiological Im portance
As a consequence of dipeptides, m contrast to tnpeptides, having the ability to easily cross the 
lysosomal membrane, DPPII together with DPPIV possibly plays a critical role in returning 
the products of proteolysis to the metabolic pool The acidic pH optimum of DPPII points to a 
localisation in acidic compartments such as lysosomes, secretory granules, and/or parts of the 
Golgi apparatus
DPPII is believed to be involved in the injestive, intrasosomal process of collagen digestion 
Eisenhauer and McDonald, 1986, demonstrated the ability of porcine ovary DPPII to 
complement the action of tnpeptidyl peptidase I (TPPI), in the breakdown of collagen’s a -  
chain TPPI produced poly Gly-Pro-Ala tnpeptides, which were subsequently degraded by 
DPPII
Huang et a l, 1996 report high levels of bovine DPPII activity in reproductive tissues 
including epididymides, testis and ampulla as well as seminal vesicles and seminal plasma It 
is proposed that DPPII, in the epididymal epithelial cells especially, plays an important role in 
digestion of the absorbed polypeptides denved from the maturing spermatozoa
High levels of DPPII m some human carcinoma cells have suggested that the enzyme could 
be a useful marker for malignancy Kamon et a l, 1991, found that DPPII serum levels were 
higher than normal from patients with cancer, rheumatoid arthritis (RA) and systemic lupus 
erythematosus (SLE), while DPPIV levels decreased Therefore the resulting increase in the 
serum DPPE/DPPIV ratio may also be used as a potential diagnostic marker Similarly, DPPII 
activity levels in synovial fluid from patients with rheumatoid arthntis were significantly 
higher than in patients with osteoarthntis As before, a reverse effect was expenenced for 
DPPIV, so agam the DPPII/DPPIV ratio may be of particular mterest That ratio is also 
elevated in the cerebrospinal fluid of patients with Parkinson’s disease, which is pnmanly as 
a result of significant increases in the levels of DPPII, which may be derived from the bram 
(Hagihara et a l, 1987) In conjunction with the presence of DPPII m the connective tissue,
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synovial fluid and osteoblasts, there is a significant lack of detectable DPPII in osteoclasts, 
multmucleate cells which break down the calcified intercellular matrix of bone This may 
reflect a higher rate of secretion from this cell type It still remains elusive why DPPII is 
found to be 6-24 fold higher m various human carcinoma cells than that m normal human 
fibroblasts As many cytokines have N-terminal Xaa-Pro or Xaa-Ala sequences, identification 
of endogenous substrates m each cell type remains to be accomplished for DPPII as reported 
for DPPI (Pham and Ley, 1999)
High levels of DPPII activity have also been reported in cases of muscular dystrophies and 
polymyosites, which are auto-immune disorders m the skeletal muscle, which is damaged by 
the inflammatory process This is probably due to an increase of lysosomal activation 
observed m these diseases
1.3 4 A ssay
DPPII preferentially releases N-terminal dipeptides from oligopeptides, especially tnpeptides, 
and from 2-naphthylamide, amides and methyl esters of dipeptides, provided their N-termim 
are unsubstituted (McDonald et a l, 1968a,b) Almost any residue may reside at the terminal 
P2 position, even though acidic residues are not favourable In general, Ala- and Pro- are the 
preferred residues in the PI position
Lys-Ala-NHNap and Lys-Pro-NHNap appear to produce the highest rates of hydrolysis of the 
naphthylamides by bovine pitutiary DPPII However Phe-Pro, Arg-Pro and Ala-Pro are also 
cleaved but at a lower rate (McDonald et a l , 1968b) DPPII from porcine ovaries optimally 
hydrolyse Phe-Pro at an 8- fold higher rate than Lys-Ala, while Lys-Pro is hydrolysed 4- 
times greater (Eisenhauer and McDonald, 1986) A similar preference for substrates with a PI 
prolyl residue is displayed from porcine seminal plasma as descnbed by Huang et a l , 1996 
where the rate on Gly-Pro-NHMec is twice that for Lys-Ala-NHMec
Activity assays can be performed at pH 5 5 with Lys-Ala-NHNap or Lys-Ala-NHMec as the 
fluorogemc substrate 1,10 phenanthroline is often used to inhibit any interfering 
aminopeptidase activity without affecting DPPII (Nagatsu et a l, 1995) Assays have also 
been performed on a tnpeptide substrate such as Ala-Ala-Ala but only at pH 4 5 The C- 
terminal, smgle amino acid is liberated and can be detected colonmetncally with a 
trmitrobenzene sulfonic acid reagent Copper is added to prevent any reaction between the 
reagent and the peptides, thus significantly increasing the assay’s sensitivity (McDonald et 
al, 1968b)
13
1 3.5, P urification
As DPPII was initially detected in bovine pituitary glands, it was also purified from that 
source (McDonald et a l, 1968b) After fractionation with Ammonium Sulphate, the dialysed 
fraction was applied to a DEAE cellulose column The eluted, pooled fraction was dialysed, 
freeze-dned and applied to an IRC-50 column ‘Dipeptidyl Arylamidase IT did not bind to the 
column but was separated from 95% of the protein This ‘run-through’ peak was subsequently 
applied onto a G200 gel filtration column, where it was purified further and resulted in an 
1125-fold increase in purity
Imai et a l, 1983, purified ‘dipeptidyl ammopeptidase’ from rat bram The chromatographies 
used were, CM-Cellulose column at pH 4 2, and Hydroxyapatite A Gly-Pro-AH-Sepharose 
column was used and the eluted enzyme was dialysed and reapplied to the equilibrated 
column This produced a purification factor of 2,600, however the affinity chromatography 
steps contributed greatly to the enzyme’s overall purity
Mentlein and Struckhoff, 1989, also purified dipeptidyl ammopeptidase II from rat bram but 
discovered both a soluble (DPPII-S) and a membrane-bound fraction (DPPII-M) The two 
fractions were separated after centrifugation, whereby the membrane-bound fraction was 
treated with Tnton X-100 for 12 hours and re-centnfuged Both ‘solubihtates’ were purified 
via a similar protocol using a combination of (i) the anion exchanger, DEAE-Sephacel, (n) 
Affinity resin, Gly-Pro-AH-Sepharose, (111) Sephacryl S-300 gel filtration column, (iv) 
Chromatofocusing with the use of polybuffer 74 and (v) Mono Q, another anion exchanger 
The only difference between the two purification protocols was that the affinity 
chromatography step was omitted for the soluble fraction, even though a reason why is not 
reported However the soluble-fraction was purified 10,490 times, while the membrane-bound 
fraction produced a similarly significant purification factor of 7,720 It must be noted that the 
Mono-Q step seemed to contribute considerably to the purity rate for both fractions
Eisenhauer and McDonald, 1986, purified DPPII from porcine ovary After a 60% ammonium 
sulphate precipitation step, the sample was dialysed and freeze-dried before being purified 
further using various chromatographic techniques The freeze-dned sample was reconstituted 
and applied to an Ultrogel Ac A 34 (LKB) column, followed by concentration and then a 
chromatofocusing resin A Con-A Sepharose resin bound any glycosylated proteins while a 
Mono S cation exchanger column as part of an FPLC system was the last column employed 
This protocol generated a final punfication factor of 1,400
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Huang et a l, 1996, punfied DPPII from porcine seminal plasma The chromatographies used 
were anion exchange, gel filtration, Matrex Gel Red A, metal-chelate with zinc as the 
immobilised metal and Phenyl Hydrophobic Interaction A 1709-fold increase in purity was 
produced with the Zn-chelate chromatography being particularly beneficial in removing 
contaminating protein while maintaining activity This suggests a possible metal or Zn2+ ion 
requirement for enzymatic functionality
Sentandreu and Toldra, 2001, used porcine skeletal muscle as their enzyme source They 
fractionated the soluble extract with 30-50% ammonium sulphate saturation The resulting 
pellet was dialysed and filtered before being applied to a HPLC Resource-Q anion exchange 
column The pool was dialysed, re-filtered, concentrated and re-injected onto the anion 
exchange column and re-eluted with a lmear gradient of 25-500mM NaCl This unusual 
second application onto the anion exchanger was extremely beneficial by increasing the 
purification factor from 131 4 to 1270
DPPII has been punfied from many other sources and tissues, e g rat kidney with a 3,740- 
fold increase m punty (Fukasawa et a l, 1983), pig spleen, 6,300-fold (Lynn, 1991) and 
human kidney, 5,000-fold (Sakai et al, 1987) This highlights the evidence of work that has 
been earned out on DPPII indicating its potential importance
1 3  6 B iochem ical C haracteristics
The molecular mass of native DPPII punfied from a vanety of sources vanes considerably 
Values range from 100 kDa in porcine ovary (Eisenhauer and McDonald, 1986) to 185kDa m 
porcine seminal plasma (Huang et a l, 1996) The latter enzyme proved to be tnmenc, 
however all other reports showed DPPII to be a homodimer, with the two protein chains non- 
covalently associated Imai et a l, 1983, found a rat bram dipeptidyl aminopeptidase whose 
properties were similar to bovine pituitary DPPII but the molecular weight was quite different 
at 220 kDa Nevertheless, DPPII normally exist as 60 kDa subunits that are glycosylated This 
explains the use of Con-A Sepharose desenbed previously during the punfication As a 
consequence, the protein is approximately 2% w/w glycosylated containing mannose and 
glucosamine, but little or no sialic acid (Mentlein and Struckoff, 1989)
DPPII is widely reported as an acidic protease Its pH optimum ranges from 5 5 to 6 3 with 
maximal activity being observed at pH 5 5, therefore allowing possible punfication via either 
anion or cation exchange chromatography without largely affecting activity
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The first 41 residues have been documented (Huang et a l, 1996) suggesting DPPII is 
homologous with lysosomal Pro-X carboxypeptidase and belongs to the S28 peptidase family 
Fukasama et a l , 2001 cloned and expressed rat kidney DPPII and from their predicted 
primary structure, the protein contained six potential N-glycosylation sites Thus they believe 
that the mature protein could contain approximately 14% carbohydrate, however it is probable 
that the COS-7 cells employed for enzyme expression could have affected this percentage
1 3  7 C atalytic  C lassification  and M echanism  o f A ction
Dipeptidyl Peptidase II is universally classified as a senne protease and DPPII from all 
sources is sensitive to the classical inhibitors Eisenhauer and McDonald, 1986 achieve 100% 
inhibition on porcine ovary DPPII with lOmM DFP while ImM PMSF inhibited activity by 
91%, both senne protease inhibitors Mentlein and Struckhoff, 1989, report 75% inhibition 
from 0 ImM DFP on their membrane bound rat brain, DPPII-M while DPPII-S was inhibited 
by over 90% Similarly 1 OmM PMSF reduced DPPII-M and DPPII-S activities by 84% and 
80% respectively Porcme seminal plasma DPPII was affected by DFP and AEBSF 
significantly where 0 5mM of each functional reagent inhibited activity by 93% and 90% 
respectively (Huang et a l , 1996) Sentandreu and Toldra, 2001, report similar inhibitory 
profiles with the sulphonyl fluoride, Pefabloc SC exerting a 76% reduction in activity at 
0 5mM
DPPII is not inhibited by cysteine peptidase inhibitors such as E-64 and p-CMB, indicating 
that there is no -SH group mvolved in the catalytic mechanism Similarly, enzymatic activity 
is not effected by chelating agents EDTA or EGTA, suggesting that the presence of metal 
cations is not necessary (Huang et a l , 1996)
It is evident that the senne residue is necessary for DPPII catalytic activity The enzyme 
seems to possess a catalytic tnad integrated by Ser/Asp/His, which is different to classical 
serine peptidases with a His/Asp/Ser tnad The active site of senne proteases classified in clan 
SC have the unclassical tnad and they also show an a/p hydrolase fold (Rawlings and Barrett, 
1994) Fukasawa et a l , 2001 report both Ser]36 and His4i8 are in the a/p hydrolase fold but 
Asp392 is not Active site Ser]36 exists between the fifth p-sheet and the third a-helix region 
from the N-terminus
Although the substrate specificity and the amino acid residue preference for hydrolysis is well 
documented, little has been reported on the protease’s specific mechanism of action One may 
only predict similar catalytic properties to other enzymes assigned to the same clan SC, such 
as scnnc carboxypeptidase (EC 3 4 16 1)
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1 3  8. Inhib itors
Specific inhibitors of DPPII have not been well documented in the literature McDonald and 
Schwabe, 1980, appears to be the only report of an active-site directed inhibitor, Lys-Ala- 
CH2C1 which provides specific irreversible inhibition This is understandable as the inhibitor 
may serve as a substrate In addition, Mentlein and Struckhoff, 1989, discovered that Z-Lys- 
Pro reduced DPPII-M and DPPII-S activity from rat brain by 62% and 79% respectively, 
suggesting another possible active-site effect Stockel-Maschek et a l , 2000, synthesized 
prolme specific peptidase inhibitors, utilising the influence of the thioxo amide bond, 
incorporated into amino acid pyrrolidides (Pyrr) and thiazolidides (Thia) All compounds 
proved to competitively inhibit DPPII Xaa-Thia was more effective than Xaa-Pyrr on DPPII 
inhibition, however the introduction of a thiocarbonyl bond (\|/[CS-N]) between the P2 and Pi 
amino acids increased the degree of inhibition by approximately, one order of magnitude
DPPII is uniquely sensitive to cations, especially those of high molecular weight e g Tns, 
Puromycin and Hyamine 10-X, which all surprisingly inhibit competitively (McDonald et a l, 
1968a) The effect of small cations on DPPII m mast cells, is of interest, seeing as the mast 
cell intragranular concentration of histamine could be 0 4M and that of Zn2+ 4-20mM 
(Struckhoff and Heymann, 1986) These concentrations may inhibit the enzyme completely 
from this source
Heavy metals, especially Hg2+ are potent inhibitors of DPPII 0 OlmM HgCl inhibited glial 
DPPII from neonatal rat bram by 94% (Stevens et a l, 1987) The effect was shown to be 
reversible once the metal chelator, EDTA was added Other papers have also reported that 
Cd2+ and Cu2+ inhibited DPPII activity (Fukasawa et a l, 1983) These findings indicate that a 
metal-binding region(s) on the DPPII may also be important for regulation of enzyme 
activity
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Properties Brain (R) Kidney (R) Kidney (H) Ovary (P) Seminal Plasma
(P)
Molecular Weight
Gel Filtration 110 000 130 000 150 000 110 000 185 000
SDS-PAGE 52 500 64 000 54 000 61 000
pi 4 2(S), 48 50 6 1
4 2-4 3 (M)
Substrate Lys-Ala-NNap Lys-Ala-NNap Lys-Ala-MCA Phe-Pro-Nnap, Lys-Ala-MCA
Specificity Gly-Pro-NPhN02 Lys-Ala-NNap Gly-Pro-MCA
Km (rM) 87 (S, Lys-Ala-) 555 250 45 (Phe-Pro-) 360 (Lys-Ala-)
210 (M, Lys-Ala) 99 (Lys-Ala-) 1330 (Gly-Pro-)
pH optimum 5 5 55 55 5 5-6 0 60
Inhibitors DFP DFP PMSF DFP DFP
PMSF PMSF Hg2+ PMSF AEBSF
Tns Tns Cu2+ Tns Tns
Na+ Hg2+ Cd2+ Hg2+ r
Cu2+ Cu2+
References Mentlein and Struckhoff, 1989 Fukasawa et a l , 2001 Sakai e ta l, 1987 Eisenhauer and McDonald, 1986 Huang, et a l , 1996
T ab le  1 2 C om parison  o f  D ipeptidyl P ep tid ase II from  variou s sources
R, Rat, H, Human, P, Porcine, S, Soluble, M Membrane-bound
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1 4 D ip e p t id y l  P e p t id a s e  LLI
1 4  1 In troduction
The enzyme was initially discovered in extracts of bovine anterior pituitary glands when a 
range of ammoacyl and dipeptidyl 2-Naphthylamide fluorogenic substrates were employed to 
ascertain the type of peptidases in that tissue (Ellis and Nuente, 1967) Its distinctive action on 
a restricted number of unsubstituted dipeptidyl-2-NHNap substrates, identified it as the third 
in a series of dipeptidyl arylamidases Its name was changed to dipeptidyl aminopeptidase 
III when peptide substrates confirmed its specificity In 1984, IUB recommended the name 
dipeptidyl peptidase III and assigned the EC number 3 4 14 4 This name was hyphenated to 
dipeptidyl-peptidase III in 1992 and abbreviated it to DPPIII Reports of its action before 
its current name was assigned included names such as ‘red cell angiotensinase’ (Kokubu et 
a l, 1969) and ‘enkephalinase B’ (Inaoka and Tamaoki, 1987) which gives an insight into the 
enzymes potential functionality
1 4  2 D istribution
The enzyme is localised generally in the cytosol of many mammalian tissues such as bovine 
pituitary gland, human placenta, lens, erthrocytes and seminal plasma, rat and guinea pig 
brains and porcine spleen
Immunohistochemical staining revealed the widespread distribution of DPPIII in rat organs 
(Ohkubo et a l, 2000) The enzyme was intensely stained in the cytosol of many tissues such 
as hepatocytes in the liver, epithelial cells of distal and collecting tubules in the kidneys, 
transitional cells in the urinary bladder, red pulp in the spleen, cortical and medullary cells in 
the adrenal gland and chonoid epithelium in the cerebrum
1 4  3 Physiological Im portance
The enzymes somewhat broad specificity on peptides, as well as its wide distribution in the 
cytosol of mammalian cells, suggests a general role for this peptidase in the terminal stages of 
intracellular protein degradation and red cell maturation
The ability of DPPIII to cleave peptides such as Substance P, p-lipotropin, Angiotensin II and 
leu-enkephahn from brain suggests that the enzyme may serve to modulate their levels in the 
brain (Hazato et a l, 1984)
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In general, enkephalin-degrading enzymes in the human neutrophils play a vital role in 
inflammation (Hashimoto et a l , 2000) During pregnancy, DPPIII levels increase 12-fold in 
retroplacental serum (Shimamon et a l, 1986) It is possible that DPPIII is synthesized in 
placental cells and released into the maternal circulation As a result, it is speculated that this 
peptidase may contribute to the elevated level of plasma angiotensin-hydrolysing activity that 
exists during pregnancy and may also regulate the level of angiotensin m the cells of origin 
However the data indicates that DPPIII expressed in many tissues may represent one of the 
housekeeping proteins
1 4  4 A ssay
Substrates employed for DPPIII activity is very restricted The enzyme from bovine pituitary 
is limited to Arg-Arg-NHNap (Ellis and Nuenke, 1967) Rat skin DPPIII is capable of 
cleaving Leu-Arg-NHNap but at 44% that of the corresponding Arg-Arg- derivative (Hopsu- 
Havu et a l , 1970) Similarly, the rat liver enzyme showed a moderate rate on Ala-Arg- 
NHNap (Ohkubo et al, 2000) Interestingly no action occurs on any of the DPPI, II or IV 
substrates Therefore its potential to contaminate any of the other dipeptidyl peptidase 
activities is eliminated
b-In general, the enzyme preferentially cleaves dipeptide residues (Arg-Arg, Ala-Arg, Asp-Arg 
or Tyr-GIy) from the ammo termini of oligopeptides or proteins at pH 6-8 (McDonald and 
Barrett, 1986) Its enkephahnase B activity has also been utilised as a substrate The enzyme 
from both rat brain cytosol and membrane can cleave enkephalins at pH 7 4, with Met- or 
Leu-enkephalin employed as the substrate (Inaoka and Tannoki, 1987)
1 4  5 Purification
DPPIII has been purified from a number of the sources in which it is distributed Hazato et 
a l, 1984, purified two DPPIII-like enzymes from monkey brain with an average purification 
factor of 162 Inaoka and Tamaoki, 1987, discovered and purified rat brain enkephahnase B 
with an impressive 9,429-fold increase in purity It is worth noting that both Mono P HR and 
Toyopearl HW-55 appear to contribute significantly to the purification factor achieved 
DPPIII from human placenta was purified 1,775-fold where the majority of contaminating 
protein was eliminated by a hydroxyapatite chromatography step (Fukasawa et a l , 1998) 
Similarly rat liver cytosolic DPPIII was separated by Ohkato et a l, 2000, with a 240-fold 
purification factor Correspondingly recombinant rat liver DPPIII was purified without 
impurities by Li et a l , 2000 They utilised a 1ml GSTrap column with elution achieved by
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incubation with 20 units of a-thrombm while on the column for 16 hours at room 
temperature However a purification factor was not reported for this method
Other sources of DPPII1 purification include human erthrocytes and rat spleen Similarly a 
mammalian DPPIII-like enzyme was purified 91-fold from Scerevmae (Watanabe et a l,
1990)
1.4 6 B iochem ical C haracteristics
Most molecular weight estimates of DPPIII are approximately 80kDa (Imaoka and Tamaoki, 
1987 and Ohkubo et a l , 2000) Hazota et al, 1984, estimated that the two dipeptidyl 
aminopeptidases in monkey bram to have a slightly greater molecular weight of lOOkDa 
However all reports believe DPPIII to be monomeric with a smgle polypeptide chain
The enzymes optimum pH is on average pH 9 0 but depends on the source The pH range at 
which the enzyme is functional is quite wide, pH 6 0-6 5 for rat bram enkephahnase (Inaoka 
and Tamaoki, 1987) to pH 10 for the enzyme from the slime mould, Dictyostehum 
discoideum (Huang et a l , 1992) An isoelectric point range of 4 4-4 6 is reported from human 
erythrocytes (Abramic et a l, 1988) This appears to be the only documentation of the 
enzymes pi value
1.4 7 C atalytic C lassification  and M echanism  o f A ction
Dipeptidyl Peptidase III has been assigned to the SX clan and the S99 family, suggestmg that 
the enzyme is a senne protease This may be due to its potential inhibition by DFP and 
PCMB, two known senne protease inhibitors (Hazato et a l, 1987) However no reports 
descnbe it as such On the contrary, DPPIII has been demonstrated to be a metallo-enzyme by 
inhibition and restoration expenment on the activity utilising metal chelators and metal ions 
Ohkubo et a l, 2000, potently inhibited DPPIII with EDTA and 1,10 phenanthroline They 
deduced from rat liver cDNA that 738 amino acids are encoded Classical metallo-peptidases 
contain the sequence ‘HEXXH’ which provides two ligands for the zinc atom, however rat 
liver DPPIII was found to have a novel zinc-binding motif, ‘HEXXXH’ The enzyme has 
only one Zn2 ' ion in its active site, proved by a zinc-binding study (Fukasawa et a l , 1998)
Fukasawa et a l , 1999 mvestigated the HELLGH motif (residues 450-455) m the sequence of 
rat liver DPPIII by replacing the Glu451 with an alanine or aspartic acid residue and by 
replacing His450 and His455 with a tyrosine residue by site-directed mutagenesis None of the 
expressed mutated proteins exhibited DPPIII activity Furthermore Glu451 seemed to
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constitute the active site as Glu451 mutants had the same zinc contents as the wild-type 
enzyme but the activity was completely abolished Li et a l , 2000 report that the mutation of 
Cys176 to Ala reduced activity by 65-75% that of the wild-type, while the same mutation to 
Gly or Glu eliminated activity completely Therefore, they report that Cys176 is essential for 
DPPIII regulation Nevertheless, it is probable that DPPIII is a metalloprotease regulated by 
SH modification and belongs to family 1 of the clan MA
1 4  8 Inhib itors
A specific, synthesized DPPIII inhibitor has not been reported and possibly has not been 
successfully attempted However, Ac-L-leucyl-L-arginmal, a naturally occurring DPPIII 
inhibitor has been isolated from a bacterium culture filtrate 0 04|ig/ml of this compound 
inhibited rat pancreas DPPIII by 50% (Nishikion et a l, 1986) A similar microbiological 
product, Propioxatins A and B had a potent inhibitory effect on enkephalinase B, with K.’s 
reported as 1 3x10 8M and 1 1x10 7M respectively (Inaoka and Tamaoki, 1987) In addition, 
spinorphin and tynorphin had a potent inhibitory effects on human neutrophil DPPIIFs 
enkephalinase activity with IC50’s of 4 2 and 0 029jug/ml respectively (Hashimoto et a l , 
2000)
All other inhibitors tested only inhibit the enzyme’s functionality and are not substrate 
analogues Some of these inhibitors include EDTA and phenanthroline as mentioned 
previously as well as DCI and NEM
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1 5 D ip e p t id y l  P e p t id a s e  IV
1 5  1. In troduction
Dipeptidyl Peptidase IV (DPPIV) activity was first reported as glyclyproline 
naphthylamidase m rat liver during a commercial preparation of acylase I by Hopsu-Havu 
and Glenner (1966) and has been named dipeptidyl aminopeptidase IV (DAPIV) and/or 
post proline dipeptidyl peptidase IV m early work (Yoshimoto et al , 1978) Smce the 
amino acid sequence Gly-Pro is frequently found in collagen, a possible metabolic 
significance m collagen metabolism was proposed However the enzyme is unable to cleave 
Pro-Pro of Pro-Hyp bonds which usually follow the Gly-Pro sequence in collagens, and 
therefore the physiological functions of DPPIV remained obscure By virtue of the enzyme’s 
predominant localisation in the brush border of small intestine and kidney proximal tubules, it 
was initially suggested that DPPIV participates in the metabolism and the uptake of proline- 
containmg peptides in tissues (Tiruppathi et a l, 1990) DPPIV has been reported to be 
identical to CD26, the surface marker on T- and B-lymphocytes and as an adenosine 
deaminase (ADA) -binding protein and is often referred to as such DPPIV is a member of 
the peptidase family S9b, which along with prolyl endopeptidase (PEP, S9a) and 
acylaminoacyl peptidase (S9c) form the prolyl oligopeptidase family It is also the fourth 
member of the Dipeptidyl Peptidase sub-group and is assigned the enzyme classification 
number EC 3 4 14 5
1 5  2 D istribution
Most vertebrate tissues contain the enzyme, but the activities often vary As the enzyme 
properties and the therapeutic potential are increasingly being investigated, the reported 
sources of the enzyme are similarly increasing In addition, the protease was been cloned and 
expressed in many bacterial and cellular systems
DPPIV is exceptionally concentrated in the kidney It is located primarily in the cortex and is 
reportedly abundant in both brush-border and microvillus-membrane fraction m its 
membrane-bound form As a result, many researchers have isolated the enzyme from kidney 
and found a Gly-Pro-X cleaving peptidase that could also hydrolyse Z-Gly-Pro-Leu-Gly-Pro 
Yoshimoto and Walter in 1979 utilised lamb cortical kidney tissue as their source, while 
Tiruppathi et a l, 1990, compared the hydrolysis of proline-contaimng peptides in the kidney 
of DPPIV positive and DPPIV-negative rat De Meester et al in 1997 employed rabbit kidney 
cortex to isolate DPPIV for inhibition studies Even Wagner et a l, 1999, isolated the enzyme 
from ostrich kidney
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In the liver, the enzyme is primarily located m cell membranes around the bile canalicular 
domain of hepatocytes and in the bile duct epithelia Wang et a l, 2001, investigated the effect 
of an anti-inflammatory drug on an enzyme from rat liver which proved to be DPPIV Rat 
liver was also the source for Dobers et a l , 2000 during their investigations mto DPPIV’s 
proteolytic activity They used transfected Chinese hamster ovary cells to express ‘modified’ 
DPPIV Ohta et al, m 1992 examined the specific activity of DPPIV in both the uterus and 
ovary of mice during the estrous cycle They noticed a change in activity only in the uterus 
with it low at estrus and high at diestrus
One research group has earned out significant work on highlighting the presence of a soluble 
form of DPPIV in guinea-pig bram O’Connor, McGovern and O’Cuinn m 1985, initially 
identified a particulate ‘post-prohne dipeptidyl aminopeptidase’, while Smyth and O’Cuinn m 
1994, confirmed DAPIV m the synaptosomal membrane and microsomes However DPPIV 
was also found in the cytoplasm of guinea-pig bram indicating that the enzyme can exist in a 
soluble form (Gilmartin and O’Cuinn, 1999) As a consequence, DPPIV can also be found in 
many mammalian body fluids, such as plasma, urine and seminal fluid as well as on a vanety 
of epithelial and endothelial cells In 1982, Puschel et a l , reported the presence of DPPIV in 
human placenta, where they found particularly high enzymatic levels in the microsomes In 
the hematopoietic system, DPPIV was identified as the activation antigen, CD26 Using this 
knowledge, De Meester et a l , 1992 isolated DPPIV/CD26 from human penpheral blood 
mononuclear cells Duke-Cohen et a l , 1995, obtained a homogeneous preparation of soluble 
serum DPPIV but found that it has no homology with recombinant soluble CD26 However 
Iwaki-Egawa et al, in 1998 also investigated human serum DPPIV and discovered no 
difference enzymatically with human kidney membrane-bound DPPIV This mcludes its 
ability to bind adenosme deaminase (ADA) which Duke-Cohen’s group claim otherwise This 
may be explained by the fact that only 95% of serum DPPIV activity is associated with a 
protein with ADA-binding properties DPPIVp was found on certain human T-cell lines and 
is similar to DPPIV but lacks an ADA-binding capacity (Blanco et a l , 1998) In addition, 
DPPT-L, which is rapidly expressed on activated T-cells, can mediate an interaction with 
monocytes and has been called attractin Attractm also can not bind ADA
Despite reports on this DPPIV-like activity, the DPPIV enzyme continues to be released into 
body fluids where it can have a potent effect, such as seminal plasma Ohkubo et a l , 1994 
analysed the enzyme from porcine seminal plasma while De Meester et a l , 1996 and Lambeir 
et a l , have reported on the corresponding human form
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Although not as frequently reported as that from mammalian sources, DPPIV has also been 
analysed m bacterial systems such as Flavobacterium memngosepticum  although its 
biochemical properties are different to the mammalian enzyme (Yoshimoto and Tsuru, 1981) 
However Koreeda et a l , m 2001 report the isolation of DPPIV from oral bacteria Prevotella  
loeschen  ACTCC 15930 and found the enzymes characteristics very similar to the 
corresponding mammalian enzyme
1 5  3 Physiological Im portance
Dipeptidyl peptidase IV has a dual function as a regulatory protease and as a binding protein 
Since its discovery over 30 years ago, due to its unique ability to liberate Xaa-Pro or Xaa-Ala 
dipeptides from the N-terminus of regulatory peptides, many more examples are emerging 
from both in vitro  and in vivo  studies Despite the minimal N-terminal truncation by DPPIV, 
many mammalian peptides are inactivated, either totally or only differentially, for certain 
receptor subtypes The modified peptides then generate a different physiological response 
once bound to the receptor
DPPIV’s considerable presence in the brush border localisation of the small intestine and 
kidney contributes to the absorption and/or recycling of proline containing peptides 
Tiruppathi et a l , 1993 fed DPPIV deficient rats a high proline diet and discovered that they 
lost weight compared to normal rats, whose expression of intestinal brush border DPPIV 
increased dramatically Wagner et a l , 1999, made a similar finding for the catalytic properties 
of ostrich kidney DPPIV, with higher Kcal values than the mammalian enzyme A possible 
explanation may be, due to the fact that re-absorption and assimilation of proline containing 
dipeptides in the kidney is very important because of the low nutritional values in the food of 
the ostrich diet in and conditions
DPPIV’s immunological role has become obvious since its presence on the surface of human 
penpheral lymphocytes was demonstrated (Schon et a l , 1984) In addition, it is concluded 
that the T-Iymphocyte surface antigen, designated CD26 and a leukocyte activation marker 
(Tpl03) were in fact DPPIV (Hegen et a l , 1990) These activation properties cause mitogenic 
interaction and results in lymphocyte differentiation and increased cytokine production 
Although it is known that activation molecules do not need to be targeted directly to the 
active site of DPPIV, it is suggested that enzymatic activity may be required for signal 
potentiation (Reinhold et a l , 1994) As well as activatmg cytokine production, DPPIV’s 
regulatory functionality is also possibly involved in the hydrolysis of susceptible cytokines 
Hoffmann et a l, in 1993 demonstrated that oligopeptides with sequence analogous to the N-
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terminal part of human IL-lp, IL-2, TNF-p and munne IL-6 were hydrolysed by DPPIV 
However the intact recombinant cytokines remained stable in vitro due to the longer chain 
length However it is speculated that possibly the hydrolysis requires one or more preceding 
endo-proteolytic steps Gutheil et a l , 1994 highlighted the binding ability of DPPIV to the 
HTV-1 Tat protein which suppresses antigen induced activation of T-cells The protein bound 
to both cell surface and soluble forms of DPPIV The high affinity of Tat for DPPIV indicates 
its influence in antigen-specific T-cell activation and makes the enzyme a plausible receptor 
for Tat’s immunosuppressive activity DPPIV/ADA binding has already been discussed, 
however the physiological significance of this process is of potential importance Severe 
depression is accompanied by immune-inflammatory alterations, such as higher levels of 
positive acute phase proteins and increased production of some interleukins and soluble 
interleukin receptors Serum DPPIV and ADA levels were measured in patients with minor 
and major depression DPPIV activity was significantly lower in major depressive than minor 
or normal controls, thus reflecting an involvement in an immune system disturbance m 
depressed patients (Elgun et a l, 1999) In addition, serum DPPIV activity is coupled to an 
increased number of CD4+ T-cells in depressed subjects (Maes et a l , 1997) Maes et a l , 
2000, explored serum DPPIV levels in cancer patients receiving treatment with interleukin-2 
(IL-2) and interferon alpha (IFNa) They discovered that DPPIV activity in serum was 
surpressed significantly when treatment with IL-2 with or without IFNa was earned out 
Dunng these treatments, IL-6 and IL-2R levels were elevated Similarly Van West et a l , 
2000, found significantly lower DPPIV activity in patients with anorexia nervosa and bulhmia 
nervosa than in normal controls It is hypothesised that a combined dysregulation of DPPIV 
and neuroactive peptides, which are substrates of DPPIV could be an integral component of 
eating disorders In contrast, DPPIV activity levels were seen to increase in the sera of 
osteoporotic patients (Kamon et a l , 1991) The increase in activity paralleled the seventy of 
osteoporosis DPPIV is also implicated in the degradation of peptides denved from collagen 
Thus the results obtained are interpreted as being an indication of increased collagen 
breakdown m the bones of patients with osteoporosis It should be noted that DPPIV activity 
decreases significantly with age and the enzymes activity is lower in woman than in men 
which should be accounted for in any clinical tnal employed (Dunnx et a l , 2001)
Dipeptidyl peptidase IV has been widely reported as being expressed in healthy, benign and 
malignant cells This has led to the enzyme being desenbed as a useful tumour burden 
marker Squamous-cell lung carcinomas showed significantly higher DPPIV levels (Sedo et 
a l , 1991) The enzyme was investigated to see if it could be useful to assess the pattern of 
heptocellular surface polanty in liver sections with vanous carcinomas (Stecca et al 1997)
26
In normal liver, DPPIV was confined to the bile canalicular plasma membrane However the 
distribution pattern of DPPIV was altered in all heptacellular carcinomas Three different 
patterns were observed, (1) canahculi were distorted and convoluted and contained 
abnormally high DPPIV activity, (11) Canalicular activity was lost and enzymatic activity was 
restricted to isolated spots, and (111) Pseudoacinar structures of hepatocytes with both 
basolateral and apical DPPIV expression appeared Therefore DPPIV is a useful bile 
canalicular enzyme to assess the functional polarization of hepatocytes Cordero et a l, 2000, 
measured the serum soluble CD26 levels in preoperative coloretal carcmoma patients They 
found over a 2-fold decrease in CD26 activity in the cancer patients, which suggests that 
sCD26 may be a prognostic variable of early carcmoma patients In contrast, Wilson et a l, 
2000, measured a 2-fold mcrease in DPPIV activity in primary human prostate cancer A 
similar mcrease was observed in benign prostatic hyperplasia (BPH) This mdicates that there 
may be some local factors produced by cancer cells that influence adjacent BPH epithelial 
cells to positively affect the immediate growth environment of the cancer Plasminogen (Pg) 
activation is involved m the proteolytic degradation of extracellular matnx components 
during malignant cell metastasis Gonzalez-Gronaw et a l, 2001, reports that the Pg type-2 
receptor m prostate tumour cells is compared primarily of DPPIV, adding another possible 
role for the enzyme not only in cancer but also indicates a significant general physiological 
role
P eptide N -T erm inus A m ino A cids
Peptide YY Tyr-Pro-Ile-Lys-Pro-Glu-Ala- 36
Neuropeptide Y Tyr-Pro-Ser-Lys-Pro-Asp-Asn- 36
Substance P Arg-Pro-Lys-Pro-Gln-Phe-Phe- 11
ß-Casomorphin Tyr-Pro-Phe-Pro-Gly-Pro-Ile-OH 7
GIP Tyr-Ala-Glu-Gly- 42
GLP-1 (7-36) amide His-Ala-Glu-Gly- 30
Endomorphin 2 Tyr-Pro-Phe-Phe-NH2 4
CRP(201-206) Lys-Pro-Gln-Leu-T rp-Pro-OH 6
IGF Gly-Pro-Glu- 70
Enterostatin Val-Pro-Asp-Pro-Arg-OH 5
T a b l e  1 3. Som e P eptides that can be cleaved by D PPIV
Abbreviations used GIP, glucose-dependent msuhnotropic polypeptide, GLP-1, glucagon- 
like peptide, CRP, corticotrophin releasing peptide, IGF, msuhn-hke growth factor
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1 5  4 A ssay
DPPIV can cleave N-terminal dipeptides from substrates consisting of three or more ammo 
acid residues or dipeptides linked to C-terminal chromogemc or fluorogenic compounds such 
as 2-naphthylamides or methylcoumann amides The enzyme preferentially cleaves substrates 
containing the sequence Xaa-Pro-Yaa The Pro residue can be substituted by an Ala or a 
hydroxyprohne although the rates of hydrolysis for these substrates are often 100 to 1000-fold 
lower than that for the corresponding Pro containing substrate (Hems et a l , 1988) The 
identity of the N-terrmnal residue (P2) of the substrate is not important for enzymatic activity, 
although it must have a free amino group (Yoshimoto et a l , 1978) The restrictions on DPPIV 
substrate hydrolysis is that Pro or hydroxyprohne can not be situated at the PI position and 
that the PI-PI bond must be in the trans configuration (Puschel et a l, 1982)
Gly-Pro- is normally the dipeptide attached C-terminally to a compound that can be measured 
and quantified either spectrophotometncally or fluonmetncally Hopsu-Havu and Glenner, 
1966 employed naphthylamide (NNap) while Natatsu et a l, 1976 measured liberated para- 
mtroaniline (NHPhN02) photometrically Para-mtroamhne has subsequently been abbreviated 
to NH-Np or pNA Both compounds are still utilised but with the advance of analytical 
technology, 7-amido-methyl coumann (AMC/MCA) is being increasingly employed to 
provide a very sensitive fluonmetnc assay
Modification of the backbone of biologically active peptides has become ever more important 
in the design of analogues possessing greater potency and enzymatic stability Some 
researchers have attempted to synthesize modified substrates to possibly create better active 
site binding affinities Schutkouski et al in 1994 synthesized substrates containing a 
thioxoaminoacyl (C-S) -prolyl peptide bond They compared the kinetics of DPPIV from 
porcine kidney on two substrates, the normal Ala-Pro-NH-Np and Ala-\f/[CS-N]-Pro-NH-Np 
They discovered that the modified derivative generated a specificity rate constant of 100- 
1000-fold lower than that compared to the unmodified substrate This may be due to the fact 
that the thioxo-carbonyl bond (C=S) is longer than the amide (C=0), where = indicates a 
double bond Similarly, thioxo peptides display a higher barrier of rotation about the C-N 
bond This may be a result of the larger covalent and van der Waals radius of sulphur, 
restricting the <|>,v|/ angles m the vicinity of the thioxo amides
The hydrolysis of the assay substrate selected is dependent on the source of enzyme and the 
substrate choice should be optimised as such To highlight this, rat liver DPPIV catalysis was 
tested on some prolyl and alanyl dipeptide naphthylamides The relative hydrolysis rates are
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Gly-Pro-NNap 100, Phe-Pro- 167, Arg-Pro- 126, Gly-Ala- 2 5 and Arg-Ala- 5 8 
(McDonald et a l , 1971)
1.5 5 P urification
DPPIV is widely distributed in a variety of aforementioned species and tissues Smce it is 
most enriched in kidney, liver and blood, it has been purified to homogeneity from these 
tissues The intact membrane form is usually separated from soluble form by centrifugation, if 
both co-exist in that source The membrane-bound form is then prepared by solubilisation 
with Triton X-100 and low pH This stage itself may generate a 25-fold increase m purity 
when purifying from kidney (Seidel and Schaefer, 1991) The anion exchanger, DEAE is the 
most common resm employed when manipulating the enzymes pi and surface charge 
However the cation exchange resm CM-Cellulose has also been used in tandem with anion 
exchanger to good effect (Kenny et a l , 1976 and Yoshimoto and Walter, 1977) 
Interestingly, a metal chelate column with Cu2+ as the metal ligand was employed to purify 
ostrich kidney resulting in a 10-fold mcrease in purity from that resm alone (Wagner et al, 
1999) Another resin that could be ‘unique5 to DPPIV at the correct pH is Gly-Leu affinity 
and Gly-Pro-EAH-Sepharose, although the increase in purity was not significant (Shibuya- 
Saruta et a l, 1996 and Seidel and Schaefer, 1991) The latter research group also utilised the 
lectin affinity, Concanavalm A-Sepharose resin, which is used widely for both membrane- 
bound and soluble DPPIV (Duke-Cohan et a l, 1995)
Hydrophobic Interaction Chromatography is not used often as a purification tool, but when it 
is, it proves very effective Gilmartin and O’Cuinn, 1999, utilised Phenyl Sepharose as part of 
the purification process of soluble DPPIV from guinea-pig brain Likewise Iwaki-Egawa et 
a l, 1998, employed Butyl-Topearl 650S to significant effect by achieving an overall 
purification factor of 14,400 for human serum DPPIV Gel Filtration Chromatography is 
another technique that is utilised less than expected The resm pore sizes employed range 
from G150 for Fmenmgosepticum (Yoshimoto and Tsuru, 1981) to S300HR for human 
serum DPPIV (Iwaki-Egawa et a l, 1998)
Although the standard chromatographic techniques mentioned previously contribute 
considerably to the overall purification of the enzyme, the affinity resins report the greatest 
purification factors De Meester et al, in 1996 used adenosine deaminase (ADA) immobilised 
onto CNBr-activated Sepharose and manipulated DPPIV-AD A binding properties from 
human seminal plasma to purify the enzyme Shibuya-Saruta et a l, 1996, achieved the 
highest purification observed of 18,000 with use of a monoclonal antibody, Tal bound to
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EAH-Sepharose 4B, when purifying human serum DPPIV. However a resulting yield of 2.2% 
might suggest that active-site binding may reduce the lifetime of the enzyme.
Structure
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F ig u r e . 1.2. Schem atic representation o f  D PPIV /C D 26.
The main structural features are listed on the left side along with a vertical bar, which highlights the 
primary structure and shows the active site residues as well as the speculated borders o f the 
extracellular domains. For the catalytic domain, an a/p  protein fold is hypothesized (top): a core a /p  
sheet comprising eight strands (arrows), linked by helices (cylinders) and loops (lines). The dotted lines 
indicate possible insertions and the catalytic residues are situated on loops. Figure reproduced from De 
Meester et al., 1999.
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1 5  6 B iochem ical C haracteristics
As expected, DPPIV’s biochemical characteristics and properties vary depending on the 
species and/or the tissue of origin However all reports agree that DPPIV cDNA predict a 766 
ammo acid type II transmembrane protein anchored to the lipid bilayer by a smgle 
hydrophobic segment located at the N-terminus with a cytoplasmic tail of only 6 ammo acids, 
(FIGURE 12) The extracellular enzyme consists of 738 amino acids (Lambeir et a l, 1997) 
The extracellular portion can be divided into three sections, a heavily glycosylated membrane 
proximal region (residues 47-323), a cysteine-nch region which contains 10 of the 12 
cysteines present in the enzyme (residues 290-552), and a catalytic domain at the C-terminus 
(residues 553-766)
The enzyme is generally reported as a dimer of varying molecular weight but an average of 
240kDa for membrane-bound DPPIV is observed with a subunit, monomeric weight of 100- 
130kDa Soluble DPPIV consists of a similar native and monomeric weight, however porcine 
seminal plasma DPPIV has been reported as a 3 lOkDa tnmer (Ohkubo et a l , 1994) Bacterial 
DPPIV appears to be a considerably smaller enzyme with a native molecular mass of 160kDa 
compared to 75-80kDa monomers (Yoshimoto and Tsuru, 1981, Ogasawara et a l, 1996 and 
Koreeda et al, 2001)
The pH optimum of DPPIV depends on the substrate used but is reported as approximately
8 0 It appears that whether the enzyme is soluble or membrane-bound has no apparent effect
on its pH optimum Lamb kidney DPPIV cleaved Gly-Pro-Nnap optimally at pH 7 8
(Yoshimoto and Walter, 1977) as did soluble DPPIV from guinea-pig brain when hydrolysing
Gly-Pro-MCA (Gilmartm and O’Cuinn, 1999) The highest pH optimum observed was from
human lymphocytes at pH 8 7 (De Meester et a l, 1992) when Gly-Pro-NA was the substrate
pH stability is another parameter considered as a useful enzymatic characteristic Human
placenta DPPIV maintained activity at room temperature from pH 6-12 However under the
same conditions, the enzyme lost 10% of activity at pH 4 0, while being completely
inactivated at pH 3 0 (Puschel et a l, 1982) Duke-Cohen et a l , 1995, found that weak acidic
conditions to be detrimental to human serum DPPIV activity Porcine seminal plasma DPPIV
experienced a similar effect with activity remaining stable from pH 5 5-9 5 pi values of 3-5
have been reported, pointing more to a heterogeneity of pi values for the enzyme Puschel et
a l, 1982 report multiple pi forms of human placenta DPPIV of pH 3-4, however after
treatment with sialidase, the isoelectric points shifted to pH 5-5 5, indicating that the enzyme
is a neurammic-acid-contaimng glycoprotein De Meester et al, 1992, determined a pi of 5 0
for human lymphocyte DPPIV however it must be noted that tins pi value was generated via
chromatofocusing which may lead to inaccuracies due to the volume of sample needed for pH
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measurement One of the mam biochemical distinctions between eukaryotic and prokaryotic 
proteases may be their isoelectric points This is highlighted by the enzyme isolated from 
Flavobactenum memngosepticum, with a reported pi of 9 5 (Yoshimoto and Tsuru, 1981), 
which is a common trend among prokaryotes However the corresponding Pseudomonas 
enzyme showed a comparatively lower pi of 5 4, indicating that the distinction drawn 
between the mammalian and bacterial enzyme may also depend on the species that it is 
isolated from
Temperature optimum is a parameter that is often utilised but it does not solely depend on the 
enzyme as substrate hydrolysis is also required to measure this property Mammalian DPPIV 
would be expected to have a temperature optimum of approximately 37°C, while all assays 
are normally earned out at this temperature However the enzyme may remain stable at 
temperatures greater than this and often their optima may also be greater as a consequence, 
e g ostnch kidney DPPIV showed an optimum at 45°C for Gly-Pro-pNA-tosylate (Wagner et 
a l, 1999) Lamb kidney DPPIV showed an even greater optimum of 60°C while the 
corresponding bactenal enzyme from F memngosepticum hydrolysed optimally at 45°C also 
(Yoshimoto and Tsuru, 1981) This temperature for bactenal DPPIV was confirmed by 
Ogasawara et a l , 1996 with 40-50°C being the optimum for Pseudomonas DPPIV
Kinetic studies can often reveal important properties about an enzyme and allow accurate 
distinctions to be made The chromophore or fluorophore attached to the dipeptide greatly 
influences the rate of hydrolysis Human placenta DPPIV hydrolysed Gly-Pro-2-Nnap 
generating a Michealis-Menton constant (KM) of 0 2mM This rate was halved when the 
substrate was prepared with 2% ethanol The KM value decreased by almost an order of 
magnitude at 0 018mM when Gly-Pro-4-methoxy-2-Nnap was used (Puschel et a l, 1982) 
Ostnch kidney DPPIV produced similar kinetics for Gly-Pro-pNA with a KM of 0 11 ImM, 
however when the dipeptide was changed to Arg-Pro, the constant decreased to 0 0784mM, 
suggesting a potential greater affinity for the latter dipeptide (Wagner et a l, 1999) Bactenal 
DPPIV show little differences in kinetics to its mammalian counterpart The Flavobactenum 
enzyme hydrolysed Gly-Pro-pNA with a KM of 0 1 mM (Yoshimoto and Tsuru, 1981) This 
was mcreased to 0 142mM for the Pseudomonas enzyme also when using Gly-Pro-pNA 
(Ogasawara et al, 1996) Prev loeschen DPPIV cleaved Gly-Pro-MCA with a dissociation 
constant of 0 2mM This was considerably greater than that for Lys-Pro-MCA, which 
generated a Km of 0 05mM (Koreeda et a l, 2001) This suggests that DPPIV hydrolyses X- 
Pro-Y peptides exclusively
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1 5  7 C atalytic C lassification
DPPIV has been mechanistically classified as a serine protease due to its inhibition by DFP 
and its resistance to sulphydryl blocking agents and chelators The enzyme is a member of the 
S9 family where the active site Ser, Asp and His residues has been identified All members of 
this family contain the active site residue within 130 amino acids of the C-terminus with the 
membrane-spanning domains near the N-terminus (Rawlings and Barrett, 1994) The linear 
order of the catalytic triad in this family of peptidases is Ser-Asp-His (nucleophile-acid-base), 
an arrangement not common for ‘classic5 senne-type peptidases such as trpsin or 
chymotrypsm-like enzymes but characteristic of clan SC enzymes The active site Ser63o of 
human CD26 is surrounded by Gly-Trp-Ser63o-Tyr-GIy-Gly-Tyr-Val, which corresponds to 
the motif Gly-X-Ser-Y-Gly proposed for these peptidases (De Meester et a l, 1999) The 
exact positions of the catalytic triad residue may vary slightly for every species, however 
munne DPPIV displays a triad of Ser624, Asp7o2 and H1S734 The general catalytic triad 
reported is Ser63o, Asp708 and H1S740
DPPIV is inhibited by classical senne protease inhibitors especially DFP, an 
organophosphate 0 ImM DFP achieved an IC50 on human placenta DPPIV while 0 5mM 
completely inhibits the enzyme Another organophosphate, Bis-(4-nitrophenyl) phosphate 
reduces activity to 36% at 0 ImM (Puschel et a l, 1982) DFP reduces human lymphocyte 
DPPIV activity to 3% at ImM while ImM PMSF inhibits by 47% (De Meester et a l, 1992) 
Similarly ImM PMSF has a 55% inhibitory effect on porcine seminal plasma 0 ImM DFP 
reduces activity to 13% while ImM almost completely inhibits the enzyme to 1 4% activity 
remaining (Ohkabo et a l, 1994) Surprisingly 14mM DFP is required to reduce human serum 
DPPIV to 1%, while ImM PMSF only has 16% inhibitory effect (Shibuya-Saruta et a l, 
1996) Bacterial DPPIV follow a similar trend, with 0 ImM DFP completely inhibiting 
Pseudomonas DPPIV, while 1 OmM PMSF reduces activity by 40% (Ogasawara et a l, 1996) 
Similarly 5 OmM DFP has a 100% inhibitory effect on the Prevotella loeschen enzyme and 
5 OmM PMSF reduces activity by 70% This may imply that phenylmethylsulphonylfluonde 
inhibits senne proteases less potently or via a different mode to the organophosphate, DFP
1 5  8. M echanism  o f A ction
In general the action of senne proteases follow a predefined mode Firstly acylation results in 
the transfer of an acyl moiety (RCO-) of the substrate to the enzymes senne group Secondly 
via deacylation, imidazole activates a water molecule by general-base catalysis leading to 
formation of a tetrahedral intermediate, which in turn breaks down by expulsion of the 
enzyme via imidazolium-catalysed protonation, leaving an acidified product (Fink, 1987)
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As DPPIV belongs to the Prolyl Oligopeptidase subfamily of senne proteases, the a/(3- 
hydrolase fold has been predicted for its catalytic domain This a/p hydrolase domain is 
covalently bound to the upper face of a seven-blade p propeller domain of 50 residues and 
four-stranded anti-parallel p sheets Substrates enter via the central pore of the propeller lower 
face to reach the large catalytic pocket formed by both domains at their interface Although 
the exact mechanism of action for DPPIV substrate hydrolysis is not well documented, it is 
proposed to be similar if not identical to that of prolyl oligopeptidase Therefore the first and 
last of the 7-bladed propeller are not closed This opening allows access via its central tunnel 
to the active site Substrates may then enter and are selected by their size and the specificity 
of the enzyme’s active site (Fulop et a l, 1998)
The formation of cysteine bndges has an important impact on the correct folding of proteins 
Incorrect folding leads to retention in the endoplasmic reticulum and the misfolded proteins 
are degraded DPPIV has a cysteine rich domain that is responsible for the binding of 
collagen I and extracellular ADA Dobers et al, 2000, earned out point mutations on all 12 
cysteine residues in DPPIV, 10 of which are present in the cysteine rich domain Five Cys 
residues were mutated to Glycine, i e C299, C326, C383, C455 and C650 while seven were 
mutated to senne, C337, C395, C445, C448, C473, C552 and C763 They discovered that 
C326G, C337S, C445S, C448S, C455G, C473S and C552S are essential for correcting 
folding, intracellular trafficking and therefore for normal biological functionality Leu294 and 
Val341 was also found to be required for ADA bindmg (Abbott et a l , 1999)
The specificity of DPPIV’s substrate hydrolysis is quite conserved Dipeptides are N- 
terminally liberated with Pro or Ala at position PI Certain peptides with other small ammo 
acids in the PI position are cleaved at low rates (See FIG 13) In the P2 position, bulky, 
hydrophobic or basic amino acids with an obligate free ammo group are preferred Peptides 
with Pro or Hyp in the PI position are not cleaved by DPPIV, while the preferential residues 
for this position are not fully known
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1 5  9 Inhibitors
Specific inhibitors are often substrate analogues that possess a high affinity for the enzyme’s 
active site, therefore binding reversibly or irreversibly and preventing enzymatic activity 
Active site-directed inhibitors such as DFP and PMSF serve to ascertain the catalytic 
classification of the enzyme, however specific, substrate analogue inhibitors ultimately may 
play a role m identifying the physiological effect of the peptidase Thus many DPPIV specific 
inhibitors have been synthesised and their effect measured both enzymatically and 
physiologically
Demuth et a l , 1988 investigated the inactivation of DPPIV by N-peptidyl-O-aroyl 
hydroxylamines, which can act as mechanism-based inhibitors of serine and cysteine 
proteases Mechanism-based inhibitors operate via two possibilities, (i) Catalytic attack 
causes the formation of an acyl enzyme which deacylates more slowly than the natural 
enzyme-product complexes The mhibitor-enzyme complex is formed covalently with the 
active site nucleophile, but without damaging the target protein or (u) catalytic attack causes 
the formation of latent chemically-reactive intermediates, which form stable covalent bonds 
with different functional groups within or near the active site, thus leading to an irreversibly 
modified protein A comparison of the turnover values for different Xaa residues in the P2 
position demonstrated that the more hydrophobic or longer the side chain of the amino acid, 
the more successfully DPPIV was inactivated For example, the rate of inactivation between 
the Gly-Pro- and Lys(Z)-Pro- derivatives enhanced by two orders of magnitude for the latter 
compounds
Flentke et a l , 1991 examined the role of DPPIV in T-cell function with the use of Xaa- 
boroPro dipeptides, where boroPro is the X-amino boronic acid analog of prolme (See FIG 
15 8 below) Pro-boroPro inhibited DPPIV with a K, of 3nM while Ala-boroPro generated
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an inhibition constant of 2nM As expected, blocking the N-terminus of Ala-boroPro 
completely abolished its affinity for DPPIV Similarly removal of the N-terminal residue to 
give boroPro reduced its affinity by 5 orders of magnitude Gutheil and Bachoichin, 1993 
investigated this molecule further by fractionating L-Pro-DL-boroPro into it component L L 
and L-D diastereomers and analysed their binding to DPPIV The l-l diastereomer is the most 
potent inhibitor with a K, of 16pM The l d isomer binds 1,000 tunes weaker than the l l with 
a 200-fold weaker inhibition constant The dipeptide boronic acids exhibit slow, tight binding 
kinetics
Li et a l, 1995 synthesised a series of ammoacyl pyrrohdine-2-nitnles (Xaa-Pyrr-2-CN), in 
which the carbonyl group of prolme is replaced by a mtnle group (FIG 14) They 
investigated the mtnle’s effect on DPPIV and discovered that they are potent and stable 
inhibitors of the enzyme Denvatives were tested with the ammo acid at position P2 varied 
Arg-Pyrr-2-CN inhibits DPPIV with a K, of 0 37fim, however when the bulky PMC 
guanidino blocking group was introduced, Arg-(PMC)-Pyrr-2-CN inhibits even further with a 
Kj of 0 19|im, while PMC represents 2,2,5,7,8-pentamethyl chroman-6-sulfonyI This increase 
in inhibition is expected due to the enzyme’s preference for bulky, hydrophobic residues at 
position P2 The nitnles are presumed to react with the active site senne to form an lmidate 
adduct, therefore highlighting its effect as a general senne protease inhibitor and possibly not 
specific for DPPIV
Another set of compounds, Xaa-pyrrolidide or Xaa-thiazolidide have shown to be specific, 
competitive inhibitors of DPPIV (FIG 14) Although the mechanism of inhibition is not 
widely reported, these molecules have prevented many physiological processes that DPPIV 
appears to be involved in Processing of neuropeptide Y and peptide YY was completely 
abolished in human serum when Lys-pyrrolidide was present (Mentlein et a l , 1993) 
Similarly, Lys[Z(N02)]-thiazohdide prevented the truncation of procalcitonin (PCT), a marker 
for bacterial infection, in blood plasma by DPPIV (Wrenger et a l , 2000a) Glucagon and 
glucagon-like peptide (GLP-1) has a direct involvement in type-2 diabetes Their sequences 
make them potential targets for DPPIV degradation Pospisilik et a l , 2001, proved that 
glucagon lost a lot of its hyperglycemic activity when incubated with DPPIV However this 
could be prevented by isoleucyl-thiazolidme In addition valme-pyrrolidide improved glucose 
tolerance and insulin secretion in mice, possibly through the augumentation of GLP-1 levels 
by inhibiting DPPIV (Ahren et a l, 2000)
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A common limitation with inhibitors is their half-life in vivo Often the molecule may 
potently inhibit the enzyme m vitro but could be rapidly degraded in the body De Meester et 
a l , 1997 explored the in vivo effect of Pro-Pro-diphenyl-phosphonate (Prodipine) on DPPIV 
in rabbit plasma DPPIV levels decreased by 20% and remained unchanged for 24 hours 
Although the mode of inhibition could not be ascertained, it was speculated from previous 
results that the inhibitor is slow-binding, irreversible and obviously very stable (FIG 14) 
Wrenger et a l , 2000b tested the N-termina! nonapeptide Tat (1-9) analogue peptides carrying 
exchanges in the first three ammo acids, for DPPIV inhibition Of all examined, Trp2-Tat(l-9) 
inhibits most potently with a IQ of 2 12|iM Database analysis of this peptide disclosed an 
identity with the thromoboxane-A2 receptor (TXA2-R), which is localised on the surface of 
monocytes which intensively interact with T-cells during antigen presentation Therefore 
TXA2-R could represent a natural, physiological inhibition of T-cell expressed DPPIV
One of the most widely utilised and therefore regarded as specific DPPIV inhibitors are 
Diprotin A (Ile-Pro-Ile) and Diprotin B (Val-Pro-Leu) As a consequence of the direct, 
substrate-like structure of both compounds, they may inhibit competitively (Rahfeld et a l ,
1991) The inhibitors have been employed regularly to uncover many DPPIV potential 
physiological roles, such as endomorphm-1 degradation (Bird et a l , 2001) and GLP-1 (7-36) 
amide degradation (O’Harte et a l , 2001) They have also been used to characterise a purified 
protein from various sources, including human lymphocytes (De Meester et a l , 1992), 
porcine seminal plasma (Ohkubo et a l , 1994) and guinea-pig brain (Gilmartin and O’Cuinn,
1999)
Although metal ions do not normally inhibit in a specific, competitive fashion, some still have 
an inhibitory effect on DPPIV Thus they also serve to allow increased accuracy when 
charactensing the enzyme At ImM, HgCl2 almost completely abolishes enzymatic activity 
Similarly the zmc (Zn2+) ion also has a potent effect at ImM (De Meester et a l , 1992 and 
Puschel et a l 1982) Due to the many possible physiological effects of DPPIV, a 
considerable quantity of inhibitors have been synthesised An even greater volume of research 
has been devoted to inhibiting the enzyme, both specifically and non-specifically
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1 6 . D P P I V  -  L i k e  E n z y m e s
Many reports have been published recently on DPPIV-hke activity m an attempt to 
distinguish between what is classified as Dipeptidyl Peptidase IV and that which has similar 
enzymatic activity Many of the ‘DPPIV-like’ enzymes may show different biochemical 
properties via inhibitor effect, pH optimum etc
Duke-Cohan et a l , 1995 isolated and characterised a novel form of DPPIV m human serum 
The soluble enzyme has a monomeric molecular weight of 175kDa instead of 105-1 lOkDa 
for membrane-bound CD26 Therefore they believe that sDPPIV is not just the shedded or 
proteolytic digested form of CD26 Another difference is the relative expression of epitopes 
detected by monoclonal anti-CD26 antibodies, which binds stronger to CD26 than to sDPPIV 
This favours the possibilty that DPPIV related enzymes may have arisen by divergent 
evolution from an a/p-hydrolase ancestor, where the distinct secondary and tertiary structure 
may be retamed despite complete differences in sequence In an attempt to distinguish 
between this larger protein and CD26/DPPIV, it was termed DPPT-L (Duke-Cohen et a l , 
1998) They confirmed that DPPT-L had DPPIV activity but they had no significant sequence 
homology To reflect this, the name was subsequently changed to Attractin
Scanlan et a l , 1994, cloned human fibroblast activation protema (FAPa), a 95kDa cell 
surface antigen They found that the cDNA codes for type II integral membrane protein with a 
large extracellular domain, transmembrane segment and short cytoplasmic tail FAPa shows 
48% ammo acid sequence identity to CD26 Niedermeyer et a l , 1998, proved that FAP has 
DPPIV activity by expressmg the protein in a baculovirus system as chirmenc CD8 -FAP 
fusion proteins, which is able to cleave Ala-Pro-NH-Mec
Blanco et a l , 1998 discovered a CD26-like 82kDa protein expressed by the lymphocytic cell 
line C8166 which, they refer to as DPPIV-p, and speculate to be solubilized from the plasma 
membrane as a monomer They discovered that there were important differences between the 
affinity of DPPIV/CD26 and DPPIV-p for some substrates and inhibitors This was illustrated 
by CD26 hydrolysing Gly-Pro-Np with a KM of 0 llpM  while DPPIV-p could only achieve a 
KM of 0 27|xM Similarly, ICI-1 la inhibits CD26 with an IC50 of 0  01 l|iM however 2  6 jaM is 
required for DPPIV-p These differences may reflect divergences in the spatial structure of 
the enzymes catalytic site
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Abbott et a l , 2000, cloned a 882-amino acid protein that has 27% identity and 51% similarity 
to DPPIV which they term DPP8 The cloned enzyme has similar biochemical characteristics 
to DPPIV such as a lOOkDa monomeric weight but seems to exist as a monomer in the 
cytoplasm, thus has no transmembrane domain An interesting difference between the two 
enzyme is that the cloned, recombinant DPP8 enzyme was not glycosylated However it is 
possible that the lack of glycosylation may be a result of the expression system employed
Chiravun et a l , 1999 report that post-prohne cleaving aminodipeptidases are potential 
regulators of quiescent cell survival Use of L-valinyl-i -boroproline (VbP) was seen to cause 
lymphocyte cell death but this was not due to the inhibition of CD26/DPPIV but a novel 
senne protease, designated quiescent cell proline dipeptidase (QPP) QPP is predicted to be a 
58kDa monomeric glycoprotein found in lysosomes but also secreted in an active form 
Although QPP has similar substrate specificities at neutral pH to CD26/DPPIV, they can be 
functionally and biochemically distinguished This was illustrated by Underwood et a l , 1999, 
with the same research group as Chiravun They found a 492 amino acid protein with a 
similar sequence to prolylcarboxypeptidase QPP activity occurred over an unusually broad 
pH range cleaving substrate molecules at acidic as well as neutral pH, indicating a role in 
lysosomes Although both CD26/DPPIV and QPP have the same catalytic residue 
arrangement (Ser, Asp, His), differences in their inhibitor profiles indicate vanation m the 
catalytic sites and/or the mode of inhibition Chiravun et a l , 2000 added that QPP also differs 
to CD26/DPPIV when it oligomerizes CD26/DPPIV forms homodimers through disulphide 
bndges, however QPP dimenzes via leucine zipper motifs which are leucine residue repeats 
that form a coiled coil structure This results in the initially reported 58kDa protein to 
dimerize to a 120-130kDa species as proved by gel filtration Interestingly, QPP also bears a 
similanty to the limited sequence of DPPII available This correlates with the affinity for 
acidic pH and localisation within acidic organelles, such as lysosomes Similarly as already 
reported, DPPII may exist as a 60kDa monomer and dimenze to a 120kDa native protein In 
addition, the DPPII sequence has also been reported as homologous to lysosomal 
prolylcarboxypeptidase Therefore it is highly probable that QPP could be identical or similar 
to DPPII
In brain tissue, DPPIV is detected only at a trace level cDNA clones obtained from a bovine
cDNA library encode a 33% identity protein with DPPIV (Km et a l , 2001) The predicted
DPPIV-related protein (DPPX) is suggested to exist as two isoforms, DPPX-S and DPPX-L,
which differ m the sequence and length of the N-terminus Thus it is assumed that DPPX and
DPPIV are different gene products The active site motif Gly-X-Ser-X-Gly and the other
active residues Asp and His are conserved in DPPX, although the active site Ser is replaced
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by Asp Despite this, the DPPX’s do not have any DPPIV activity Even when the active site 
Asp is substituted for Ser, it still fails to generate an enzymatically active form This may be 
due to a conformational difference between DPPX and DPPIV, such as the same 
conformationally active triad structures differing Therefore it appears that the link between 
DPPX and DPPIV may be quite insignificant, none more than two ‘similar’ Senne proteases
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1 7  D P P I V  -  P O  T h e  L i n k
Both DPPIV and Prolyl Oligopeptidase (PO) have been assigned to the Carboxypeptidase 
clan SC In addition, the two peptidases have been grouped in the same family, S9, which is 
also known as the Prolyl Oligopeptidase Family A common characteristic that S9 family 
enzymes share is the unclassical senne protease catalytic triad arrangement of Ser, Asp and 
His This similarity is furthered by the fact that the catalytic tnad for both enzymes is within 
130 residues of the C-terminus (Rawlings and Barrett, 1994) In comparison to other 
classified senne proteases, DPPIV and PO have a unique ammo acid sequence around the 
reactive senne reside (TABLE 1 4 )
Enzyme Sequence around the active site, Serine
Trypsin-like 
Subtihsin-like 
Carboxypeptidase-like 
Dipeptidyl Peptidase IV 
Acylaminoacyl-Peptidase 
Prolyl Oligopeptidase
Table 1 4 Amino acid sequence around the active site serine of some serine 
protease families
DPPIV and PO are included in the same family The reactive sennes are bold and underlined
Senne has as many as six potential nucleotide codons and all six have been found to encode 
the active site sennes of different senne proteases However the same tnplet (TCA) codes for 
the active site senne residue of both DPPIV and PO (Polgar and Szabo, 1992d) Similarly, the 
glycine residues 5 and 6 in TABLE 1 4 , is also encoded by the identical tnplet for both 
enzymes even though glycine has four possible codon representations This suggests the 
existence of an evolutionary relationship between the peptidases
Even though the whole amino acid sequence of both enzymes only generated a 16 5% 
identity, the homology of the C-terminal is somewhat higher at 21 7% This correlates well 
with the previously descnbed similanty dunng the catalytic process via their tertiary 
structure The a/p hydrolase is a unique but definite charactenstic, highlighting the similanty 
between DPPIV and PO Such is this similanty that within the S9 or Prolyl Oligopeptidase 
family, PO is classified in subfamily A (S9a), while DPPIV is assigned to subfamily B (S9b)
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Glv-Asn-Ser-Glv-Glv-Pro
Glv-Thr-Ser-Met-Ala-Ser/Thr
Glv-Glu-Ser-Tyr-Ala-Gly
Glv’Trp-Ser-Tyr-Glv-Glv
Gly-Gly-Ser-His-Gly-Gly
Glv-Glv-Ser-Asp-Glv-Glv
1 .8 . P r o l y l  O l i g o p e p t i d a s e
1.8.1. Introduction
Prolyl Oligopeptidase (PO) was first discovered in human uterus as an oxytocin-degrading 
enzyme (Walter et a l., 1971). Due to its high affinity for hydrolysing the peptide bond on the 
carboxyl side of proline, it was originally named post-proline cleaving enzyme. Since its 
discovery and isolation from many sources, the enzyme was often named according to the 
bioactive peptide it cleaved, i.e. Kininase B from rabbit brain (Oliveira et a l., 1976) and TRH 
deamidase from rat brain (Rupnow et a l., 1979). The name post-proline endopeptidase was 
recommended in 1978 by IUBMB and then changed to prolyl endopeptidase in 1981. On the 
basis of the oligopeptidase nature of the reactions catalysed, the amino acid sequence 
homology with other oligopeptidases and the substrate-size limitation, Barrett and Rawlings 
proposed the name prolyl oligopeptidase in 1991 and the EC number, EC 3.4.21.26 was 
assigned.
1.8.2. Distribution
Prolyl Oligopeptidase is widely distributed in mammalian plant and microbial sources. In 
mammalian sources, many species have shown considerable levels of PO, such as human 
(Kato et a l., 1980), rat (Yoshimoto et a l 1979) and rabbit (Orlowski et a l., 1979). All species 
reveal ubiquitous tissue distribution with uniformly high levels found in the brain. 
Localisation studies carried out have shown substantial species-species variation. In humans, 
the highest PO levels are observed in skeletal muscle and testes with the lowest levels 
occurring in the heart and serum (Kato et a l., 1980). In contrast, skeletal muscle shows the 
lowest levels in rabbit (Orlowski et a l., 1979), while the small intestine and lung show 
comparatively higher levels. Consistently high levels have been reported from brain, however 
localisation studies have revealed species variation in the regional distribution within the 
brain. The frontal cortex in human brain has 5-fold higher PO levels than the hypothalamus 
(Kato et a l 1980). The piriform cortex has over 3 times higher levels that the mamillary body 
in rat brain (Dauch et a l., 1993), while the entorhinal of rabbit brain has over 2.5 times 
enzyme levels than the medulla (Orlowski et al., 1979). Due to PO’s cytosolic nature, the 
enzyme is often released into mammalian body fluids. Yoshimoto et a l ., 1978 reported from 
human, that semen shows the highest bodily fluid PO levels followed by serum and saliva.
Plant PO sources usually consist of carrot and mushroom while bacterial sources tested have 
resulted in Halocynthia roretzi and especially F. meningosepticum  among the most common 
bacteria producing the enzyme (Chcvaillcr et al., 1992). The hyperthermophilic archaeon,
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Pyrococcus furiosus is another reported microbial source (Harwood and Schreider, 2001). In 
this case, the P.furiosus structural gene was identified, sequenced and expressed in an E.coli 
strain. This is a common technique employed to analyse many different PO sources.
1.8.3. Physiological Importance
Due to Prolyl Oligopeptidase’s ability to cleave many proline-containing peptides, the 
enzyme is believed to have a significant physiological effect. Similarly the enzymes 
distribution in many tissues and biological fluids, indicates the potential function it may 
possess. However any in vitro studies carried out on the enzyme must be correlated with a 
measured in vivo effect, in both healthy and diseased states.
Perhaps the most striking example of rapid cell growth and proliferation is the growth of 
cancer cells and tumour development. It is now established that peptidases play a very 
important role in tumour development and progression. Studies have determined a link 
between elevated PO levels and cancerous tumours. Increased PO levels have been found in 
lung tumours, prostate and breast malignancies (Goosens et a l ,  1996a; Sedo et a l., 1991). It is 
evident that from the investigations on cell growth and development, it is possible that PO 
may be intrinsically linked with DNA synthesis specifically.
Comparative PO activity studies have been extensively researched and have generated 
significant results. Maes et a l., 1994 observed lower PO levels in patients suffering from 
major depression in comparison to controls and it was inversely related to the severity of 
depression. It has been established that major depression is characterised by considerable 
neuroendocrine and immunological disturbances. This includes (a) Increased concentration of 
certain neuropeptides like TRH and Substance P in cerebrospinal fluid, (b) Increased 
secretion of arginine vasopressin, CRH, p-endomorphin, etc, in the Hypothalmic-Pituitary- 
Adrenal axis and (c) T-cell activation, B-cell proliferation and increased levels of phagocytic 
cells in peripheral blood. It is uncertain if lowered PO activity levels of major depressive 
patients is involved from the onset of this disease or even if the enzyme is a marker for the 
condition. However treatment of major depressed patients with anti-depressants resulted in a 
significant increase in PO activity (Maes et a l., 1995). Therefore it is possible that PO may be 
involved in the modulation of some of the aforementioned neuroactive peptides, in vivo and 
may have a role in generating an immune response.
PO activity levels were also measured in the plasma of manic and schizophrenic patients and 
enzyme levels appear to be increased in comparison to normal controls (Maes et al., 1995).
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PO’s potential role in these disorders is unclear, however its involvement is strengthened by 
decreases in cerebrospinal fluid arginine vasopressin and neurotensin and post-mortem brain 
TRH in schizophrenic patients Similarly, treatment with the anti-psychotic drug, Valproate 
reduced PO activity In addition, higher PO levels were observed in the serum of patients with 
post-traumatic related (Maes et al, 1998), while the majority of alcohol-dependent patients 
showed a decrease in serum PO levels (Maes et al, 1996b)
A common trend observed in neurodegenerative disorders is abnormally low PO brain 
activity levels Data obtained by Mantle et al, (1996) suggest a 65-70% reduction in activity 
in tissues from Parkinson’s, Hungtington’s and Alzheimer’s disease and it is speculated that 
this reduction may be a characteristic of a generalised process of neurodegeneration It is 
unlikely that PO is simply a marker for cell damage as it was also observed that PO activity 
uniformly decreased in both grey and white matter of post-mortem Alzheimer disease 
patients The link between PO and Alzheimers disease (AD) has been investigated to establish 
the enzymes possible influence in the generation of amyloid protein, which is found m the 
deposits of the senile plaques, characteristic of AD Amyloid protein (Ap) is derived from a 
larger transmembrane amyloid precursor protein (APP) and Ishiura et al, (1990) identified 
PO as a possible y-secretase that cleaves APP between residues Ala713 and Thr714, 
generatmg Ap As a result, a number of PO specific inhibitor have been analysed to ascertain 
possible prevention of Ap production Shinoda et al, in 1997 retarded Ap formation in a 
neuronal cell line upon JTP-4819 addition, implicating PO in the pathogenesis of Alzheimers 
disease However a number of factors question PO’s involvement in this process As already 
discussed, PO is believed to be capable of cleaving peptides no greater than 25 residues long, 
yet APP is over 700 residues However it is possible that APP is first cleaved by a P-secretase 
which may produce an APP fragment short enough for PO to hydrolyse
Several studies have established a potential link between PO and cerebral ischemia effects 
(blood supply reduction), memory and learning TRH, Substance P and argmine vasopressin 
(AVP) are a number of substrates, m vivo, that can exert neuroprotective effects as well as 
improving the performance of animals in memory and learning tasks (Griffiths, 1987) The 
degradation of these peptides by PO is highly possible, therefore the effect of PO inhibitors 
were employed on peptide hydrolysis Oral administration of Z-Pro-Prolmal cause a 
significant increase in AVP levels in rat brain (Miura et al, 1995) Similarly, JTP-4819 
enhance memory processes m aged rats (Toide et al, 1995) and reverse an age-decrease of 
Substance P and TRH levels (Shinoda et al, 1995)
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1.8.4. Assay
Oxytocin and arginine-vasopressin were initially employed as natural substrates for the 
enzyme (Walter et a l ,  1976). Koida and Walter (1976) reported the use of the Z-Gly-Pro- 
Leu-Gly as substrate, with the ninhydrin assay being employed to detect the cleavage product 
Leu-Gly. The development of spectrophotometric and fluorimetric substrates in the late 
1970’s, led to the synthesis of a number of potential chromogens and fluorophores. The basic 
structure of PO substrates focuses on N-blocked proline containing dipeptides linked to a 
molecule that is readily detected on cleavage. The N-terminal blocking agents N- 
benzyloxycarbonyl- (Z-) and succinyl- (Sue-) are most commonly linked to Gly-Pro residues 
such is the case for Z-Gly-Pro-MCA.
Various reports of novel fluorogenic synthetic substrates have been published since, and the 
superior sensitivity of fluorimetric over spectrophotometric assays is well-documented 
(Willard et al., 1988). Knisatschek et a l., 1980 reported a KM value of 14|iM for Z-Gly-Pro-2- 
NNAp, an alternative fluorogenic substrate. Although PO assays incorporating 2-NNAp (p- 
naphthylamide) have been reported, MCA shows enhanced sensitivity over the naphthylamide 
derivative (Polgar, 1994). A ten-fold lower KM (1.4jaM) was determined by Noula et al., 1997 
using 7-amino-4-methyl-2-quinoline (Meq) as an alternative to MCA. The enhanced affinity 
of PO was as a direct result of replacement of the P2 positioned Gly with a cysteine-benzyl 
residue. Spectrophotometric assays have also been described using Z-Gly-Pro-4-nitroanilide 
(Polgar, 1995) although they are generally less sensitive than their fluorescent counterparts. 
To date, Z-Gly-Pro-MCA or Z-Gly-Pro-NHMec has been the most widely used, 
commercially available substrate employed for the detection of PO activity (Rennex et al., 
1991; Goossens et al., 1995; Cunningham and O’Connor, 1998). It should be noted however, 
that the identification of a Z-Pro-Prolinal insensitive Z-Gly-Pro-MCA degrading peptidase 
(ZIP) by Cunningham and O’Connor (1997a) questions the classification of Z-Gly-Pro-MCA 
as a specific PO substrate.
1.8.5. Purification
As previously described, PO is distributed in many species and many tissues. Similarly the 
enzyme has been purified from many of these sources, incorporating a number of different 
chromatographic techniques. Depending on the source, the tissue samples are initially 
homogenised and then subjected to ammonium sulphate fractionation, of up to 80% saturation 
required to precipitate the enzyme (Yoshimoto et al., 1982). The anion exchanger, DEAE is 
often used with sephadex or sepharose employed as the stationary matrix. This resin 
manipulates a potentially low isoclectric point for the enzyme, in comparison to the pH of the
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buffer used. Goosens et a l , 1995 used this column when purifying PO from human 
lymphocytes but followed it with Q-Sepharose, another anion exchanger and employed 
exactly the same protocol for both columns. Molecular size is another property of proteins 
that can be utilised for purification purposes. Depending on the source the enzymatic 
molecular size will vary and the resin pore size used varies accordingly. They range from 
Sephadex G-150 (Moriyama and Sasaki, 1983) to S-300 (Chevallier et a l., 1992), illustrating 
the wide molecular weight variety to be accounted for. Hydrophobic Interaction 
Chromatography is also employed with Phenyl Sepharose representing one of the resins 
(Goosens et al., 1995; Cunningham and O’Connor, 1998). However this technique is not as 
popular as the two aforementioned chromatograhies.
Some of the better purification factors generated during PO purification, have been achieved 
by somewhat ‘unorthadox’ resins, as they may have been constructed specifically for PO. 
Yoshimoto et a l., 1977 employed the affinity resin, Z-Pro-D-Ala-poly(Lys)-Sepharose 4B to 
bind the enzyme’s active site and provide a quick purification method. In 1982, Yoshimoto et 
al, incorporated trypsin onto Sepharose to purify ‘post-proline cleaving enzyme’. Goosens et 
al., 1995 immobilised albumin-reactive antibodies onto a resin and it provided a very 
effective method to purify PO. The purification factor increased from 348 to 2,550 after the 
anti-albumin step illustrating the resin’s potential.
The range of purification factors generated during Prolyl Oligopeptidase purification vary 
widely depending on the resin utilised as well as the source of enzyme origin. It should be 
noted too that sources of comparatively low protein content may not return as high a specific 
activity value as others, mainly due to the smaller fractional decreases in protein content.
1.8.6. Biochemical Characteristics
PO has been extensively characterised to date, however early reports return conflicting 
evidence. The enzyme was thought to be a dimer with a molecular weight of 115-140kDa 
(Koida and Walter, 1979). It is now widely known that mammalian, plant and microbial 
forms of PO are monomeric with an average molecular weight of 75kDa (Kanatani et al
1993). Amino acid sequences have been obtained from cDNA clones of PO which verify a 
monomeric structure. Porcine brain PO revealed a 710 amino acid sequence (Rennex et a l., 
1991) which is a common characteristic of the human enzyme. PO from F. meningosepticum 
is a slightly smaller protein of 705 amino acids (Yoshimoto et a l , 1991), which Chevailler et 
al confirmed in 1992. However they also discovered a signalling pro-peptide of 20 amino 
acids preceding the mature enzyme, which when removed reduced the molecular weight from 
78.71kDato 76.78kDa.
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\Mammalian and bactenal PO generally have a broadly neutral pH optimum, depending on the 
source PO from mammalian species have an acidic isoelectric point of approximately 4 8 
(Goosens et a l , 1995) Bactenal PO isoelectnc points are somewhat higher and are 
considerably dependent on the microbial source This was illustrated by Yoshimoto et al, in 
1988 when Lyophyllum cinerascens PO had a pi of 5 2, however previously in 1980, PO from 
F memngoseptjcum had a comparatively very high pi of 9 6
Both mammalian and microbial PO have a physiological temperature optimum of 37-40°C 
(Kanatam et a l , 1993, Yoshimoto et a l , 1983) Most temperature stability studies involve 
carrying out the enzymatic reaction at different temperatures for 30 minutes to ascertain the 
temperature at which 50% of activity is reduced For carrot PO, this proved to be 43°C 
(Yoshimoto et a l , 1987), while the same temperature was observed for lamb kidney PO 
(Yoshimoto et a l , 1981) However Harwood and Schreier, 2001 report a temperature 
optimum and stability in the region of 85-90°C for the thermophile, P furious
18 7. Catalytic Classification
PO is classified as a senne protease mainly based on its inhibition by DFP, prohne-contaimng 
chlorometanes and to a lesser extent PMSF This is achieved by the high specificity of DFP 
for the catalytic senne of PO This was confirmed by Yoshimoto et al, in 1981 when 0 ImM 
DFP completely inhibited PO activity from both lamb bram and kidney PO is also 
surpnsingly, inhibited by cysteine protease inhibitors The most potent reagent is p- 
chloromercunbenzoate (pCMB), when 0 ImM completely abolished bovine bram PO activity 
and reduced carrot PO to 8 9% Interestingly, pCMB had almost no effect on F  
menmgosepticum (Yoshimoto et a l , 1987) A study of two other cysteine protease inhibitors 
N-ethylmaleimide (NEM) and lodoacetamide was earned out on PO The larger molecule 
NEM seemed to inhibit the enzyme effectively (85%) while lodoacetamide only reduced 
activity by 50% This would suggest the presence of a cysteine residue that is close enough to 
the active site and exclusion of a substrate when complexed with a bulky molecule could 
result A smaller reagent such as lodoacetamide may only be able to exert an incomplete 
stenc hinderance (Polgar, 1991) The cysteines of the non-catalytic p-propeller domain was 
also proved to influence catalytic capability (Szeltner et a l , 2000) The Cys255 residue was 
mutated to three different vanants, one of which, Thr was not inhibited by NEM, indicating 
that Cys255 contnbutes to the catalysis of the peptidase domain In contrast, it appears that 
this cysteine residue may not be adjacent to the active site for microbial PO and therefore not 
close enough to influence catalytic activity A common agreement with all reports is the 
absence of a metallo residue near the enzyme’s active site This was illustrated by the use of
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common metallo-protease inhibitors, where lamb brain and kidney PO were not effected by 
lOmM EDTA nor phenanthroline (Yoshimoto et al., 1981).
Confirmation of PO as a serine protease was ultimately achieved by cloning the PO and 
deducing its amino acid sequence. However it also shows no apparent similarity with other 
proteins in its class. As previously discussed, PO is classified as an ‘uncIassicaF serine 
protease like DPPIV but dissimilar to trypsin or subtilisn, containing the catalytic triad 
arrangement of Ser-Asp-His. Also like DPPIV, the active site is located at the C-terminal end 
of the protein. The position of the active site serine may vary depending on the source, 
however the general consensus is that Ser554 represents the active site serine in the 710 
amino acid mammalian enzyme. His680 is the common third residue of the catalytic triad, 
however the position of the Asp residue initially caused some confusion. Asp529 was 
concluded to be located in a neutral, hydrophilic segment and possibly a member of the active 
site (Barrett and Rawlings, 1992). However Goosens et al, in 1995 confirmed that in fact 
Asp641 was the final active site residue, resulting in a catalytic triad arrangement of Ser554, 
Asp641, His680.
PO’s similarity to DPPIV reveals an identical consensus sequence around the active site 
serine such as GXSXGG, which is significantly dissimilar to other serine proteases (FIG.
1.8.6.) This sequence may be of considerable benefit in identifying other members of this 
family. Members of the Prolyl Oligopeptidase Family (S9) are quite diverse. It includes PO, 
which is confined to action on oligopeptides (EC 3.4.21.26), DPPIV, an ectopeptidase that 
cleaves N-terminal dipeptides only when the N-terminal is unblocked (EC 3 .4.14.5) and acyl- 
aminoacyl peptidase, an omega peptidase that preferentially cleaves N-terminal acetyl- 
aminoacyl residues from polypeptides (EC 3.4.19.1) (Rawlings et al., 1991).
1.8.8. Mechanism of Action
Prolyl Oligopeptidase catalytic mechanism has revealed further distinctions from other
extensively characterised serine proteases, such as the chymotrypsin and subtilisin families,
but has similarities with DPPIV. A common phenomenon for all serine peptidases is that the
catalytically competent histidine residue facilitates both the formation and decomposition of
the intermediate acyl-enzyme that is formed. It is the ionisation of this residue that determines
the pH dependence on catalysis. In general, it is these acid/base reactions that are rate-limiting
for chymotrypsin/subtilisin families while ionic strength has little or no effect. In contrast, PO
catalysis displays remarkable sensitivity to ionic strength (Polgar, 1991). As a consequence, it
is postulated that two catalytic active PO forms could exist. As expected, ionisation of the
catalytic histidine exhibits a pKa of 8.0. However a second significant ionisation event in pH
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dependent kinetics is observed at pKa 6 0 Analysis of the two PO forms revealed that the 
rate-determmmg step of the low pH form followed the general acid/base catalysis, while that 
of the high pH form was due to a physical step This was confirmed by Polgar, 1992c, usmg 
substrates with different leaving groups which did not seem to affect the rate of PO catalysis
Thus it was concluded that the rate was limited physically rather than chemically, as a 
substrate with a better leaving group is known to react with a peptidase at a higher rate, 
providing the rate-limiting step is chemical
Like DPPIV, PO is a member of the a/p hydrolase fold family, which comprises of a catalytic 
or peptidase domain and a non-catalytic p-propeller domain (Goosens et a l , 1995) This 
propeller domain contains a seven-fold repeat of four-stranded anti-parallel p-sheets radially 
arranged around a central tunnel, which leads to cavity that contains the catalytic tnad 
residues The entrance to the active site is via a narrow hole at the bottom of the central tunnel 
but is normally too narrow to allow access of peptide substrates (Fulop et a l , 1998) The 
flexible side chains that partially cover this hole may allow movement, thus widening the 
entrance, which in turn could be assisted by the opemng of the propeller between the first and 
seventh blade This opening induced by a substrate may explam the rate-limiting physical step 
or conformational change and any substrate-size limitations
The ability of PO to hydrolyse a substrate is dictated by the presence o f a particular residue 
(proline or alanine), the location of the residue and the length of the substrate Studies on PO 
from several sources indicate that the active site of the enzyme is composed of five bindmg 
subsites, SI, S2, S3, SI and S 2 \  showing high stereospecificity in the S2, SI and SI subsites 
(see FIG 1 5 ) PO’s ability to also hydrolyse alanyl bonds is significant but occurs at a much 
lower rate than prolyl bonds However PO is unable to hydrolyse Pro-Pro bonds or 
oligoproline while it can hydrolyse oligoalanine, suggesting that the mode of hydrolysis is 
different for both residues or the restrictions conferred by these residues may differ The lack 
of hydrolysis of D-isomer oligoalanine in the PI and PI position has highlighted the high 
specificity of the interactions of the PI-SI and PI -SI residues (Koide and Walter, 1976, 
Yoshimoto et a l , 1977) It is accepted that the SI subunit of PO is designed to specifically fit 
proline residues (PI) but can tolerate residues carrying substituent groups, provided they do 
not exceed the size of the proline pyrrolidine (Nomura, 1986) The rate of cleavage of the 
Pro-Xaa bond was observed to be fastest when Xaa (P I) was a hydrophobic residue with a 
decreased rate for basic and acidic residues The smallest peptide cleaved is a tetrapeptide or 
an N-blocked tnpeptide amide, illustrating that the enzymes S3, S2, SI and SI subsites (FIG
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1 5 ) need to be occupied for catalysis Another characteristic of PO substrate hydrolysis is 
that low molecular weight peptides seem to be hydrolysed much quicker than larger 
molecules In addition, PO is unable to act on larger proteins, such as albumin, collagen and 
myoglobin and in general can not hydrolyse peptides/proteins greater than 25-30 ammo acids 
long (Koida et al, 1976) This substrate-size limitation is believed to be influenced solely by 
the tunnel/ (3-propeller structure deduced
Su b s t r a t e  Scissile Bond
E n z y m e
Figure 1 5 Schematic Representation of an Enzyme-Substrate Complex
Prolyl Oligopeptidase has 3 catalytic subsites at the amino terminal side of the cleavage site 
(S3, S2 and SI) and 2 at the carboxyl side (SI and S 2) (Nomenclature Committee, 1992)
18 9 Inhibitors
An enzyme’s catalytic mode of hydrolysis as well as its physiological function may often be 
ascertained with the use of specific inhibitors The compounds are typically substrate 
analogues that can bind to the enzyme’s active site Therefore many PO specific inhibitors 
have been synthesised and are used in vivo but ideally should be able to cross the blood-brain 
barrier
The first compound that was synthesised and successfully inhibited PO specifically was Z- 
Pro-Prohnal (ZPP) (Wilk and Orlowski, 1983) This compound is very suitable structurally, 
as its chain length can fit the required three catalytic enzyme subsites, SI-S3 The compound 
was reported to be a non-competitive, transition state inhibitor with a K, of 14nM for rabbit 
brain PO However in 1990, Bakker et al, proposed that ZPP is a competitive, slow-tight 
binding inhibitor of mouse and human brain PO, generating K, values of 0 35nM and 0 5nM
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respectively. It was assumed that this compound has such a potent effect by binding to the 
enzyme’s subsite and forming a hemiacetal with the active site of the enzyme.
As a consequence of the potency of ZPP, many analogues have been investigated as potential 
PO inhibitors. With the P2, prolyl residue substituted for other amino acids, Z-Val-Prolinal 
proved most potent with a Kj of 2.4nM for PO (Yoskosawa et a l , 1984). Similarly, alternative 
studies changed the prolyl residue to thioproline and prolinal to thioprolinal or thiazolidine. 
The resulting compounds, Z-thiopropyl-thioprolinal and thioprolyl-thiazolidine, yielded 
improved Ki values of 0.0InM and 36nM respectively (Tsuru et a l ,  1988). These reports 
acknowledge the significant effect of the benzyloxycarbonyl (Z) group at the P3 position, 
fulfilling the S3 subsite preference for bulky, hydrophobic residues. Joyeau et a l ,  2000 
synthesised a number of pyrrolidinyl and thiazolidinyl-dipeptide derivatives as potential PO 
inhibitors from Trypanosoma cruzi, the agent for Chagas disease in Latin America. They 
introduced either (i) a vinyl sulfone, (ii) a 2-ketobenzothiazole, (iii) a nitrile or (iv) a 
benzimidazole as surrogate of the PI-PI scissile bond in the substrate. Only the 2- 
ketobenzothiazole and nitrile derivatives have a significant potent effect on PO activity with 
K, values of 139 and 38nM respectively. The nitrile derivative is especially potent, possibly 
by mimicking the initial covalent enzyme adduct through an imidate function and it inhibits 
reversibly.
The N-terminal blocked inhibitors proved very potent when developing Fmoc dipeptide nitrile 
derivatives, for PO inhibition (Li et a l ,  1996). Both Fmoc-Ala-Pro-CN and Fmoc-Pro-Pro- 
CN inhibited in a similar potent manner with Kj’s of 5nM. In addition, the inhibitors are 
stable, cell permeable and capable of penetrating the blood-brain barrier. BOC is also another 
N-blocking group that when attached to particular di- or tripeptides, results in potent PO 
inhibitors with Kj values in the sub (am range (Yoshimoto et a l ,  1985; Demuth et a l ,  1993; 
Stockel-Maschek et a l ,  2000). JTP-4819 contains a benzylaminocarbonyl blocked dipeptide 
carboxamide and has a strong resemblance to Z-Pro-Prolinal (Toide et a l ,  1996). The 
inhibitor is orally active with a Ki of 0.83nM and it has been found to cause no significant 
toxicity. It has been used for the treatment of Alzheimer’s disease by restoring TRH levels 
and therefore reducing memory impairment (Shinoda et a l ,  1996).
Many bacterial derived inhibitors have been analysed to ascertain potential PO inhibition both 
in vitro and in vivo. Postatin, produced by Streptomyces viridochromogenes is a significant 
PO inhibitor exhibiting an IC50 value of 0.03 jig/ml (Aoyagi et a l ,  1991). A variety of postatin 
derivatives have been synthesised in an attempt to obtain a greater inhibitory potency and
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selectivity The (s)-3-amino-2-oxovaleryl moiety analogue increases inhibition to an IC50 of 
58ng/ml (Tsuda et a l , 1996) However it should be acknowledged that it is possible that the 
bacterial inhibitor may not be specific to PO
A number of naturally occurring inhibitors have been purified from a variety of mammalian 
tissues, including porcine pancreas (Yoshimoto et a l , 1982) and bovine bram (Ohmori et a l ,
1994) Ammo acid analysis on the purified inhibitor from bovine bram, revealed it to be 
identical to segment 38-55 of glial fibrillary acidic protein and generated a Kj of 8 6|iim
Inhibitor Potency Reference
Mammalian
Fmoc-Ala-Pro-CN K, = 5nM Li e ta l ,  1996
Fmoc-Pro-Pro-CN Kt = 5nM Li e ta l ,  1996
JTP-4819 IC50 = 0 83nM Toide e t a l , 1995
Z-Thioprolyl-thioprolinal Kj = 0 OlnM T sx m ie ta l, 1988
Z-Pro-Prolmal IC50 = 0 74nM Wilk and Orlowski, 1983
Bacterial
Eurystatm A IC50 = 0 004jag/ml Toda e t a l , 1992
Postatin IC50 = 0 03(xg/ml Aoyagi e t a l , 1991
Table 1 5 PO Specific Inhibitors
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2 .0 . M a t e r i a l s  a n d  m e t h o d s
2 . 1 .  M a t e r i a l s
S igm a C h em ica l C o m p a n y  (P o o le , D o rset, E n g lan d )
1 , 1 0  Phenanthroline 
1 ,7  Phenanthroline 
2-Iodoacetam ide  
2-M ercaptoethanol 
4, 7 Phenanthroline
7-am ido-4-m ethylcoum ann
8-H ydroyquinolm e  
A cetic A cid  
A d enosine D eam inase  
AE B SF  
A la-M C A
Am m onium  Persulphate
A m m onium  Sulphate
Antipam  H yd roch londe
A p ofem tin
Aprotimn
Arg-M C A
Bacitracm
B en /am id in e
B isacrylam ide
Biuret R eagent
B lue Dextran
B ovin e Serum  Album in
Brilliant B lu e Concentrate
Cadmium C hlonde
Cadmium Sulphate
Calcium  Sulphate
CD TA
C ellu lose D ia lysis  Tubing
C ellu lose type 50
Cobalt Sulphate
Dithiothreitol
D T N B
E D T A
E G T A
G lycine
HEPES
H igh  Range M olecular w e igh t markers
H yd roch londe A cid
Im idazole
Iodoacetate
Iodoacetic A cid
Isopropyl A lcoh ol
Leupeptin
M agnesium  Sulphate 
M anganese Sulphate 
M ercu nc Sulphate 
M E S  
M ethanol
M ethyl-D -M annoside
M O PS
N -E thylm aleim ide  
N ick el Sulphate 
pC hlorom ercunbenzoate  
P E G -8000  
Pepstatin
P henylm ethylsulphonylfluonde
Potassium  Phosphate (chbasic)
Potassium  Phosphate (m onobasic)
Pro-M CA
Purom ycin
SD S
Sodium  C hlonde  
Sodium  Phosphate (dibasic)
TEM ED  
T hyroglobulin  
T nzm a B ase  
Z inc Sulphate
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B D H  C h em ica ls  L t d  (P o o le , D o rse t, E n g la n d )
A ciy lam id e  
Biuret R eagent 
B rom ophenol B lu e  
Calcium  Chloride 
Citric A cid  
Copper Sulphate
D im ethylform am ide
D im eth ylsulp hoxide
D io xan e
G lycerol
P olyethylene G lycol 60 0 0
P h a rm a cia  F in e  C h em ica l C o m p an y  (U p p sa la , S w ed en )
B enzam idine Sepharose 6B  
Chelating Sepharose F ast F low  
C N Br-activated Sepharose 
C on-A  Sepharose 
D E A E  Sepharose F ast F low  
G 100 Sephadex
Hiprep 16/60 Sephacryl S300  
Phenyl Sepharose C L-4B  
P olybuffer 74  
Polybuffer E xchanger 94  
Q A E  Sepharose H iload Fast F low  
Sephacryl S300  H R
P erS ep tiv e  B io sy stem s (C a m b r id g e , M A , U S A )  
Poros 50 HQ A n ion E xchanger
B io-R ad  L a b o ra to r ies  (H ercu les , C a lifo rn ia , U S A )  
C oom assie B lu e Stain Solution  
Coom assie D etain  Solution
IEF standards (p i 4 6-9 6)
K ep a k  M eats  (C lo n ee , C o M ea th , Ire la n d )
B ovin e W hole B lood
P ierce  C h em ical C om p an y  (Illin o is , U S A )  
B C A  Reagent
C oom assie Protein A ssay K it  
Coom assie Protein P lus A ssay  K it
G elcode B luesta in  
G lycoprotein  K it
N o vex  (San  D ieg o , C a lifo rn ia , U S A )  
Anode Buffer  
Cathode B uffer
Precast IEF gels
M erck  C h em ica l C om p an y  (F ra n k fu rt, G erm an y )
Potassium  C h londe  
Sodium  H ydrogen Phosphate
Sodium  H ydroxide
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NUI Galway (Courtesy of Dr G O'Cuinn)
Ala-Pro
A la-Pro-G ly
Arg-Pro-Pro
A sp-Pro-G ln-Phe-Tyr
Glu-Pro-Glu-Thr
Gly-Pro
G ly-Pro-A la
G ly-Pro-G ly-G ly
G ly-Pro-H yp
G ly-Pro-Pro
H is-Pro
Lys-Pro-Arg
Phe-Pro-A la
Pro-Pro
Pro-Pro-G ly-Phe-Ser-Pro
Pro-Pro-Pro
Pro-Pro-Pro-Pro
Calbiochem-Novabiochem (UK) Ltd. (Nottingham, England)
A ngiotensin  I Pepstatm
A ngiotensin  III A n giotensin  I
Bachem Feinchemikalein AG (Bebendorf, Switzerland)
ACTH
A la-M C A
Arg-M C A
Arg-Pro
Bradykim n
ß-Casom orphin
C R P (201-206)
Enterostatm  
G ly-M C A  
G ly-Pro-Arg  
G ly-Pro-M CA  
GRP (H um an)
IG F -I(l-3 )
Leu-M C A
L ys-A la-M C A
L ys-Pro
L ys-Pro-M C A
Neuropeptide Y ( l-2 4 )  am ide
N eurotensin (9-13)
pG lu-M C A
Pro-M CA
Substance P
Tyr-Pro-Phe
Val-Pro
Z -G ly-Pro-M C A
Z-Phe-A rg-M C A
School of Biotechnology, Dublin City University
Ethanol
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2.2  F L U O R E S E N C E  Q U A N T IF IC A T IO N  O F  7-A M E D O -4-M E T H Y L -C O U M A R IN  (M C A )
2.2.1. MCA Standard Curves
100|iM of stock MCA solution was prepared in lOOmM potassium phosphate (KP04), pH 7.4 
when analysing PO activity or 50mM Hepes buffer, pH 8.0 for DPPIV analysis. This was 
stored in a light sensitive container at 4°C to minimise any fluorescence. Lower MCA 
concentrations were prepared using lOOmM potassium phosphate, pH 7.4 or 50mM Hepes, 
pH 8.0 to form standard curves of 0-2.5(j,M O-lOjiM and 0-20|nM. All curves were prepared 
as follows;
• lOOul lOOmM KP04, pH 7.4 or 50mM Hepes, pH 8.0
• 400(xl appropriate MCA concentration
• 1ml 1.5M acetic acid
Fluorescent Intensities were measured and recorded using a Perkin Elmer LS-50 
Luminescence Spectrometer at excitation and emission wavelengths of 370nm and 440nm
respectively. The Excitation slit width was maintained at 10 while the emission slit width was
adjusted according to the extent of fluorescent intensity observed from each standard curve. 
The emissions slit widths used were as follows;
MCA Range Emission Slit Width
0-2.5 |nM 10
0-10|iM 5.0
0-20 |nM 2.5
All solutions were assayed in triplicate and the mean fluorimetric intensity was calculated.
2.2.2 Inner Filter Effect
The inner filter effect or ‘quenching’ was determined as 2.2.1. but 100|j,l of lOOmM KP04, 
pH 7.4 or 50mM Hepes, pH 8.0 was substituted for 100(xl of enzyme sample. These samples 
were also prepared and assayed in triplicate.
2.2.3. MCA excitation and emission wavelengths
The optimum excitation and emission wavelengths for MCA were investigated using the 
fluorimeter scan functions. 5|iM MCA was made up in distilled water, lOOmM potassium 
phosphate, pH 7.4 and 50mM Hepes, pH 8.0, containing 0.2%v/v EtOH. 1.5ml 5|xM MCA 
was placed in a glass cuvette and a pre-scan was performed. The excitation wavelength 
obtained from the pre-scan was set and an emission scan was performed from 400-600nm at 
5nm increments. Similarly an excitation scan was performed between 300nm and 500nm
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using the previously determined optimum emission wavelength Optimal wavelengths were 
taken to be those at which fluorescence was at a maximum
2 3. P r o te in  D eterm in ation  
2 31 Absorbancy at 280nm
The absorbance of proteins based on the kmax of trytophan residues was used as a qualitative 
method of determining protein levels in post column chromatography fractions dunng 
purification procedures where the protein levels were greater than lOmg/ml or when a high 
concentration of salt was present A Shimadzu UV 160A Spectrophotometer was used to 
determine this absorbance The fraction or sample was placed in a quartz cuvette and inserted 
into the cuvette holder of the machine and the optical density was recorded UV light at 
280nm
2 3 2 Biuret Assay
The Biuret assay was used to quantify the protein concentration in samples of 2-10mg/ml 
protein These samples include bovine serum and post phenyl sepharose pooled samples 
Where necessary, the sample being analysed was dialysed against lOOmM potassium 
phosphate, pH 7 4 or 50mM Hepes, pH 8 0 for a minimum of 3 hours at 4°C to remove 
interfering substances such as incompatible buffers or salts Any sample that may have a 
higher protein concentration than lOmg/ml was diluted with lOOmM potassium phosphate, 
pH 7 4 or 50mM Hepes, pH 8 0 In order to quantify the protein concentration, a BSA 
standard curve was included from O-lOmg/ml in triplicate The assay was carried out on a 96 
Well plate as follows,
• 50fil Sample/BSA standard
• 200|il Biuret Reagent
• Incubate for 30mins at 37°C
Absorbancies from the incubation were measured at 570nm using a Tecan Spectra Classic 
Plate Reader and a standard curve was constructed where necessary and the concentration of 
protein of the unknown samples estimated
2 3.3 Coomassie Plus Protein Assay
The Coomassie Plus Protein assay was performed on fractions and samples of 0-1 5 mg/ml 
protein content and when interfering substances such as DTT were present thus dialysis 
wasn’t always necessary In order to quantify the protein concentration, a BSA standard 
curve was included of 0-1 5mg/ml m triplicate The assay was earned out on a 96 Well plate
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by adding 200|xl of Coomassie Plus Protein reagent to 50|xl of fraction or standard and read 
immediately after shaking using the Tecan Spectra Classic Plate Reader using a wavelength 
of 595nm A standard curve was constructed and the protein concentration of the unknown 
fractions could be calculated
2 3 4 Standard BCA Assay
The standard bicinchommc acid (BCA) assay was used to quantify protein concentrations of 
samples between 0-2mg/ml As a result of DTTs interference with the assay, post column 
PO fractions could not be measured using this method Where necessary, samples were 
dialysed agamst 50mM Hepes, pH 8 0 to remove any interfering substances BSA standards 
of 0-1 2mg/ml were made up m 50mM Hepes, pH 8 0 and were included with the unknown 
fractions or post column pools The assay was earned out as desenbed in section 2 3 2 200(il 
of BCA reagent was added to 50|xl of sample or BSA standard m tnphcate in a 96 well 
micro-plate and incubated for 30 minutes at 37°C Absorbance of each well was recorded as 
desenbed in 2 3 2 and standard curves were calculated
2 3 5 Enhanced BCA Assay
The enhanced BCA assay was earned out to quantify the protem concentration of samples 
that could not be determined by the less sensitive standard BCA assay protocol The assay 
was performed as desenbed in 2 3 3 but with an incubation temperature of 60°C for 30mins 
Alternatively the assay could also be performed as desenbed in section 2 3 3 with an 
incubation temperature of 37°C for 60mins In addition, a microwave method was also 
employed The micro-plate was placed inside the microwave with a 100ml beaker of water, 
which acted as a heat sink The plate was microwaved for 15-20 second and turned to ensure 
even heating This was repeated in 5 second intervals until adequate colour development was 
observed Absorbancies were read at 570nm with a BSA standard curve of 0-100}ig/ml
2 4 Enzyme Assays
2 4 1 Quantitative Measurement of Prolyl Oligopeptidase Activity
Human salivary Prolyl Oligopeptidase activity was determined by the degradation of Z-Gly- 
Pro-MCA lOmM Z-Gly-Pro-MCA stock was prepared in 100% Methanol The stock 
solution was diluted to IOOjxM with lOOmM potassium phosphate, pH 7 4 with 5mM DTT 
and 0 5mM EDTA and the methanol concentration was adjusted to 4% IOOjj-1 of enzyme 
sample was added to 400^1 of thermally equilibrated IOOjjM  Z-Gly-Pro-MCA in tnphcate 
and incubated at 37°C for 60minutes The reaction was terminated by the addition of 1ml of 
1 5M acetic acid Negative controls were included by the addition of 1ml of 1 5M acetic acid
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to the substrate pnor to the addition of the sample The controls were also incubated at 37°C 
for 60minutes Liberated MCA was fluonmetncally determined as described in section 2 2 1 
Fluonmetnc intensities observed were converted as outlined m section 2 4 1 Total enzyme 
units could then be defined as nanomoles of MCA released per min at 37°C (section 6 2)
2 4 2 Quantitative Measurement of Dipeptidyl Peptidase IV Activity
Dipeptidyl Peptidase activity was determined by the degradation of Gly-Pro-MCA lOmM 
Gly-Pro-MCA stock was prepared in 100% Ethanol The stock solution was diluted to 
100|iM with 50mM Hepes, pH 8 0 to a final Ethanol concentration of 1% lOOjil of enzyme 
sample was added to 400fil of thermally equilibrated lOO^M Gly-Pro-MCA in triplicate and 
incubated at 37°C for 60 minutes The reaction was terminated by the addition of 1ml of
1 5M acetic acid Negative controls were included by the addition of 1ml of 1 5M acetic acid 
to the substrate pnor to the addition of the sample The controls were also incubated at 37°C 
for 60minutes Liberated MCA was fluonmetncally determined as descnbed in section 2 2 1 
Fluonmetnc intensities observed were converted to picomoles MCA released per mm per ml 
usmg the relevant quenched MCA standard curve as outlined in section 2 2 1 Total enzyme 
units could then be defined as nanomoles of MCA released per min at 37°C
2 4 3 Non-Quantitative Measurement of Prolyl Ohgopeptidase activity
The non-quantitative assay was developed to also assist in the rapid detection of Z-Gly-Pro- 
MCA degrading activity in post column chromatography fractions 200jjl1 of 100|jiM Z-Gly- 
Pro-MCA in lOOmM potassium phosphate, pH 7 4 with 5mM DTT and 0 5mM EDTA was 
added to 100|Ltl of sample in each well and the micro-plate was mcubated at 37°C for 60 
minutes MCA released was determined fluonmetncally as outlined in section 2 2 1 usmg the 
Perkin-Elmer LS50 Luminescence Spectrometer plate reader attachment
2.4 4 Non-Quantitative Measurement of Dipeptidyl Peptidase IV activity
The non-quantitative assay was developed to assist in the rapid detection of Gly-Pro-MCA 
degrading activity in post column chromatography fractions 2 0 0 jll1 of IOOjxM Gly-Pro-MCA 
m 50mM Hepes, pH 8 0 was added to 100|il of sample in each well and the micro-plate was 
mcubated at 37°C for 60 minutes MCA released was determined fluonmetncally as outlined 
in section 2 2 1 usmg the Perkin-Elmer LS50 Luminescence Spectrometer plate reader 
attachment
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2 5 P u r ifica tio n  o f  Human S a liva  PO
All the purification procedures were carried out at 4°C at lml/min and 3ml fractions were 
collected unless otherwise stated
2 5.1 Saliva Preparation
Saliva was collected at least 1 hour after eating to maximise PO levels The resulting volume 
was diluted with an equal volume of 200mM potassium phosphate, pH 7 4 with lOmM DTT 
and ImM EDTA This created a final buffered saliva solution of lOOmM potassium 
phosphate, pH 7 4 with 5mM DTT and 0 5mM EDTA
2 5.2. Ammonium Sulphate Precipitation
Solid ammonium sulphate was added to 20ml of buffered saliva with constant stirring at 4°C 
to achieve 80% saturation which is equivalent to 4 molar ammonium sulphate, (Hams, 1989), 
while adjusting the pH to 7 4 with 1M NaOH After I hour of constant stirring the aliquot 
was centrifuged at 27,200g for 45mins at 4°C usmg a Beckman J2-MC refrigerated centrifuge 
fitted with a JA-20 rotor The resulting supernatants were decanted off, pooled and their 
volumes recorded Residual PO activity and protein content in the supernatants was detected 
as described in sections 2 4 2 and 2 3 2 respectively The pellets were re-suspended in a total 
volume of 4ml of lOOmM potassium phosphate, pH 7 4, with 5mM DTT and 0 5mM EDTA 
to give a final ammonium sulphate concentration of 1M
2 5 3 Phenyl Sepharose Hydrophobic Interaction Chromatography
A 25 ml phenyl sepharose CL-4B hydrophobic interaction column (2 5cm x 7cm) was 
equilibrated with 100ml of lOOmM potassium phosphate, pH 7 4 with 5mM DTT and 0 5mM 
EDTA containing 1M ammonium sulphate at lml/min 4ml of post ammonium sulphate 
precipitation PO sample was applied to the equilibrated column followed by a 100ml wash of 
the equilibration buffer Bound protein was eluted by a 50ml isocratic step of 25 mM 
potassium phosphate, pH 7 4 with 5mM DTT and 0 5mM EDTA A further 25ml wash of 
25mM potassium phosphate, pH 7 4 with 5mM DTT and 0 5mM EDTA ensured all bound 
protein was eluted Fractions were assayed for PO activity as outlined in section 2 4 5 
Protein was determined usmg the UV 280nm Protein protocol as described in section 2 3 I 
Fractions containing Z-Gly-Pro-MCA degrading activity was combined and the volume 
recorded to yield post-phenyl sepharose PO The phenyl sepharose resin was regenerated 
with a 30% isopropanol wash and then equilibrated as described previously
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2.5 4 Q-Sepharose Fast Flow Anion Exchange Chromatography
A 20ml pre-packed Q-Sepharose column attached to a BioRad BioLogic Chromatography 
system was equilibrated with 50ml of 50mM Tns/HCl, pH 8 0 with 5mM DTT and 0 5mM 
EDTA The post-phenyl sepharose PO sample was dialysed overnight agamst 31 of Tns/HCl, 
pH 8 0 at 4°C The resulting dialysate was concentrated via reverse osmosis using 
Polyethylene glycol 6000 for 1 hour until the volume was reduced to a quarter of its initial 
volume 1ml of the concentrated dialysate was applied to the column and washed with 50ml 
50mM Tns/HCl, pH 8 0 with 5mM DTT and 0 5mM EDTA Partially bound protein was 
eluted with a 50ml linear gradient of 50mM Tns/HCl, pH 8 0 with 5mM DTT and 0 5mM 
EDTA to 50mM Tns/HCl, pH 8 0 with 5mM DTT, 0 5mM EDTA and 1M NaCl PO was 
eluted with a further 50ml wash of 50mM Tns/HCl, pH 8 0 with 5mM DTT, 0 5mM EDTA 
and 1M NaCl Fractions were analysed for Z-Gly-Pro-MCA degrading activity as descnbed 
in section 2 4 4 and the fraction protein content was determined using the Coomassie assay 
as outlined in section 2 3 3 as well as the online system momtonng of the 280nm UV 
detector Fractions with PO activity were pooled and the volume noted The rate of MCA 
hydrolysis from Z-Gly-Pro-MCA was quantified as descnbed in section 2 4 2 The QAE resin 
was regenerated with 50ml 2M NaCl and re-equilibrated with 50mM Tns/HCl, pH 8 0 with 
5mM DTT and 0 5mM EDTA AH the punfication protocols were earned at room 
temperature
Pooled post-QAE fractions represented partially pure human PO, which was employed for 
any initial charactensation as enzymatic instability didn’t allow for any further punfication 
Where necessary, dialysis was performed for over 3 hours to remove Tns buffer or salt pnor 
to charactensation The most commonly used dialysis buffer was lOOmM potassium 
phosphate, pH 7 4 with 5mM DTT and 0 5mM EDTA Future reference to punfied human 
PO during the charactensation procedure indicates post-Q Sepharose PO
2 5 5 Alternative Chromatographic Techniques Used to Purify Human 
Salivary PO
2 5 5 1  Diethylaminoethyl Sepharose Anion Exchange Chromatography
A 20ml DEAE Sepharose column was equilibrated with lOOml 50mM Tns/HCl, pH 8 0 with 
5mM DTT and 0 5mM EDTA Post Phenyl Sepharose PO sample was dialysed and 
concentrated as descnbed in section 2 5 4 2ml of the dialysate was applied onto the column 
followed by a 50ml wash of equilibration buffer Protein and enzymatic elution was earned 
out by 50ml of 50mM Tns/HCl, pH 8 0 with 5mM DTT, 0 5mM EDTA and 0 5M NaCl 
Fractions were analysed for Z-Gly-Pro-MCA degrading activity and protein using the
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Coomassie assay as outlined in sections 2 4 4 and 2 3 3 respectively Fractions that 
contained PO activity were pooled and the volume recorded The resin was regenerated with 
2 column volumes of 2M NaCl and re-equilibrated with equilibration buffer
2 5 5 2 Benzamidine Sepharose Chromatography
The p-aminobenzamidine sepharose 6B resin was employed to purify trypsin or trypsin-hke 
senne proteases The 5ml column was equilibrated with 50ml 50mM Tns/HCl, pH 8 0 with 
5mM DTT and 0 5mM EDTA 2ml of dialysed post-phenyl sepharose was applied to the 
column and washed with 45ml of equilibration buffer Elution was performed by a 50ml 
isocratic wash of 50mM Tns/HCl, pH 8 0 with 5mM DTT, 0 5mM EDTA and 0 5M NaCl A 
further 25ml wash of 50mM Tns/HCl, pH 8 0 with 5mM DTT, 0 5mM EDTA and 0 5M 
NaCl ensured all bound protein was eluted Fractions were analysed for PO activity and 
protein as descnbed in sections 2 4 4 and 2 3 3 respectively Any fraction that contained Z- 
Gly-Pro-MCA degrading activity was pooled and its volume noted The resin was 
regenerated with 20ml lOOmM Tns/HCl, pH 8 0 with 1M NaCl followed by 20ml lOOmM 
Sodium Acetate, pH 4 5 with 1M NaCl This regeneration step was earned out 3 tunes and 
re-equihbrated with equilibration buffer
2 6 Purification of Bovine Serum DPPIV
All the purification procedures were earned out at 4°C unless otherwise stated 
2 6 1 Serum Preparation
Bovine whole blood was collected from a freshly slaughtered animal and kept tn a 4°C cold 
room for 24 hours to allow a clot to form and shnnk The remaining unclotted blood was then 
decanted and centnfuged at 6,3 70g for 60mins at 4°C using a Beckman J2-MC refrigerated 
centnfuge fitted with a JL-10 5 rotor The supernatant and loose cellular debns was decanted 
and re-centnfiiged at 48,400g for 15mins at 4°C using a JA-20 rotor The serum was 
collected, pooled and stored in 20ml aliquots at -17°C
2 6 2 Phenyl Sepharose Hydrophobic Interaction Chromatography
A 25ml phenyl sepharose CL-4B hydrophobic interaction column (2 5cm x 7cm) was 
equilibrated with 100ml 50mM Hepes, pH 8 0 with 5mM EDTA containing 1M ammonium 
sulphate Crude serum was thawed at 37°C and solid ammonium sulphate was added to give a 
final ammonium sulphate concentration of 0 5M 5ml of salted serum was applied to the 
equilibrated column followed by a 100ml wash of the equilibration buffer to pass through any 
unbound protein Bound protein was eluted by a 50ml linear gradient of 50mM Hepes, pH 8 0 
with 5mM EDTA containing 1M ammonium sulphate to 50mM Hepes, pH 8 0 with 5mM
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EDTA. A further 25ml wash of 50mM Hepes, pH 8.0 with 5mM EDTA ensured all bound 
protein was eluted. Fractions were assayed for DPPIV activity as outlined in section 2.4.4. 
Protein was determined using the Biuret assay as described in section 2.3.2. Fractions 
containing Gly-Pro-MCA degrading activity was combined and the volume recorded to yield 
post-phenyl sepharose DPPIV. The phenyl sepharose resin was regenerated with a 30% 
isopropanol wash and then equilibrated as described previously.
2.6.3. HiPrep 16/10 Sephacryl S-300 HR Gel Filtration Chromatography
The post-phenyl sepharose DPPIV pool was concentrated via reverse osmosis using PEG. 
Glycerol was added to the concentrated sample to give a final glycerol concentration of 10% 
(v/v). The 120ml Hiprep 16/10 Sephacryl S300 High Resolution Gel Filtration separated 
proteins by molecular size. It was equilibrated with 150ml 50mM Hepes, pH 8.0 with 5mM 
EDTA using the Bio-Rad Biologic system or until a steady conductivity baseline could be 
observed. 1.5ml of concentrated post-phenyl sepharose DPPIV was loaded onto the column 
and washed with 150mM of equilibration buffer. Fractions collected were assayed for DPPIV 
activity using the micro-plate assay outlined in section 2.4.4. The protein content was 
detected using the standard BCA assay described in section 2.3.4 parallel with online UV 
monitoring at 280nm. Fractions that contained DPPIV activity were pooled and stored at 4°C. 
All the purification steps were performed at room temperature.
2.6.4. POROS 50 HQ Strong Anion Exchange Chromatography
A 25ml Poros 50 HQ anion exchange column was equilibrated with 50ml 50mM Hepes, pH 
8.0 with 5mM EDTA. 5ml of post-Sephacryl S300 HR DPPIV was applied onto the column 
followed by a 50ml wash with equilibration buffer. Any bound protein was eluted with a 
50ml linear gradient of 50mM Hepes, pH 8.0 with 5mM EDTA to 50mM Hepes, pH 8.0 with 
5mM EDTA and 0.5M NaCl. A further 25ml wash of 50mM Hepes, pH 8.0 with 5mM 
EDTA and 0.5M NaCl ensured that all bound protein was eluted. Fractions were assayed for 
DPPIV activity as described in section 2.4.4. and protein content was determined by use of 
the enhanced BCA assay as described in section 2.3.5. Fractions that contained DPPIV 
activity were pooled and labelled. The Poros resin was regenerated with 2M NaCl and re­
equilibrated with equilibration buffer.
2.6.5. Desalting by G100 Gel Filtration Chromatography
A 50ml G100 Gel Filtration column was equilibrated with 100ml 50mM Hepes, pH 8.0 with 
5mM EDTA. 10ml of the post POROS DPPIV pool was applied onto the column and the 
resin was washed with 150ml 50mM Hepes, pH 8.0 at 0.5ml/min with 5mM EDTA. 3ml 
fractions were collected and were analysed for Gly-Pro-MCA degrading activity as outlined
64
in section 2 4 3 Protein content of the fractions was measured using the enhanced BCA assay 
as described in section 2 3 5 The conductivity was measured by a Jenway 4071 Conductivity 
Meter which gave an accurate ‘real time’ conductivity reading in units of mS/cm which is 
directly proportional to the salt content The fractions had be to individually poured into 
universals so that the conductivity electrode could be immersed in the solution and therefore 
give an accurate reading Fractions with DPPIV activity were combined, labelled and stored 
at-17°C until required
Pooled post-GlOO fractions represented purified bovine serum DPPIV, which was used in all 
DPPIV characterisation studies Future reference to punfled DPPIV indicates post-POROS 
50 HQ DPPIV which was desalted via a G100 column
2 6.6 Alternative Chromatographic Regimes Employed to Purify DPPIV 
2 6 6 1 Con-A Sepharose Chromatography
A 5ml Concanavalm A resin was employed to purify glycoproteins from bovine serum The 
column was equilibrated with 25ml 50mM Hepes, pH 8 0 with 0 1M NaCl 2 5ml of post- 
Sephacryl S300 HR DPPIV was applied onto the column and washed with 25ml of 
equilibration buffer Bound protein was eluted with a 25ml linear gradient of 50mM Hepes, 
pH 8 0 with 0 1M NaCl to 50mM Hepes, pH 8 0 with 0 1M NaCl and 0 5M 
Methylmannoside This was followed by a final 10ml wash of 50mM Hepes, pH 8 0 with 
0 1M NaCl and 0 5M Methylmannoside Fractions were assayed for DPPIV activity as 
descnbed in section 2 4 4 The enhanced BCA assay was employed to detect protein content 
in the fraction was outlined in section 2 3 5 Fractions that contained DPPIV activity was 
pooled and stored at -17°C The resin was regenerated by washing the gel alternatively with 3 
column volumes of high pH and low pH buffer solutions containing 0 5M NaCl The buffers 
and volumes were 20ml 50mM Hepes, pH 8 5 with 0 5M NaCl followed by 20ml 50mM 
Sodium Acetate, pH 4 5 with 0 5M NaCl This step was repeated three times and the resm 
was finally regenerated with equilibration buffer
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2 .7 .  P u r i t y  D e t e r m i n a t i o n
2 7 1 Polyacrylamide Gel Electrophoresis
Sodium dodecyl sulphate polyacrylamide gel electrophoresis (SDS-PAGE) was employed to 
determine the purity and monomeric molecular weight of both post-QAE Human Salivary PO 
and post-Poros 50 HQ Bovine Serum DPPIV pools based on the method of Laemmli, (1970)
2 7 1 1  Sample Preparation
Samples collected dunng the purification process, namely, (i) buffered saliva, post 80% salt 
precipitation, post-phenyl sepharose PO, post-QAE PO and (11) crude serum, post-phenyl 
sepharose DPPIV, post-S300 DPPIV and post-Poros 50 HQ DPPIV were electrophoresed 
using SDS-PAGE All samples were extensively dialysed for 18 hours at 4°C against 21 
62 5mM Tns/HCl, pH 6 8, with buffer changes after 3 and 6 hours Dialysed samples were 
diluted with an equal volume of solubilisation buffer, which was composed of 62 5mM 
Tns/HCl, pH 6 8, 20%v/v glycerol, 8% SDS, 10% 2-mercaptoethanol and 0 01%w/v 
bromophenol blue Sigmamarker High Range molecular markers were used which consisted 
of Myosin (205,000Da), p-Galactosidase (116,000Da), Phosphorylase b (97,000Da), 
Fructose-6-phosphate kinase (84,000Da), BSA (66,000Da), Glutamic Dehydrogenase 
(55,000Da), Ovalbumin (45,000Da) and Glyceraldehyde-3-phosphate Dehydrogenase 
(36,000Da) Samples in solubilisation buffer and markers were denatured by immersion in a 
boiling water bath for 60 seconds and kept on ice until application onto the gel
2 7 1 2  Preparation of SDS Gel
TABLE 2 1 lists the solutions and their compositions used in the SDS gel All solutions were 
prepared in ultra-pure water
Solution Composition
Acryl/Bisacryl Stock 30% w/v Acrylamide, 0 8%w/v Bisacrylamide
Resolving Gel Buffer 3M Tns/HCl, pH 8 8
Stacking Gel Buffer 0 5M Tns/HCl, pH 6 8
Ammonium Persulphate 1 5%w/v ammonium persulphate
SDS 10%w/v SDS
Running Buffer 0 025M Tns/HCl, 0 192M Glycine, 0 1% SDS, pH 8 3
Table 2 1 SDS Page Buffer Preparation
A 10%v/v resolving gel with a 3 75 %v/v stacking gel was poured with the volumes 
documented in T a b l e  2 2
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S o l u t io n  1 0 % v /v  r e s o l v i n g  G e l  3 7 5 % v /v  S t a c k in g  G e l
(Volume) (Volume)
Acryl/bisacryl solution 5ml 1 5ml
Resolving Gel Buffer 1 8ml
Stackmg Gel Buffer - 2 5ml
Ammonium Persulphate 0 75ml 0 5ml
SDS 0 15ml 0 1ml
Ultra-Pure Water 7ml 5 4ml
TEMED 7 5 1^ 7 5jxl
Table 2 2 SDS PAGE Gel Preparation
Gels were cast in a BioRad Mini Gel set and positioned in an ATTO vertical electrophoresis 
system The gel box was filled with running buffer and 20jll1 of the prepared samples and 
markers were loaded into the wells under buffer head Electrophoresis was earned out at a 
constant current of 25mA per gel and 300V for approximately 2 5 hours
2 713 Visualisation of Proteins
Polyacrylamide gels were stained using a Bnlhant Blue G Colloidal stain kit or a Gelcode 
Blue stain reagent TABLES 2 3 and 2 4 outline the stages performed An image of each 
stained gel was recorded using an Olympus digital camera coupled to Olympus C-2 OW95E 
software Gels were also scanned using a Microtek ScanMaker 330
Step Reagent VOLUME TIME
Fixing 30%v/v Ethanol 2 x 200ml 1 x lOmins
10%v/v glacial acetic acid 1 x 30mins
Rinsing Ultra-pure water 3 x 300ml 3 x 15mins
Staining 80%v/v bnlhant blue 300ml Overnight
20%v/v Methanol
De-staming 10%v/v acetic acid 200ml 5mins
25 %v/v Methanol
Rinsing 25%v/v Methanol 2 x 200ml 2 x 30mins
Table 2 3 Brilliant Blue G Colloidal Staining Procedure
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STEP REAGENT VOLUME TIME
Fixing 30%v/v Ethanol 2 x 200ml 1 x lOmins
10%v/v glacial acetic acid 1 x 30mins
Rinsing Ultra-pure water 3 x 300ml 3 x 15mins
Stauung Gelcode Blue Stain 200ml 60mins
Rinsing Ultra-pure water 2 x 200ml 2 x 15mms
Table 2 4 Gelcode Blue Staining Procedure 
2 7 2. Fluorimetric Assays
Post-column chromatography PO and DPPIV activities were assayed for the presence of 
various peptidase activities incubating the enzyme with different fluonmetnc substrates The 
substrates, their preparation and the peptidases they are commonly used to detect are listed in 
TABLE 2 7 6
Substrate Activity Detected Preparation
Ala-MCA Alanine Ammopeptidase Buffer
Arg-MC A Arginine Ammopeptidase Buffer
Glu-Phe-MCA Chymotrpsin Buffer
Gly-Pro-MCA Dipeptidyl Ammopeptidase IV 50mM Hepes, pH 8 0
Leu-MCA Leucine Ammopeptidase Buffer
Lys-Ala-MCA Dipeptidyl Ammopeptidase II Buffer
Lys-MCA Ammopeptidase B Buffer
Lys-Pro-MCA Dipeptidyl Peptidase IV Buffer
Na-benzoyl-Arg-MCA Papain 4%v/v Ethanol
Pro-MCA Proline Ammopeptidase Buffer
Pyr -MCA Pyroglutamyl Ammopeptidase I 4%v/v Ethanol
Pyr-His-Pro -MCA Pyroglutamyl Ammopeptidase II Buffer
Z-Arg-MCA Trypsin, Papain, 4 %v/v Ethanol
Soya-bean trypsin-like enzyme
Z-Gly-Pro-MCA Prolyl Oligopeptidase 4%v/v Ethanol
zip
Z-Phe-Arg-MCA Plasma kallikrem, Papain, Cathepsin B Buffer
and L, Oligopeptidase B
Table  2 5. Fluorimetric Substrates Tested
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The buffer used for all assays was lOOmM potassium phosphate, pH 7 4 for Prolyl 
Oligopeptidase and 50mM hepes, pH 8 0 for Dipeptidyl Peptidase IV All substrates were 
prepared to IOOjjM and purified enzyme was incubated with each substrate and assayed as^  
outlined in sections 2 4 1 and 2 4 2 Negative controls of each substrate were included which 
consisted of buffer being substituted for enzyme
2 8. A ssay Development
2 8 1. Substrate Solvent Determination (PO/DPPIV)
In order to determine the most compatible solvent to prepare the substrate, lOmM Z-Gly-Pro- 
MCA in the case of PO and lOmM Gly-Pro-MCA for DPPIV stock solutions were dissolved 
in 100% Dimethyl Sulphoxide (DMSO), Dimethylformamide (DMF), Dioxane (DXN), 
Ethanol and Methanol These solutions were diluted to IOOjjM  (0 ImM) with lOOmM 
potassium phosphate, pH 7 4 for PO and 50mM Hepes, pH 8 0 for DPPIV Each substrate 
had the solvent concentration adjusted to 4%v/v Both enzymes were assayed in triplicate 
with suitable negative controls as outlined in sections 2 4 1 and 2 4 2
2 8 2. Solvent Concentration Determination (DPPIV)
0 ImM Gly-Pro-MCA was prepared in a range of increasing Ethanol concentrations to assess 
the optimum for DPPIV activity lOmM Gly-Pro-MCA in 100% Ethanol was diluted to 
0 ImM with 50mM Hepes, pH 8 0 and the ethanol concentration was adjusted to 1%, 2%, 
4%, 6%, 8% and 10% The assay was earned out as desenbed in section 2 4 2 and the 
suitable negative controls included
2 8 3. Linearity of Enzyme Assays with Respect to Time 
2 8 3 1 Discontinuous Assay
In order to assess the effect of the punfied enzyme in cleaving its corresponding substrate 
over the allocated assay time the enzymes were assayed as desenbed in sections 2 4 1 and 
2 4 2 Reactions were terminated with 1 5M acetic acid after 10, 20, 30, 40, 50 and 60mins 
and the fluorescence measured Plots of fluorescent intensity versus time were constructed
2 8 3 2 Continuous Assay
In addition to the discontinuous assay, a continuous assay was also performed 300|il of 
punfied enzyme and 1 2ml of 0 ImM Z-Gly-Pro-MCA in lOOmM potassium phosphate, pH 
7 4 with 5mM DTT for PO and 1 2ml of 0 ImM Gly-Pro-MCA in 50mM Hepes, pH 8 0 for 
DPPIV were pre-incubated separately at 37°C for 15mms to allow thermal equihbnum
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Substrate and enzyme were combined in a pre-warmed cuvette in a holder attached to a water 
bath at 37°C. The fluorescence was continuously monitored by the Perkin Elmer LS-50 
Luminescence Spectrometer for 60mins. Plots of fluorescent intensity versus time were 
prepared.
2.8.4. Linearity of Enzyme Assays with Respect to Enzyme Concentration 
(DPPIV)
A range of dilutions of purified DPPIV were prepared in 50mM Hepes, pH 8.0. The enzyme 
dilutions were assayed in triplicate with 0.1 mM Gly-Pro-MCA as described in section 2.4.2. 
A plot of fluorescent intensity versus enzyme concentration (%) was constructed.
2.8.5. Optimum Assay Temperature (DPPIV)
Purified DPPIV was assayed at 4°C, 24°C, 30°C, 35°C, 37°C, 40°C, 50°C and 60°C by a 
modification of the method described in section 2.4.2. Both the substrate and enzyme were 
pre-incubated at the appropriate temperature for 15 minutes prior to the assay to ensure 
uniform thermal equilibrium had been reached.
2.8.6. Effect of DTT on Substrate Hydrolysis
2.8.6.1. Effect of DTT on PO activity
2ml aliquots of 0.1 mM Z-Gly-Pro-MCA in 4%  Methanol were prepared incorporating 0, 5, 
10, 15, 20, 25 and 30mM of the cysteine protease activator, dithiothreitol (DTT) to assess its 
requirement for inclusion in the substrate in addition to the chromatography running buffers. 
Purified PO was assayed in triplicate as outlined in section 2.4.1.
2.8.6.2. Effect of DTT on DPPIV activity
1.6ml aliquots of O.lmM Gly-Pro-MCA in 4% Ethanol were prepared incorporating 0, 2.5, 5, 
10, 15, 20mM dithiothreitol (DTT). Purified DPPIV was assayed in triplicate as outlined in 
section 2.4.2.
2.8.7. Effect of EDTA on Substrate Hydrolysis
2.8.7.I. Effect of EDTA on PO activity
2ml aliquots of O.lmM Z-Gly-Pro-MCA in 4% Methanol were prepared incorporating 0, 0.2, 
0.4, 0.6, 0.8, 1, 1.5 and 2mM of the metal chelator, EDTA to explore its potential for 
inclusion in both the substrate and chromatography running buffers. Purified PO was assayed
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in triplicate as outlined in section 2 4 2 The protocol was repeated including 5mM DTT to 
assess the optimised conditions Purified PO was assayed as described in section 2 4 1
2 8 7 2 Effect of EDTA on DPPIV activity
1 6ml aliquots of 0 ImM Gly-Pro-MCA in 4% Ethanol were prepared incorporating 0, 1,2 5, 
5, 7 5, 10, 15 and 20mM EDTA Purified DPPIV was assayed in triplicate as outlined in 
section 2 4 2
2 9 Stability  Studies of PO
2 9 1 Effect of 37°C pre-incubation on PO activity
In order to determine the thermal stability of the Prolyl Oligopeptidase enzyme during the 
assay, purified PO was mcubated at 37°C over time and stored at 4°C until it’s activity was 
monitored 6ml of purified PO was placed in a container and immersed in a 37°C water-bath 
Over a period of 4 hours, 450|il aliquots of the sample were removed from the water-bath, 
labelled and stored at 4°C In addition, the stabilising effect of the protein, bovine serum 
albumin was also investigated 1% and 10% w/v BSA was added to the ‘purified PO’ and 
both were maintained at the required temperature for 90mins The activity of all fractions was 
assayed as outlined in section 2 4 1
2 9.2 Stability of PO when stored at-20°C
Post QAE PO was normally stored in a frozen state in the freezer Therefore the stability of 
the enzyme in these conditions was explored The difference in stability when 1% BSA w/v 
was added to the enzyme was also investigated Two sets of five 0 5ml aliquots of post-QAE 
PO were prepared To one set of the aliquots, 1% BSA w/v was added (5mg BSA in 0 5ml) 
Four of the five fractions were then labelled and frozen 20ml of 100|xM Z-Gly-Pro-MCA 
with 5mM DTT and 0 5mM EDTA was also prepared, aliquoted into five 4ml fractions, 
labelled and frozen The remaining aliquot of PO and PO with 1% BSA was assayed as 
outlined in section 2 4 1 The activity results were then labelled as Day 0 or Positive 
Controls After 24 hours (Day 1), one of each aliquot was removed from the freezer, thawed 
and the PO enzymatic activity analysed and recorded This was repeated for Days 2, 3 and 31 
(1 month)
A similar study was earned out on buffered saliva The saliva was prepared as desenbed in 
section 2 5 1 The buffered saliva was labelled, aliquoted and frozen as already outlined One 
set of buffered saliva samples had 20% glycerol added to determine any potential stabilising 
effect Both sets were then assayed as outlined in section 2 4 1 for Days 0, 3, 5, 6 and 22
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2  1 0  C h a r a c t e r i s a t i o n
2.10 1. Relative Molecular Mass Determination
The native molecular mass of Bovine Serum Dipeptidyl Peptidase IV was determined by Gel 
Filtration Chromatography while its monomenc molecular weight was estimated by 
Polyacrylamide Gel Electrophoresis
2 10 1 1 Sephacryl S-300 HR Gel Filtration Chromatography
A L20ml Hiprep 16/10, Sephacryl S-300 High Resolution, column was used The protocol
used was a modification of that described in section 2 6 3
2 1 0 1 1 1  Void Volume Determination
The Sephacryl S-300 HR column was equilibrated with 200ml 50mM Hepes, pH 8 0 with 
lOOmM NaCl 1ml of 2mg/ml blue dextran solution was loaded via the Inject mode on the 
BioLogic system The column was washed with equilibration buffer until the blue dextran 
was visibly eluted The online absorbance at 280nm was monitored and the volume at which 
the absorbance reached a maximum was estimated to be the void volume (V0)
2 10 1 1  2 Column Calibration
The S300 HR column was equilibrated as outlined in section 2 9 1 1 2  1ml of each standard 
was applied at a concentration of 2mg/ml containing 10% v/v glycerol TABLE 2 6 lists the 
standards used and their molecular weights The elution volume (Ve) of each standard was 
monitored and calculated by the Biologic in situ 280nm UV detector as outlined in section 
2 10 1 1 1 A plot of Log molecular mass versus V /V 0 of each standard, was prepared and a
calibration curve for the column was constructed
STANDARD MOLECULAR WEIGHT (kDa)
Thyroglobulm 669
Apofemtin 443
Alcohol Dehydrogenase 150
BSA 66
Carbonic Anhydrase 29
Cytochrome C 12
TABLE 2 6 MOLECULAR WEIGHT MARKERS USED IN S300 CALIBRATION
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2 10 1 1  3 Estimation o f  Relative Molecular Mass o f  Purified DPPIV  
The sephacryl S300 column was prepared and equilibrated as described in section 2 9 1 12  
lml of purified DPPIV with 10% v/v glycerol was loaded onto the column 3ml fractions 
were collected and assayed for DPPIV activity as outlined in section 2 4 4 In addition, the 
protein content of the fractions was monitored online by the 280nm UV detector Both 
protocols allowed for the determination of the elution volume (Ve), where the maximum 
DPPIV activity corresponded with the maximum protein peak The molecular mass of the 
enzyme was determined using the calibration curve constructed from section 2 9 1 13
2 10 1 2 SDS Polyacrylamide Gel Electrophoresis
The SDS PAGE of the standards and samples was earned out as desenbed in section 2 7 1 
The gel obtained for punty assessment was also used for molecular weight determination as 
well as the number of sub-units that are present A standard curve of the Log Molecular Mass 
versus the Relative Mobility (Rf) of each standard was constructed The Rf value is defined as 
the distance migrated by the standard or sample divided by the distance of the bromophenol 
blue dye front The Log molecular mass of the punfied enzymes was thus calculated from the 
calibration curve and its relative molecular mass estimated
2 10 2 DPPIV Glycosylation Estimation of SDS gel
Polyacrylamide gels were also stained with a Gelcode Glycoprotein Staining kit The gels 
were prepared and run as desenbed in section 2 7 12 No markers were included but were 
substituted for a Positive glycosylated control of Horseradish Peroxidase and a Negative 
glycoslated control of Soyabean Trypsin Inhibitor Each control was applied onto the gel in 
separate lanes When electrophoresis was complete, the gels were stained employing the 
method outlined in TABLE 2 7 The gels were scanned using a Microtek ScanMaker 330 and 
the image was recorded
Step REAGENT Volume Time
Fixing 30% Ethanol 100ml 30mins
RmsingAV ashing 3% Acetic Acid 100ml lOmins
Oxidising Oxidation Solution 25 ml 15mins
Washing 3% Acetic Acid 100ml 3 x 5mins
Staining Staining Solution 25 ml 15mins
Reducing Reduction Solution 25 ml 5mins
Washing 3% Acetic Acid 100ml 30mins
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2 10 1 1 3 Estimation o f  Relative Molecular Mass o f  Purified DPPIV  
The sephacryl S300 column was prepared and equilibrated as described in section 2 9 1 12  
lml of purified DPPIV with 10% v/v glycerol was loaded onto the column 3ml fractions 
were collected and assayed for DPPIV activity as outlined in section 2 4 4 In addition, the 
protein content of the fractions was monitored online by the 280nm UV detector Both 
protocols allowed for the determination of the elution volume (Ve), where the maximum 
DPPIV activity corresponded with the maximum protein peak The molecular mass of the 
enzyme was determined using the calibration curve constructed from section 2 9 1 1 3
2 10 1 2 SDS Polyacrylamide Gel Electrophoresis
The SDS PAGE of the standards and samples was earned out as desenbed in section 2 7 1 
The gel obtained for punty assessment was also used for molecular weight determination as 
well as the number of sub-units that are present A standard curve of the Log Molecular Mass 
versus the Relative Mobility (Rf) of each standard was constructed The Rf value is defined as 
the distance migrated by the standard or sample divided by the distance of the bromophenol 
blue dye front The Log molecular mass of the punfied enzymes was thus calculated from the 
calibration curve and its relative molecular mass estimated
2 10 2 DPPIV Glycosylation Estimation of SDS gel
Polyacrylamide gels were also stained with a Gelcode Glycoprotein Staining kit The gels 
were prepared and run as desenbed in section 2 7 12 No markers were included but were 
substituted for a Positive glycosylated control of Horseradish Peroxidase and a Negative 
glycoslated control of Soyabean Trypsin Inhibitor Each control was applied onto the gel in 
separate lanes When electrophoresis was complete, the gels were stained employing the 
method outlined in TABLE 2 7 The gels were scanned using a Microtek ScanMaker 330 and 
the image was recorded
Step Reagent Volume Time
Fixing 30% Ethanol 100ml 30mins
Rinsing/Washing 3% Acetic Acid 100ml lOmins
Oxidising Oxidation Solution 25 ml 15mins
Washing 3% Acetic Acid 100ml 3 x 5mins
Staining Staining Solution 25 ml 15mins
Reducmg Reduction Solution 25 ml 5mins
Washing 3% Acetic Acid 100ml 30mins
2 10 4 3 pH Inactivation (DPPIV)
5ml of post Poros 50 HQ Sepharose DPPIV was dialysed overnight against 21 distilled water 
at 4°C 50jil of dialysate was pre-incubated with 50|il of each 50mM buffer listed in TABLE 
2 8 at 37°C for 15 minutes IOOjiM Gly-Pro-MCA was prepared m 50mM Hepes, pH 8 0 
The effect of the pH was determined by assaying enzyme activities in triplicate as outlined in 
section 2 4 2
2 10 5 Isoelectric Point Determination of DPPIV 
2 10 5 1 Chromatofocusing Chromatography
A 25ml polybuffer exchanger (PBE 94) column was equilibrated with 300ml 50mM 
Imidazole/HCl pH 7 8 Polybuffer 74 was diluted 8-fold in distilled water and the pH 
adjusted to 4 5 using HC1 15ml of the diluted polybuffer was applied to the column after 
equilibration 5ml purified DPPIV was dialysed overnight against 3L lmidazole/HCL, pH 7 8 
at 4°C and applied onto the chromatofocusing resin The resin was washed with 300ml 
polybuffer, pH 4 5 3ml fractions were collected throughout and assayed for DPPIV activity 
as outlined in section 2 4 4 The pH of the fractions was also measured and a plot of both 
fluorescent intensity and pH versus fraction number was constructed
2 10 5 2 Isoelectric Focusing
A vertical pre-cast isoelectric focusing (IEF) gel system was employed to determine the 
isoelectric point of purified DPPIV The enzyme was dialysed overnight against 21 50mM 
Hepes, pH 8 0 to remove any IEF contaminants such as salt The dialysed sample was diluted 
with an equal volume of sample buffer (TABLE 2 9 ) The gels were prepared in an ATTO 
vertical electrophoresis system (160mm x 160mm x 1mm) After the bottom of the chamber 
was filled with lx  anode running buffer, the gels were placed in position and the upper 
chamber filled with cathode buffer 20|il of each prepared sample and reconstituted markers 
were load into the wells under the cathode buffer Electrophoresis was earned out at 100V for 
60mins, 200V for the second 60mins and 500V for the final 30mins with the current running 
from 5mA-6mA/gel Staining was performed on the gel using bnlhant blue G colloidal stain 
as outlined in TABLE 2 3 The stained gel image was captured using a UVP white/UV 
transluminator camera unit dnven by Image-Store 7500 software A standard curve was 
constructed of the pi versus the Rf for each of the IEF markers electroforesed The Rf 
represents the distance migrated by the standard or sample divided by the distance to the 
anoidic lip of the gel The pi of DPPIV was estimated using the calibration curve by 
calculating its Rf value from the stained gel
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SOLUTION COMPOSITION
Anode buffer (50X) 4 7%w/v phosphonc acid
Cathode buffer (10X) 3 5%w/v arginme, 2 9%w/v lysme
Sample buffer 20%v/v 10X cathode buffer, 30%v/v glycerol
Table 2 9 IEF Buffers used for pi determination
MARKER pi
Cytochrome C (horse heart) 10 7
Ribonuclease A (bovine pancreas) 95
Lectin {Lens cuhnans) 8 3, 8 0, 7 8
Myoglobin (horse muscle) 7 4 ,6 9
Carbonic anhydrase (bovine erythrocytes) 6 0
p-Lactoglobulin (bovine milk) 5 3 ,5 2
Trypsin inhibitor (soyabean) 45
Glucose oxidase (Aspergillus mger) 4 2
Amyloglucosidase (Aspergillus mger) 35
TABLE 2 10 IEF MARKERS USED FOR Pi DETERMINATION 
2 10 6. Catalytic Classification of DPPIV
A range of functional reagents was prepared as presented in TABLE 2 9 4 to assess the 
catalytic classification of Bovine Serum DPPIV 20ml purified DPPIV was dialysed 
overnight at 4°C against 31 of 50mM Hepes/HCl, pH 8 0 All stock solutions were prepared 
in 50mM Hepes and 1M HC1 was added to ensure a final pH of 8 0 Water insoluble reagents 
were first dissolved in a minimum volume of acetone and the volume’s and pH’s adjusted 
using HCI Lower concentrations of each functional reagent were achieved using 50mM 
Hepes/HCl, pH 8 0 ± acetone as appropnate (TABLE 2 11) 50fxl of the dialysed enzyme was 
pre-mcubated for 15min at 37°C with an equal volume of each functional reagent under 
investigation Positive controls were included where the functional reagent was replaced 
with 50mM Hepes/HCl buffer, pH 8 0 containing the appropnate percentage v/v acetone as 
the corresponding reagent DPPIV activity was determined fluonmetncally in tnphcate as 
detailed in section 2 4 1 The fluorescent filtenng effect of these functional reagents was 
assessed by the construction of unfiltered and filtered MCA standard curves as descnbed in 
sections 2 2 1 ,2 2 2  and 2 4 2
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Class Reagent Stock Conc 1 Preparation
Senne protease inhibitors AEBSF 45mM Buffer
APMSF 20mM 5%v/v acetone
Aprotimn 2 5mg/ml Buffer
Benzamidine 20mM Buffer
Leupeptin 2mM Buffer
PMSF 5 mg/ml Buffer
Metallo-protease inhibitors 1,10-phenanthrohne3 40mM 10%v/v acetone
1,7-phenanthrolme3 30mM 10%v/v acetone
4,7 -phenanthroline3 40mM 10%v/v acetone
8-hydroxyquinohne3 20mM 5%v/v acetone
CDTA2 20mM Buffer
EDTA 40mM Buffer
EGTA2 20mM Buffer
Imidazole 20mM Buffer
Cysteine protease inhibitors DTNB 20mM Buffer
Iodoacetamide 20mM Buffer
Iodoacetic acid 40mM Buffer
NEM 20mM Buffer
Cysteine protease activators 2-mercaptoethanol 2 %v/v Buffer
DTT 20mM Buffer
Table 211 Reagents used in th e  C a ta ly tic  C lassification  o f  DPPIV 
Buffer is 50mM Hepes/HCl, pH of 8 0
1 Concentration of the functional reagent before added to the enzyme (l e 2X)
2 Samples had to be heated at 37°C to achieve dissolution 
3Samples had to be maintained at 50°C until diluted
2 10 7 Effect of General Functional Reagents on DPPIV
The effect of a range of some general functional reagents on DPPIV activity was also tested 
As m section 2 10 6 all stock solutions were prepared in 50mM Hepes/HCl pH 8 0 
Addition of minimum volume acetone aided the dissolution of water-insoluble compounds 
and as before 50mM Hepes/HCl pH 8 0 ± acetone was used as diluant 6ml of purified 
DPPIV was dialysed against 21 of 50mM Hepes/HCl pH 8 0 overnight at 4°C 50|xl dialysed
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enzyme was pre-mcubated for 15min at 37°C with an equal volume of each functional 
reagent to be tested Positive controls and blanks were included and DPPIV activity was 
determined fluonmetncally in triplicate as detailed in section 2 4 1 The effect of fluorescent 
filtering by these functional reagents was assessed as outlined in section 2 2 2
Reagent Inhibits Stock Preparation
Antipain Papain, Trypsin 5 mg/ml Buffer
Bacitracm Protein proteases 2 mg/ml Buffer
Carnitine PO 20mM Buffer
Pepstatin A Pepsin, Renin 2 mg/ml 5 %v/v acetone
HIV-I protease
Puromycin Protein proteases 2mg/ml Buffer
Trypsin Inhibitor Trypsin 2mg/ml Buffer
Table 2 12 PREPARATION OF OTHER FUNCTIONAL REAGENTS TESTED
Buffer is 50mM Hepes/HCl, pH 8 0 Pepstatin A was initially dissolved m 100%v/v acetone 
and adjusted to stock concentration by addition of 50mM Hepes buffer
2 10.8 Effect of Metal Ions on DPPIV Activity
The effects of metal salts on DPPIV activity was assessed using Ca, Cd, Co, Cu, Mg, Mn, 
Hg, Na, Ni, Zn sulphates 5mM stock solutions were prepared in 50mM Hepes/HCl pH 8 0 
Punfied DPPIV was dialysed against 41 50mM Hepes/HCl, pH 8 0 for 5hr at 4°C 50|li1 metal 
salt and 50^1 dialysed enzyme was pre-incubated in triplicate at 37°C for 15min Negative 
controls had 50|xl buffer added to the metal instead of enzyme while positive controls 
consisted of 50jxl buffer in place of the metal salt Following pre-incubation, 400fxl of 
0 ImM Gly-Pro-MCA substrate was added to each triplicate and assayed as descnbed in 
section 2 4 2
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Metal Concentration
(mM)
Preparation and COMMENTS
50mM Hepes/HCl, pH  8.0
CaS04 5.0 Normal
CdS04 5.0 Normal
CoS04 5.0 Heating at 37°C required
CuS04 5.0 Potassium phosphate
HgS04 5.0 Initially dissolved in 1M HC1 then diluted with Hepes, 
pH 8.0
MnS04 5.0 Readily falls out of solution
MgS04 5.0 Normal
NaS04 5.0 Normal
NiS04 5.0 Normal
ZnS04 5.0 Normal
Table 2.13. Preparation o f  M eta l S a lts  Tested on DPPIV A ctiv ity  
2.10.9. Effect of General Salts on DPPIV activity
2.10.9.1. Effect of Ammonium Sulphate on DPPIV
2.10.9.1.1. Ammonium Sulphate effect in the substrate
0.2mM Gly-Pro-MCA was prepared in 50mM Hepes/HCl, pH 8.0. 0, 200, 600, 1200, 1600 
and 2000mM Ammonium Sulphate was also prepared in 50mM Hepes and the pH was 
adjusted to 8.0 with 1M NaOH. 1ml of the substrate was added to an equal volume of 
appropriate Ammonium Sulphate solution in triplicate and incubated at 37°C to reach thermal 
equilibrium. This gave a final Ammonium Sulphate concentration of 0, 100, 300, 600, 800 
and lOOOmM. lOOpl of purified DPPIV was added to the triplicates and assayed as outlined 
in section 2.4.2. Negative controls were included which consisted of substituting 100|xl of 
enzyme with 100|xl of 50mM Hepes/HCl. The positive control was included by the presence 
of the OmM Ammonium Sulphate/substrate solution. The influence of the salt on fluorescent 
filtering was taken into account as described in section 2.2.2.
2.10.9.1.2. Ammonium Sulphate effect with the enzyme
0, 400, 800, 1200, 1600 and 2000mM Ammonium Sulphate was prepared in 50mM Hepes 
and the pH was adjusted to 8.0 with 1M NaOH. 200jj,1 of the enzyme was added to an equal 
volume of appropriate Ammonium Sulphate solution, divided into triplicates and pre­
incubated at 37°C to reach thermal equilibrium. This gave a final Ammonium Sulphate
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concentration of 0, 200, 400, 600, 800 and lOOOmM 400^1 of substrate was added to each 
triplicate and assayed as outlined in section 2 4 2 Negative controls were included which 
consisted of substituting lOOjxl of enzyme with 100|il of 50mM Hepes/HCl with the 
appropriate Ammonium Sulphate concentration The positive control was included by the 
presence of the OmM Ammonium Sulphate/enzyme solution The influence of the salt on 
fluorescent filtering was taken into account as described in section 2 2 2
2 10 9 2 Effect of Sodium Chloride on DPPIV activity
2 10 9 2 1 Sodium Chloride effect in the substrate
0 2mM Gly-Pro-MCA was prepared in 50mM Hepes/HCl, pH 8 0 0, 400, 800, 1200, 1600 
and 2000mM Sodium Chloride was also prepared in 50mM Hepes/HCl, pH 8 0 1ml of the 
substrate was added to an equal volume of the appropriate Sodium Chloride solution in 
triplicate and incubated at 37°C to reach thermal equilibrium This gave a final Sodium 
Chloride concentration of 0, 200, 400, 600, 800 and lOOOmM 100fxl of purified DPPIV was 
added to the triplicates and assayed as outlined in section 2 4 1 Negative controls were 
included which consisted of substituting 100p,l of enzyme with lOOjxl of 50mM Hepes/HCl 
The positive control was mcluded by the presence of the OmM Sodium Chlonde/substrate 
solution The influence of the Sodium Chloride salt on fluorescent filtering was taken into 
account as described in section 2 2 2
2 1 0 9  2 2 Sodium Chloride effect with the enzyme
0, 200, 600, 1200, 1600 and 2000mM Sodium Chloride was prepared m 50mM Hepes/HCl , 
pH 8 0 200^1 of the enzyme was added to an equal volume of appropriate Sodium Chloride 
solution, divided into triplicate and incubated at 37°C to reach thermal equilibrium This gave 
a final Sodium Chloride concentration of 0, 200, 400, 600, 800 and lOOOmM 400jil of the 
substrate was added to each triplicate and assayed as outlined in section 2 4 2 Negative 
controls were mcluded which consisted of substituting 100|xl of enzyme with lOOjil of 50mM 
Hepes/HCl with the appropriate Sodium Chloride concentration The positive control was 
mcluded by the presence of the OmM Sodium Chlonde/enzyme solution The influence of the 
salt on fluorescent filtering was taken into account as described in section 2 2 2
2 10 9 3 Effect of Potassium Chloride on DPPIV activity
2 10 9 3 1 Potassium Chloride effect with the enzyme
0, 200, 600, 1200, 1600 and 2000mM Potassium Chloride was prepared in 50mM 
Hepes/HCl, pH 8 0 200jj] of the enzyme was added to an equal volume of appropnate
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Potassium Chloride solution, divided into triplicate and incubated at 37°C to reach thermal 
equilibrium This gave a final Potassium Chloride concentration of 0, 200, 400, 600, 800 and 
lOOOmM 400fil of the substrate was added to each triplicate and assayed as outlined m 
section 2 4 2 Negative controls were included which consisted of substituting lOOjutl of 
enzyme with lOOjxl of 50mM Hepes/HCl with the appropriate Potassium Chloride 
concentration The positive control was mcluded by the presence of the OmM Potassium 
Chlonde/enzyme solution The influence of the salt on fluorescent filtering was taken into 
account as described in section 2 2 2
2.10.10 Substrate Specificity
2 10 10 1 Reverse Phase HPLC Analysis
HPLC analysis was earned out in order to ascertain the substrate specificity of DPPIV 
towards a number of synthetic and bio-active peptides A Beckman Chromatographic system 
was used incorporating a Programmable module (dual pump), a 526 Photo-Diode array 
Detector and a 507 autosampler served by Beckman 32 Karat HPLC software A Waters 
Sphensorb ODS-2 C-18 analytical column (250mm x 4 6mm) and a Supelguard LC-18 guard 
column was employed for all analysis TABLES 2 15 and 2 16 lists the peptides analysed and 
the mode of preparation required 400|il of each peptide was incubated with lOOjil of purified 
DPPIV at 37°C for 24 hours Negative controls (no enzyme) and blanks were also included 
25}il 0 5 %v/v TFA was added to terminate the reaction after 24 hours 20jlx1 of each post- 
incubation sample, control and blank was applied at 0 5ml/min to the column which has been 
equilibrated 100% buffer B A 4ml wash of buffer B was earned out followed by a 10ml 
linear gradient from 100% buffer B to 100% buffer A A further 5ml wash of 100% buffer A 
eluted any strongly bound peptides from the column The absorbance of the eluant was 
continuously monitored online at 214nm and 280nm The column was equilibrated between 
injections with 100% buffer B
Component Buffer A Buffer B
%v/v %v/v
Ultra-pure Water 
HPLC-grade Acetomtnle 80
19 8 94 8
5
TFA 02 02
Table 214 Buffer Composition employed for HPLC Analysis
Buffer were filtered and degassed through a 0 45 pm membrane filter pnor to use
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Peptide Concentration
(mM)
Preparation
Ala-Pro-Gly 5mM Buffer
Asp-Pro-Gln-Phe-Tyr 3mM Buffer*
Glu-Pro-Glu-Phe-T yr 3mM Buffer*
Gly-Pro-Ala 5mM Buffer
Gly-Pro-Arg 5mM Buffer
Gly-Pro-Gly-Gly 5mM Buffer
Gly-Pro-Hyp 5mM Buffer
Gly-Pro-Pro 5mM Buffer
Phe-Pro-Ala 5mM Buffer
Tyr-Pro-Phe 5mM Buffer
Z-Pro-Ala 1 3mM 10%v/v ACN
Z-Pro-Gly 1 3mM 10%v/v ACN
Z-Pro-Leu 1 3mM 10%v/v ACN
Z-Pro-Pro 1 3mM Buffer*
Table 215 Preparation o f  Synthetic HPLC Peptides
Buffer refers to 50mM Hepes, pH 8 0, was also the diluent for water insoluble peptides 
* Somcation was required to achieve complete dissolution
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Peptide Concentration
(mM)
Preparation
APi U 0 2 50%v/v Acetic Acid
Ap20 29 05 Buffer
Aß29 40 02 0 4%v/v TFA
Angiotensin I 2 Buffer*
(Arg)8 -Vasopressin 1 Buffer
p-Casomorphin 3 Buffer
Bradykinin 2 Buffer
CRP20I 206 3 Buffer
Enterostatin 3 Buffer
IGF! 3 5 Buffer
LHRH 2 10%v/v ACN
Neuropeptide Y (1-24) 0 2 Buffer*
Neurotensin9 ]3 3 Buffer
Substance P 3 Buffer*
TRH 1 3 10%v/v ACN
Table  2 16 Preparation  of Bioactive HPLC Peptides
Buffer refers to 50mM Hepes, pH 8 0, which was also used for water insoluble peptides 
*Sonication was employed to achieve complete dissolution
2 10 10 11  Inhibition o f  p-Casomorphin hydrolysis
2mM of p-Casomorphin was prepared as described in Table 2 16 2 x KT4 M H-Ile- 
Pyrohdide, a specific DPPIV inhibitor was also prepared as outlined in Table 2 17 200jil of 
P-Casomorphin was pre-incubated with 200^1 of the inhibitor for 15 minutes at 37°C 50|il of 
purified DPPIV was added and the reaction was earned out and analysed as outlmed in 
section 2 10 8 1
2 1010 2 Kinetic Analysis
2 10 10 2 1  KM Determination fo r  Gly-Pro-MCA
A stock solution of 0 5mM Gly-Pro-MCA in 50mM Hepes/HCl, pH 8 0 was prepared The 
stock solution was diluted to a range of Gly-Pro-MCA concentrations with 50mM 
Hepes/HCl, pH 8 0 The DPPIV enzyme activity was assayed on each substrate concentration 
in tnphcate as desenbed in section 2 4 2 The Michaclis-Menten constant, Km and the
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maximum velocity value, Vmax for the substrate was determined using Michaelis-Menten, 
Lineweaver-Burk, Eadie-Hofisee and Hanes-Woolf plot analysis
2 10 10 2 2 KM Determination fo r Lys-Pro-MCA
As outlined in the previous section 2 9 8 1 1, a stock solution of 0 5mM Lys-Pro-MCA was 
prepared and analysed as described The KM and Vmax constants were also calculated using 
the aforementioned plot analyses
2 10 11 Inhibitor Studies of DPPIV
2 10 111 ICS0 Determination of DPPIV Specific Inhibitors
A range of DPPIV specific inhibitors were assayed to investigate its potency against DPPIV 
activity TABLE 2 17 outlines the preparation and stock concentration of each inhibitor 
investigated Stock solutions were prepared in 50mM Hepes/HCl, pH 8 0 (+/- solvent where 
necessary) Dilutions of each inhibitor were made up in 50mM Hepes/HCl, pH 8 0 to produce 
a range of serial dilutions 1ml of each dilution was added to double strength substrate 
resulting in a final concentration of 0 ImM Gly-Pro-MCA IOOjliI of purified DPPIV was 
incubated in triplicate with 400(4,1 of appropriate substrate/inhibitor solution for 1 hour at 
37°C Suitable blanks and controls were included The IC50 for each inhibitor was determined 
for DPPIV
2 10 11 2 Kj Determination of DPPIV Specific Inhibitors
The effect of specific inhibitors on the cleavage of DPPIV on Gly-Pro-MCA was evaluated 
A l,000|j,M stock solution of Gly-Pro-MCA A range of substrate dilutions was prepared 
from 0-l,000|iM usmg 50mM Hepes, pH 8 0 as diluant 800 \i\ of a predetermined inhibitor 
concentration was added to an equal volume of each substrate dilution resulting in a final 
substrate range of O-SOO^ iM DPPIV was assayed in triplicate as described in section 2 4 1 
The resulting data was applied to Micheahs-Menton and Lineweaver Burk plot a n a ly se s  
where the mode the inhibition could be ascertained and the inhibition constant, K, calculated
Inhibitor Stock Solution (M) Preparation
Diprotin A 1x105 Hepes
Diprotin B lxlO 3 Hepes
H-Ile-Thiazolidide 1x10" 10%v/v MeOH
H-IIe-Pyrrolidide lxlO 3 10%v/v MeOH
Table 217 Preparation  of Specific  DPPIV Inhibitors
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2 10 11 3 K, Determinations of p-Casomorphin and Substance P
The effect of two proline containing peptides on the cleavage of DPPIV on Gly-Pro-MCA 
was evaluated A range of substrate dilutions was prepared from 0-l,000|xM using 50mM 
Hepes, pH 8 0 as diluant 800 pJ of either 0 3mM p-Casomorphin or 0 2mM Substance P was 
added to an equal volume of each substrate dilution resulting in a final substrate range of 0- 
500jnM DPPIV was assayed in triplicate as described in section 2 4 1 The resulting data was 
applied to a number of kinetic models where the mode the inhibition could be ascertained and 
the inhibition constant, K, calculated, (See Appendix, section 6 4 2 )
85
3 .0 . R e s u l t s
3  o  R e s u l t s
The majority of upcoming graphs illustrate data points that represent the average of triplicate 
fluorescence or absorbance readings, minus the blank measurement All error bars represent the 
standard error of the mean of these triplicate values (see section 6 1)
3 1  M CA S ta n d a rd  C u rv es  and t h e  In n er  F i l t e r  E f f e c t  
MCA standard curves were prepared as outlmed in section 2 2 1 Plots of fluorescent intensity 
versus MCA concentration were constructed for both MCA ranges and the slope of the lines 
calculated FIGURES 3 11 and 3 12 represent typical MCA standard curves at emission slit 
widths of lOnm and 2 5nm respectively Demonstration of the inner filter effect was also 
performed as described in section 2 2 2 to assess the effect on fluorescence of including crude or 
post column fractions m the assay mixture FIGURES 3 13 and 3 1 4 are plots of fluorescence 
versus MCA concentration for buffered saliva and crude serum TABLE 3 1 lists the slopes 
calculated for each curve and the degree of filtering observed for enzyme samples
Sample "  i F ............... Slope Filtering
%
lOnm, 2 5nm
Buffer 0 998 12 98 0 0
Serum 0 999 10 51 19
Post-phenyl sepharose DPPIV 0 999 12 55 33
lOnm, lOnm
Buffer 0 998 149 25 0 0
Buffered Saliva 0 997 13175 11 7
Post-phenyl sepharose PO 0 999 149 10 0 0
Table 3 1 Slopes of Filtered Standard  Curves
3 1.1 Optimum MCA Excitation and Emission Wavelengths
Scans of fluorescence versus wavelength were performed on free MCA as outlined in section 
2 2 3 m order to determine the optimum excitation and emission wavelengths for this compound 
Figures 3 1 5 and 3 16 show that the optimum excitation and emission wavelengths for MCA 
are 370nm and 440nm respectively
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Figure 3 .1 1
6 50  - ,
M C A  concentration (jaM)
Figure  3 .1 2 .
M C A  concentration (joM)
Figures 3 .1 1 and  3.1 2 M CA Standard Curves for slit w idths 10 ,10  and 
10, 2 5 Plot of fluorescent Intensity versus free MCA concentration
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F i g u r e  3 .1 .3
M C A  Concentration (}iM )
F igure 3.1.4.
M C A  concentration ((jM )
Figures 3.1.3 and 3.1.4. MCA Quenched Standard  Curves for slit widths 
10, 10 AND 10, 2.5
Plots of Fluorescent Intensity versus free MCA concentration. The quenching agents used 
were Buffered Saliva and Bovine Serum respectively.
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F i g u r e  3 .1 .5
Excitation  W avelength  (nm )
Figure 3.1 6.
E m ission  W avelength (nm )
Figures 3 1 5  and  3 1 6 . MCA Excitation and Em ission  Scans
Plot of fluorescent intensity versus wavelength for free MCA in solution FIGURE 3 15 illustrates an 
optimum excitation wavelength of 370nm for MCA while FIGURE 3 1 6 shows an emission 
wavelength of 440nm as optimal
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BSA standard curves were prepared according to the methods given m section 2 3 Plots of 
protein absorbance versus BSA concentration are presented in FIGURES 3 2 1 , 3 2 2  and 3 2 3  
for the Biuret, standard BCA and enhanced BCA assays respectively
3  2  P r o t e i n  D e t e r m i n a t i o n
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F i g u r e  3  2 1
BSA concentration (mg/ml)
Figure 3 2 1 Biuret Protein Standard Curve 
Plot of absorbance at 570nm versus BSA concentration
Figure 3 2.2
BSA concentration (mg/ml)
Figure 3 2 2 BCA Protein  Standard Curve 
Plot of absorbance at 570nm versus BSA concentration
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F i g u r e  3  2  3
BSA concentration (^ ig/ml)
F igure 3 2 3 Enhanced BCA P ro te in  Standard Curve  
Plot of absorbance at 570nm versus BSA concentration
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3  3  P u r i f i c a t i o n  o f  H u m a n  S a l i v a r y  P r o l y l  O l i g o p e p t i d a s e
3 3 1 Ammonium Sulphate Precipitation
An 80% ammonium sulphate precipitation was earned out as desenbed in section 2 5 2 PO 
activity was precipitated into the pellet after centrifugation The pellet was re-suspended and 
analysed along with the supernatant for PO activity as desenbed m section 2 4 1 The pellet was 
prepared and stored for phenyl sepharose application as outlined in section 2 5 2 FIGURES 
3 3 11 and 3 3 12 show the enzymatic activity present in the supernatants and pellets 
respectively
3 3 2 Phenyl Sepharose Hydrophobic Interaction Chromatography
4ml of post ammonium sulphate precipitation PO was applied to the 25ml phenyl sepharose 
column and partially punfied as desenbed in section 2 5 3 Post column fractions were analysed 
for PO activity as outlined in section 2 4 3 while the protein content of the fractions was also 
determined via UV absorbancy as desenbed in section 2 3 1 FIGURE 3 3 2 1 shows the elution 
profile of PO, where one activity peak is observed when the ammonium sulphate concentration is 
reduced to zero Contaminating protein was washed through the column dunng the 100ml wash 
of lOOmM Potassium Phosphate, pH 7 4 with 5mM DTT and 0 5mM EDTA containing 1M 
ammonium sulphate Fractions containing PO were combined to give the post Phenyl Sepharose 
PO pool 1ml of the pool was retained for activity and protein analysis
3.3 3 Q-Sepharose Fast Flow Anion Exchange Chromatography
lml of dialysed and concentrated post phenyl sepharose PO sample was applied onto the Q- 
Sepharose column and punfied as outlined in section 2 5 4 PO was found to bind and elute to the 
column while separated from the bulk contaminating protein as seen in FIGURE 3 3 3 1 All 
fractions were analysed for Z-Gly-Pro-MCA degrading activity and Coomassie plus protein assay 
as desenbed in sections 2 4 3 and 2 3 3 respectively Fractions containing PO were combined 
and labelled post QAE PO lml was retained as before for activity and protein estimation The 
post QAE PO pool was used as partially pure human salivary PO
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Figure 3 3 1 .1  PO Activity in  Supernatants After Salt Fractionation
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Figure 3 3 2.1. Phenyl Sepharose Profile of Salivary Prolyl Oligopeptidase
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A purification table was constructed to assess the overall effectiveness of the purification protocol for Human Salivary PO (Table 3 2 )  Calculations 
were performed as highlighted in the appendix
Purification Stage Total Activity
unit
Total Protein
m g
Specific Activity
U m t/m g
Purification Factor Yield
%
Buffered Saliva 2 241 23 78 0 094 1 100
80% Salt Cut 0 8752 5 173 0 1692 1 8 39 1
Post Phenyl Sepharose 0 1891 2 256 0 084 0 9 8 44
Post Q Anion Exchange 0 01686 1 72 0 00984 0 104 0 75
Table 3 2. Purification Table for Human Salivary PO
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3  3  4  A l t e r n a t i v e  C h r o m a t o g r a p h i c  T e c h n i q u e s  t o  P u r i f y  H u m a n  S a l i v a r y  P O
3 3 41 DEAE Sepharose Anion Exchange Chromatography
Post phenyl sepharose PO was dialysed and concentrated as described in section 2 5 4 It was 
applied and eluted from a DEAE Sepharose column as outlined in section 2 5 5 1 Fractions were 
assayed for PO activity as described m section 2 4 3 while the protein content was measured via 
the Coomassie Plus Protein assay as outlined in section 2 3 3 FIGURE 3 3 4 1 illustrates the 
elution of PO activity where it was partially separated from the run through protein Fractions 
containing PO were combined and it’s activity and protein content measured as described in 
sections 2 4 1 and 2 3 3 respectively
3 3 4 2 Benzamidine Sepharose Chromatography
The benzamidine sepharose resin was prepared as described in section 2 5 5 2 Dialysed post 
phenyl sepharose was applied and eluted from the column at the start of the NaCl linear gradient 
while being separated from most of the protein that does not bind as illustrated in FIGURE 3 3 4 2 
Any fractions containing PO activity was pooled and labelled As before 1ml of the post- 
benzamidine pool was retained for evaluations on enzyme recovery and protein determination
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FIGURE 3.3.4.1. DEAE CHROMATOGRAPHY OF SALIVARY PO
Plots of fluorescent intensity, absorbance at 570nm and sodium chloride concentration versus 
fraction number.
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Figure 3.3.4.2. Benzamidine Sepharose Chromatography of Salivary PO
Plots of fluorescent intensity, absorbance at 570nm and ammonium sulphate concentration 
versus fraction number.
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3 4. P u r i f i c a t i o n  o f  B o v i n e  S e r u m  D P P I V
3 4 1 Serum Preparation
91 fresh bovine whole blood was collected and left to clot at 4°C as outlined in section 2 6 1, 
resulting in the formation of 1 81 unclotted serum and particulate matter Centrifugation yielded 
1 31 of serum
3 4 2 Phenyl Sepharose Hydrophobic Interaction Chromatography
The crude serum containing 1M (NH4)2S04 was applied to a phenyl sepharose hydrophobic 
interaction chromatography column as outlined in section 2 6 2 An run-through activity peak was 
observed from this column as shown in FIGURE 3 4 2 1, while being separated from a significant 
proportion of bound protein Any fractions with DPPIV activity were combined yielding a post 
phenyl sepharose DPPIV pool 1ml of this pool was retamed for both total activity and protein 
estimation
3 4 3 HiPrep 16/10 Sephacryl S-300 H R  Gel Filtration Chromatography
Following concentration by reverse dialysis, 1 5ml of the post phenyl sepharose chromatography 
pool was applied onto a S300 column as outlined in section 2 6 3 FIGURE 3 4 3 1 illustrates the 
molecular sieving effect of the resin on the enzyme's purification Any fractions containing 
DPPIV activity were combined and labelled to give the post S300 DPPIV pool 1ml of this pool 
was retamed for quantitative activity and protein analysis as outlined in sections 2 4 2 and 2 3 4
3 4 4 P O R O S  Anion-Exchange Chromatography
5ml post-S300 DPPIV pool was applied to a POROS 50 H Q  column as described m  section 2 6 4 
DPPIV activity was detected m  the bound fractions from this amon-exchange column while no 
run-through protein could be visibly detected The elution profile may be seen in FIGURE 3 4 4 1 
lml was retamed for estimation of enzyme recovery and protem determinations while the main 
pool was labelled and stored at -17°C
3.4 5 Desalting by G100 Gel Filtration Chromatography
Post POROS DPPIV pool was passed through a GI00 Gel Filtration column and washed with 
150ml 50mM Hepes, pH 8 0 as outlined in section 2 6 5 FIGURE 3 4 5 1 illustrates the molecular 
sievmg effect of the resin by the delayed elution of the salt Any fractions containing DPPIV 
activity was combined, aliquoted, labelled as purified DPPIV and stored at -17°C until used for 
characterization studies
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3 4 6 Alternative C h r o m a t o g r a p h i c  Techniques used to purify D P P 1 V
3 4 6 1 Concanavalm-A Sepharose Chromatography
The Con-A column was prepared as described in section 2 6 6 1 2 5ml of post S3 00 DPPIV was 
applied onto the column and eluted with an isocratic step of 0 5 M  Methylmannoside FIGURE 
3 4 6 1 illustrates the removal of contaminating protein but the inability to elute the enzyme 
sharply Fractions containing DPPIV activity were combined and 1ml of the resulting pool was 
retamed for both total activity and protein estimation
For the Concanvalin A  Sepharose Chromatography method, the DPPIV activity was deemed too 
low to be further purified or characterised This may be due to over dilution or partial degradation 
as a consequence of inefficient binding and eluting from the resin
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A  purification table was constructed to assess the overall effectiveness of the purification protocol (TABLE 3 3) Calculations were performed as 
highlighted in section 6 3
P u r i f i c a t i o n St a g e T o t a l  A c ti vity
unit
T o t a l  P r o t e i n
m g
Specific
A cti vity
umt/mg
P u r i f i c a t i o n
F a c t o r
Y i el d
%
Serum 1718 910 1 9 1 100
Post PS 4512 49 91 3 48 1 26 3
Post S300 169 5 1 2 14125 74 99
Post Q A E 49 5 0 104 475 96 250 5 29
Post G100 87 0 0178 488 8 257 3 05
Table 3.3 Purification Table for Bovine Serum DPPIV
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Plots of fluorescent intensity (•), absorbance at 570nm (□) and methyl mannoside 
concentration (V) versus fraction number
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3 5 D e t e r m i n a t i o n  o f  E n z y m e  P u r i t y
3 5.1 SDS Polyacrylamide Gel Electrophoresis
SDS polyacrylamide gel electrophoresis was performed as described m  section 2 7 1 FIGURES 
3 5 11 and 3 5 12 represent images of gel-code stained gels of salivary PO and serum DPPIV 
respectively, showing molecular weight markers and the various post-column PO and DPPIV 
pools TABLE 3 4 summarises the labels used to identify each of the markers on the gels and the 
relative molecular weight of each
3 5 2 The Activity of‘Purified Samples’ Using Fluorimetrie Substrates
The presence of contaminating peptidase activities in the purified PO and DPPIV pools were 
determined by the detection of the hydrolysis of a number of fluonmetnc substrates These 
substrates were prepared and tested as outlined in section 2 7 2 TABLE 3 5 demonstrates the 
cleavage of many of these substrates by purified PO, indicating its impurity TABLE 3 6 
illustrates that no cleavage, other than those expected, was detected in the presence of purified 
DPPIV activity
Su b s t r a t e  H y d r o l y s i s Su b s t r a t e  H y d r o l y s i s
Ala-MCA No Lys-Pro-MCA Yes
Arg-MCA Yes Na-benzoyl-Arg-MCA Yes
Glu-Phe-MCA Yes Pyr-His-Pro-MCA No
Gly-Pro-MCA Yes Pro-MCA Yes
Leu-MCA Yes Z-Arg-MCA No
Lys-Ala-MCA Yes Z-Gly-Pro-MCA Yes
Lys-MCA No Z-Phe-Arg-MCA Yes
T a b l e  3 5 P u r i t y A s s e s s m e n t o f  P O  u s i n g F l u o r i m e t r y
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S u b s t r a t e H y d r o l y s i s S u b s t r a t e H y d r o l y s i s
Ala-MCA No Lys-Pro-MCA Yes
Arg-MCA No N a-ben2oyl-Arg-MCA No
Glu-Phe-MCA No Pyr-His-Pro-MCA No
Gly-Pro-MCA Yes Pro-MCA No
Leu-MCA No Z-Arg-MCA No
Lys-Ala-MCA Yes Z-Gly-Pro-MCA No
Lys-MCA No Z-Phe- Arg-MCA No
T a b l e  3 6. P u r i t y A s s e s s m e n t o f  DPPIV u s i n g Fl u o r i m e t r y
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L A N E  S A M P L E
1. Markers
2. Post QAE
3. Post PS
4. Post Salt Cut
5. Buffered Saliva
6. Markers
LANE 1 2 3 4 5 6
f i g u r e 3.5.I.I. G e l c o d e  St ai n o f  Sa l i v a r y P O  SDS P A G E
The red arrow ( ^  within the gel represents purified salivary PO.
Label Marker Molecular Weight
kDa
I Myosin 205
II ß-Galactosidase 116
m Phosphorylase b 97
IV Fructose-6-phosphate kinase 84
V BSA 66
VI Glutamic Dehydrogenase 55
VII Ovalbumin 45
v m Glyceraldehyde-3 -phosphate dehydrogenase 36
T a b l e  3.4. M o l e c u l a r  W e i g h t M a r k e r s  u s e d  in SDS P A G E
1 1 0
L a n e  Sa m p l e
1. 1/10 Serum
2. Post PS
3. Post S300
4. Post AE
5. Post-G100
6. Markers
1. 2. 3. 4. 5. 6.
F i g u r e 3.5.I.2. G e l c o d e  St a i n e d SDS P A G E  o f  B o v i n e Se r u m  DPPIV 
The green arrow ( — within the gel represents the purified DPPIV band.
Label Marker Molecular Weight
kDa
I Myosin 205
n ß-Galactosidase 116
in Phosphorylase b 97
IV Fructose-6-phosphate kinase 84
V BSA 66
VI Glutamic Dehydrogenase 55
VII Ovalbumin 45
VIII Glyceraldehyde-3-phosphate dehydrogenase 36
T a b l e  3.4. M o l e c u l a r  W e i g h t M a r k e r s  u s e d in SDS P A G E
1 1 1
3 6 A s s a y  D e v e l o p m e n t
3 6 1. Substrate Solvent Determination (PO/DPPIV)
Stock substrates were prepared as outlined m  section 2 8 1 m  DMSO, DMF, DXN, EtOH and 
M e O H  The effects of using these solvents on both enzymes activities is illustrated in FIGURES 
3 6 11 and 3 6 12 Methanol and ethanol was chosen to be the most suitable solvents for PO and 
DPPIV activities respectively and was thus used for subsequent substrate solubilisation
3 6 2 Solvent Concentration Determination (DPPIV)
The optimum ethanol concentration was determined as described m  section 2 8 2 FIGURE 3 6 2
shows the effect of increasing ethanol concentration m  substrate preparations on purified DPPIV
Although 4%v/v EtOH yielded the highest activity of DPPIV, the substrate could be dissolved at 
lower ethanol concentrations while not interfering with the enzyme Therefore l%v/v EtOH was 
chosen as the most suitable final solvent concentration m  the substrate for the assaying of DPPIV
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F i g u r e  3  6 1 1
Substrate Solubilisation Solvent
F i g u r e 3.611 Su b s t r a t e  So l v e n t  D e t e r m i n a t i o n  f o r  P O  
Bar chart of fluorescent intensity versus substrate solvent
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F i g u r e  3.6.I.2.
Substrate S o lu bilisation  S olven t
F i g u r e 3.6.1 2 Su b s t r a t e  So l v e n t  D e t e r m i n a t i o n  f o r  DPPIV
Bar chart of fluorescent intensity versus substrate solvent
Fi g u r e  3.6 2
120
2 4 6 8 10
Ethanol Concentration (%)
F i g u r e  3 6 2 So l v e n t  C o n c e n t r a t i o n  D e t e r m i n a t i o n  f o r  DPPIV
Bar chart of fluorescent intensity versus substrate solvent concentration
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3 6 3 Linearity of E n z y m e  Assays with Respect to T i m e
3 6 31 Discontinuous Assay
The linearity of the Z-Gly-Pro-MCA and Gly-Pro-MCA degrading activity assays as a function of 
tune was examined as described in section 2 8 3 1 FIGURE 3 6 3 1 1 illustrates that salivary PO 
activity in post QAE purified sample is linear over a period of 60 minutes (R2 0 996) Similarly, 
DPPIV activity is linear (R2 0 97) over the same time period (FIGURE 3 6 3 1 2)
3 6 3 2 Continuous Assay
Continuous assays of PO and DPPIV were also earned as outlmed in section 2 8 3 2 PO was 
observed to be linear over the assay duration, 60 minutes (Graph not shown) FIGURE 3 6 3 2 1 
illustrates DPPIV’s enzymatic linearity over 120 minutes (R2 0 995)
3 6 4 Linearity of Enzyme Assay with Respect to Enzyme Concentration (DPPIV)
Linearity of the Gly-Pro-MCA degrading activity assays with respect to enzyme concentration 
was determined as outlined in section 2 8 4 FIGURE 3 6 4 indicates that the purified DPPIV 
assay is linear (R2 0 991) with respect to enzyme concentration
3 6 5 Optimum Assay Temperature
The effect of incubating purified DPPIV at different temperatures was investigated according to 
section 2 8 5 An optimal temperature for the assay of bovine serum DPPIV was not fully 
determined However 37°C was used for all assays due to the enzymes mammalian source, even 
though FIGURE 3 6 5 illustrates DPPIV's mcreased activity at temperatures higher than 37°C
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F i g u r e  3.6 4.1.
Time (min)
F i g u r e  3 6 4 l.l P O  D i s c o n t i n u o u s A s sa y
Plot of fluorescent intensity versus time illustrating linear enzyme activity
F i g u r e  3.6 4.1 2.
Time (min)
F i g u r e 3 6 4 12 DPPIV D i s c o n t i n u o u s A ss a y
Plot of fluorescent intensity versus time, indicating linear enzyme activity Activity is 
expressed as percentage of the 60 minute value
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Plot of fluorescent intensity versus time, illustrating linear enzymatic activity
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Enzyme Concentration (%)
F i g u r e 3 6 4 L ine a r i t y o f  DPPIV C o n c e n t r a t i o n
Plot of fluorescent intensity versus enzyme concentration Activity is represented by a
percentage of the 100% enzyme value
Fi g u r e  3 6 5
Temperature ( °C)
F i g u r e  3.6 5 E f f e c t  o f  A s s a y  T e m p e r a t u r e  o n  D P P I V  A c t i v i t y .
P l o t  o f  f l u o r e s c e n t  i n t e n s i t y  v e r s u s  t e m p e r a t u r e  A c t i v i t y  i s  r e p r e s e n t e d  a s  a  p e r c e n t a g e  o f  t h e
3 7 ° C  v a l u e
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3 6 6  Effect of D T T
3 6 61 Effect of D T T  on PO  Activity
The incorporation of DTT into Z-Gly-Pro-MCA was earned out as detailed in section 2 8 6 1 
FIGURE 3 6 6 1 illustrates the absolute requirement of salivary PO for DTT with a steady increase 
of activity up until 20mM DTT
3 6 6 2 Effect of D T T  on DPPIV Activity
The incorporation of DTT mto Gly-Pro-MCA was earned out as detailed in section 2 8 6 2 
FIGURE 3 6 6 2 illustrates the insignificant effect of DTT on punfied DPPIV activity DTT 
slightly inhibited DPPIV activity with 5% inhibition observed at 20mM DTT
36  7 Effect of E D T A  
3 6 7 1 Effect of E D T A  on P O  Activity
The influence of the metal chelator EDTA on PO was determined by its inclusion in the Z-Gly- 
Pro-MCA substrate as outlined in section 2 8 7 1 FIGURE 3 6 7 1 shows increased substrate 
catalysis up until 0 8 m M  EDTA with 113% activity
3 6 7.2 Effect of E D T A  on DPPIV Activity
The influence of EDTA on DPPIV was also determined by its mclusion in the Gly-Pro-MCA 
substrate as outlined in section 2 8 7 2 FIGURE 3 6 7 2 clearly shows mcreased substrate catalysis 
up to 7 5 m M  EDTA with 153% activity
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F i g u r e  3.6 6.1
DTT Concentration (mM)
Fi g u r e  3 6 6 1 E f f e c t o f  D T T  o n  P O  A ctivity
Plot of fluorescent intensity versus DTT concentration Activity is expressed as a percentage 
of O m M  DTT
F i g u r e 3 6 6 2
DTT concentration (mM)
F i g u r e 3.6 6.2 E f f e c t o f  D T T  o n  DPPIV A ctivity
Plot of fluorescent intensity versus DTT concentration Activity is expressed as a percentage 
of the zero DTT value
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F i g u r e  3 6.7 1
EDTA Concentration (mM)
F i g u r e  3 6 7 1 E f f e c t  o f  E D T A  o n  P O  A ctivity
Plot of fluorescent intensity versus EDTA concentration Activity is expressed as a percentage 
of O m M  EDTA
F i g u r e 3 6 7 2
EDTA Concentration (mM)
F i g u r e 3.6 7 2. E f f e c t  o f  E D T A  o n  DPPIV A ctivity
Plot of fluorescent intensity versus EDTA concentration Activity is expressed as a percentage 
of O m M  EDTA
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3 7 S t a b i l i t y  S t u d i e s  o n  P O
3 7 1 Thermostability of P O  
3 711 Effect of 37°C Pre-incubation on PO  activity
The effect of physiological temperature on PO activity was investigated as outlined m  section
2 9 1 FIGURE 3 7 1 illustrates the significant detrimental effect the temperature has on enzymatic 
activity After 60 minutes of 37°C pre-incubation, 60% of activity was lost which was even 
further degraded slowly to 20% activity after 4 hours 1% BSA w/v had a minimal effect on 
stabilizing PO However on increasing the BSA concentration to 10%w/v, the enzymatic activity 
was still reduced but only by 46% after 90 minutes in comparison to a degradation of 60% when 
in the presence of 1% BSA w/v
3 712 Stability of PO  when stored at -20°C
The effect of frozen storage conditions of -20°C on PO with and without 1% BSA w/v included 
was earned out as desenbed in section 2 9 2 FIGURE 3 7 2 1 illustrates that over the 31 days 
analysed, there is a notable decrease m  enzymatic activity (32%) when no BSA was present The 
degradation process was reduced to only 9% when 1% BSA w/v was mcluded with the partially 
punfied enzyme dunng storage
The effect of frozen conditions was also investigated for buffered saliva PO both with and 
without 20% glycerol FIGURE 3 7 2 2 clearly highlights that a similar trend is observed for both 
buffered saliva and that with glycerol Over the first 6 days, considerable activity is lost with 
buffered saliva being reduced to 40% activity In companson, glycerol seems to reduce the 
degradation with 64% activity remaining The loss of activity appears to plateau off over the 
following 15 days for both frozen aliquots
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F i g u r e  3.71
Time (nun)
Figure 3.7.1 Effect of 37°C Pre-incubation on P O  after B S A  Addition 
Plot of fluorescent intensity versus time m  mmutes Activities are expressed as a percentage 
of the 0 minutes values Plot includes no BSA (•), 1% BSA w/v (¿S) and 10% w/v BSA (□)
F i g u r e  3 7.2
Time (Day)
F i g u r e 3 7.2 Stability o f  P o s t  Q A E  P O  w h e n  s t o r e d  a t  -20°C
Plot of fluorescent intensity versus time in days Activity is expressed as a percentage of the 
Day 0 value The plot includes no BSA (•) and 1% BSA w/v (□)
1 2 3
F i g u r e  3 7.2 2
Time (Day)
F i g u r e 3 7 2 2 Stability o f  B u f f e r e d  Sa l i v a P O  a t  -20°C
Plot of fluorescent intensity versus time m  days Activity is expressed as a percentage of the
Day 0 value The plot includes buffered saliva (•) and buffered saliva with 20% glycerol (□)
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3.8 C h a r a c t e r i s a t i o n
3 8 1 Relative Molecular Mass Determinations
3 8 1 1 SDS P A G E
A  non-native SDS gel was prepared as outlined in section 2 7 1 and employed to estimate the 
relative molecular weights of the purified PO and DPPIV activities The distance migrated by the 
bromophenol blue dye front was calculated for the colloidal brilliant blue and gelcode stained 
gels respectively A  plot of log of molecular weight versus relative mobility (Rf) was constructed 
for the eight standards as described in section 2 10 2 1 FIGURES 3 8 111 and 3 8 112 show 
the calibration curves obtained from PO and DPPIV gels when stained with gelcode respectively 
TABLE 3 7 list the equations of the line for PO generated from the calibrated gels and was used to 
evaluate the molecular weight of Human Saliva PO Weights such as 82,700 Da from the brilliant 
blue stain and 78,900 from the gelcode stain It was speculated that the enzyme existed as a 
monomer
From the equations of the lines shown in TABLE 3 8 , the molecular weight of DPPIV was 
determined to be 67,100 Da (blue stain) and 74,300 Da (gelcode) It was deduced from this that 
bovine serum DPPIV is a tetramer
St ai n E q u a t i o n M o l e c u l a r  W e i g h t
Da
Brilliant Blue Log M W  = -0 9571 (Rf) + 5 412 82,668
Gelcode Log M W  = -0 93(Rf) + 5 387 78,862
T a b l e  3 7 M o l e c u l a r  W e i g h t D e t e r m i n a t i o n  o f  Sa l i v a r y P O
The average molecular weight of the enzyme was determined to be 80,765 ± 1,903Da
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F i g u r e 3 8 2 SDS P A G E  St a n d a r d  C u r v e  f o r  M o l e c u l a r  W e i g h t 
D e t e r m i n a t i o n  o f  Se r u m  DPPIV
Plots of log molecular weight versus Rf value, where the R  value represents the distance 
migrated by the standard (•) or sample (o) divided by the distance migrated by the 
bromophenol blue dye front
1 2 6
3 812 Size Exclusion Chromatography
The relative molecular mass of purified DPPIV was estimated using two different size-exclusion 
chromatography resins, namely sephacryl S-300 and a HiPrep sephacryl S-300 High Resolution 
Each of these columns was calibrated with a range of standards as outlined in section 2 10 11 
The void volume of the Sephacryl S-300 was 70ml while the HiPrep Sephaciyl S-300 was 40ml 
This allowed for the production of a calibration graph for each resin representing the log 
molecular weight versus WJV0 as described in section 2 10 1 1 3 These graphs (FIGURES 
3 8 12 1, and 3 8 1 2 2) were then used to estimate the molecular weight of purified DPPIV 
TABLE 3 8 shows the equation of the lines obtained and the deduced molecular weights obtained 
using PAGE and size exclusion chromatography
M e t h o d E q u a t i o n  o f  L ine R2 M W
Da
SDS PAGE (blue stain) Log M W  = -0 96 (Iy  + 5 504 0 94 268,556*
SDS PAGE (gelcode stain) Log M W  03 ( R ^  5 34 0 97 297,367*
Sephacryl S-300 Log M W  = -2 06(VJVt)+ 8 06 0 97 275,966
HiPrep sephacryl S-300 Log M W  = -1 525(V/VJ+ 7 673 0 97 328,010
T a b l e  3.8 M o l e c u l a r  w e i g h t s  d e t e r m i n a t i o n  o f  B o v i n e Se r u m  DPPIV 
* These molecular weights are estimated based on the SDS PAGE indication that DPPIV is a 
hetero-tetramer
The average molecular weight of DPPIV was determined to be 292,475 ± 23,083 Da 
3 8 2 Glycosylation Estimation of DPPIV SDS gel
SDS polyacrylamide gel electrophoresis was performed as described in section 2 10 2 FIGURE 
3 8 2 represents the Gelcode Glycoprotein stained gel of serum DPPIV, illustrating magneta 
bands for the enzyme on a colourless background, indicating glycosylation
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F i g u r e s 3 8 2 3 a n d  3 8 2 4 Size e x c l u s i o n  C h r o m a t o g r a p h y  St a n d a r d  
C u r v e s  f o r  N a t i v e M o l e c u l a r  W e i g h t D e t e r m i n a t i o n  o f  DPPIV
Plots of log molecular weight versus V e/V0, where V e is the elution volume of the standard (•) 
or sample (o) and V 0 is the void volume of the column used FIGURE 3 8 2 3 illustrates the 
standard curve from Sephacryl S-300 and FIGURE 3 8 2 4 shows that of a Hiprep Sephacryl 
S-300 resin
1 2 8
1. HRP
2. Post S300
3. Post Q A E4. Post G 100
L a n e  S a m p l e
Figure 3.8.2. Glycoprotein Stain of DPPIV
DPPÍV
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3.8 3  Thermostability Studies of D P P I V
3 8 3 1 Overnight Stability
The stability of DPPIV at 37°C over 24hr was examined as outlined in section 2 10 3 1 Enzyme 
activity remained relatively stable over this time frame, with a maximum loss of 20% activity 
after 18 5hr However DPPIV activity was restored following further incubation for 24hr 
FIGURE 3 8 3 1 illustrates the activity profile at 37°C overnight for purified DPPIV This allows 
for accurate overnight or 24 hour assays such as that required for substrate specificity via HPLC 
analysis
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F i g u r e  3 8 3 1
Time (hours)
Fi g u r e 3.8 3 1. T h e r m o s t a b i l i t y  o f  DPPIV a t  37°C
Plot of fluorescent intensity versus time in hours The enzymatic activity is expressed as a percentage 
of the 1 hour value
1 3 1
3 8 4. p H  Effects
The effects of pH on PO and DPPIV activities were monitored m  two ways Primarily, both 
enzymes were incubated at a range of pH values and buffers and then assayed for activity The 
effect of pH on PO is described in section 2 10 4 1 FIGURE 3 8 4 1 clearly indicates that optimal 
PO activity occurs at pH 7 5 especially in Potassium Phosphate buffer The enzyme was seen to 
be particularly inactive in low pH buffers
The activity of DPPIV at various pH’s was also assessed as descnbed in section 2 10 4 2 where 
the enzyme was incubated with substrates prepared in a range of pH values FIGURE 3 8 4 2 
illustrates this pH profile, suggesting activity is optimum between pH 7 0 and pH 8 5, while 
enzymatic activity is completely inhibited at pH’s below 5 and above pH’s 8 5 The enzyme 
exhibits a slight preference towards a potassium phosphate buffering system however all 
optimised assays were performed in Hepes buffer as it was found that potassium phosphate buffer 
potentially resulted in the auto-catalysis of the Gly-Pro-MCA substrate
The inactivation of DPPIV is graphically illustrated in FIGURE 3 8 4 3 A  classical bel 1-shape 
curve was not observed as the enzyme remained active over the pH range However Gly-Pro- 
M C A  catalysis was showed to be at its most optimum between pH 6 0 and pH 9 0
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F i g u r e  3.8 4 1.
¡3
3
pH
F i g u r e 3 8 41. p H  A c t i v a t i o n o f  P O
Plot of fluorescent intensity versus pH Buffers tested were citrate (□), phosphate (•), tns 
(▼), glycine (A)
1 3 3
F i g u r e  3.8 4 2.
pH
F i g u r e 3 8 4 2 p H  A c t i v a t i o n o f  DPPIV
Plot of fluorescent intensity versus pH The buffers used were citrate (□), phosphate (•), 
hepes (■»•), glycine (A )
PH
F i g u r e  3 8 4 3. p H  In a c t i v a t i o n  o f  D P P I V
P l o t  o f  f l u o r e s c e n t  i n t e n s i t y  v e r s u s  p H  T h e  b u f f e r s  t e s t e d  w e r e  c i t r a t e  ( o ) ,  p h o s p h a t e  ( • ) ,
h e p e s  ( ■ ) ,  g l y c i n e  ( V )
1 3 4
3.8 5 Isoelectric Point Determination
3 8 51 Chromatofocusing
A  PBE 94 chromatofocusing resin was employed in an attempt to determine the isoelectric point 
of DPPIV as described in section 2 10 5 1 The elution profile obtained from this column can be 
seen in FIGURE 3 8 5 1 DPPIV activity was eluted in a decreasing linear pH gradient and activity 
was detected in fractions corresponding to a pH of between 5 45 and 5 6 The pH of this pool was 
measured to be 5 52, which was taken to be the pi of bovine DPPIV
3 8 5 2 Isoelectric Focusing
A  vertical IEF acrylamide gel was run as outlined m  section 2 10 5 2 and stained with brilliant 
blue G  colloidal FIGURE 3 8 5 2 represents the stained gel image showing the pi markers and 
purified DPPIV The relative mobility (Rf) of each standard and DPPIV was calculated as 
described in section 2 10 5 2 The distance to the anoidic edge of the plate was 30cm A  plot of 
Rf versus pi was constructed (FIGURE 3 8 5 3 ) and the pi of DPPIV was estimated using the 
following equation of the line
pl = -5 9932xRf+9 3232 
The pi of DPPIV was calculated to be 4 71
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F i g u r e  3 8  5.1
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F i g u r e 3 8 5 1. pi D e t e r m i n a t i o n  o f  DPPIV v u  C h r o m a t o f o c u s i n g
Plots of protein absorbance at 570nm and pH versus fraction number The graph indicates a pi
estimation of 5 2
F i g u r e  3.8.5.3.
Rf
F i g u r e s  3.8.5.2. a n d  3.8.5.3. pi D e t e r m i n a t i o n  v i a Is o e l e c t r i c  F o c u s i n g  
Figure 3.8.5.2. represents the IEF gel generated for pi estimation with the black arrow indicating the 
DPPIV band. FIGURE 3.8.5.3. is a plot of isoelectric point versus Rf, where Rf is the distance migrated 
by the standard (•) or sample (o) divided by the length of the gel plate.
3 8 6 Catalytic Classification
The effect of vanous functional reagents on DPPIV activity was mvestigated as outlined in 
section 2 10 6 TABLES 3 9, 3 10, 3 11 and 3 12 outline residual DPPIV activity following 
incubation with a range of senne, metallo- and cysteine protease inhibitors and cysteine protease 
activators respectively Residual enzyme activity is expressed as a percentage of positive control 
activity where no functional reagent was added (represented as 100% activity) The concentration 
listed is the concentration of functional reagent in the pre-mcubation mixture (lOOjxl) These 
results suggest that DPPIV is inhibited by the metallo protease inhibitors, 4,7-phenanthrohne 
(53 8% residual activity at 20 OmM) and 1,10-phenanthrolme, (75% activity at 20 OmM) Senne 
protease inhibitors had relatively no effect on DPPIV while the cysteine protease inhibitors 
mainly had an enhancing effect on DPPIV activity Similarly, the cysteine protease activator, 2- 
mercaptoethanol had an enhancing effect on substrate hydrolysis
1 3 8
Se r i n e P r o t e a s e  
In h i b i t o r
AEBSF
C o n c e n t r a t i o n
22 50mM 
11 25mM
A ctivity
%
99 2
94 6
R e s i d u a l  D P P I V S t a n d a r d  E r r o r
%
0 28
4 26
APMSF lOOOmM 
5 OOmM 
2 50mM 
1 25mM
96 8 
100 
100
97
9 78
2 97
3 49 
1 05
Aprotimn
Benzamidine
1 25mg/ml 
0 63mg/ml 
0 25mg/ml
0 13 mg/ml
5 OOmM
1 OOmM
107
100
100
100
97 7 
93 6
3 77
0 23
1 13 
8 65
2 87 
5 42
Leupeptin 1 OOmM 
0 25mM
103 
98 1
2 01 
3 57
PMSF 2 50mg/ml 
1 25mg/ml 
0 50mg/ml 
0 25mg/ml
95 
93 1 
95 3 
92 6
2 27 
1 58
3 67 
3 37
T a b l e  3 9 E f f e c t  o f  Se r i n e P r o t e a s e  In h i b i t o r s o n  DPPIV A ctivity
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M e t a l l o - C o n c e n t r a t i o n R e s i d u a l DPPIV St a n d a r d  E r r o r
p r o t e a s e A ctivity
In h i b i t o r m M % %
1,10-phenanthroline 20 00 75 2 5 24
10 00 78 7 7 75
5 00 82 5 0 42
100 87 6 167
1,7-phcnanthrolinc 15 00 91 8 2 22
7 50 96 0 5 38
3 75 92 0 7 79
4,7 -phenanthroline 20 00 53 8 1 90
10 00 85 7 0 28
5 00 88 6 157
1 00 96 7 4 41
8-hydroxyquinoline 10 00 79 7 2 29
5 00 81 3 6 12
1 0 90 9 231
CDTA 10 00 87 10 4 65
5 00 87 03 3 88
1 00 88 74 1 85
e d t a 20 00 80 4 2 91
10 00 83 4 0 26
5 00 81 4 0 16
1 00 87 3 0 44
e g t a 10 00 81 2 1 82
5 00 87 2 4 14
100 88 9 2 65
Imidazole 10 00 99 15 2 93
5 00 99 34 7 99
1 00 103 19 0 10
T a b l e  3 10 E f f e c t o f  M e t a l l o -p r o t e a s e  In h i b i t o r s o n  DPPIV A ctivity
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C y s t e i n e C o n c e n t r a t i o n R e s i d u a l DPPIV St a n d a r d  E r r o r
Pr o t e a s e A ctivity
In h i b i t o r m M % %
d t n b 10 0 85 72 5 89
5 00 76 53 4 84
1 00 80 60 7 53
N E M 10 00 53 22 2 60
5 00 72 82 2 50
1 00 77 66 3 20
Iodoacetamide 10 00 90 31 2 65
5 00 85 63 2 71
1 00 88 94 1 58
Iodoacetic Acid 20 00 113 14
10 00 122 59
5 00 120 57
T a b l e  311 e f f e c t  o f  C y s t e i n e P r o t e a s e  inhibitors o n  DPPIV A ctivity
C yst eine C o n c e n t r a t i o n R e s i d u a l DPPIV St a n d a r d  E r r o r
Pr o t e a s e A ctivity
A c t i v a t o r m M % %
2-mercaptoethanol 10 00 125 45 2 22
5 00 119 93 2 46
1 00 113 56 4 11
DTT 10 00 102 0 105
5 00 105 4 141
1 00 104 0 2 94
T a b l e  3.12. E f f e c t o f  C yst e i n e P r o t e a s e  A c t i v a t o r s o n  DPPIV A ctivity
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3 8 7 Effect of Other Functional Reagents
The effect of a range of other functional reagents on DPPIV activity was also examined as 
outlined in section 2 10 7 The residual activities and standard error of the means detected 
following incubation with these reagents are listed in TABLE 3 13 Trypsin inhibitor was the only 
reagent to have an inhibitory effect on enzyme activity with 19 60% inhibition at 0 05mg/ml 
1 25mg/ml Pepstatin A  resulted in an enzymatic increase of 24% while 1 25mg/ml Antipain 
increased activity by 17% Bacitracin, Carnitine and Puromycm all had an insignificant effect on 
DPPIV activity
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F u n c t i o n a l C o n c e n t r a t i o n R es i d u a l DPPIV St a n d a r d  E r r o r
R e a g e n t A ctivity
% %
Antipain 2 50mg/ml 95 76 4 37
1 2 5 mg/ml 85 90 0 74
0 50mg/ml 117 04 3 56
0 25mg/ml 114 98
Bacitracin 1 00mg/ml 94 50 2 48
0 50mg/ml 88 61 0 89
0 I0mg/ml 97 87 124
0 05mg/ml 95 47
Carnitine lOOOmM 93 70 8 53
5 OOmM 96 21 0 55
1 OOmM 101 13 4 97
Pepstatin A 1 25mg/ml 106 47 1 70
0 75mg/ml 124 08 3 72
0 31 mg/ml 100 92 1 15
Puromycin 2 25mM 99 74 4 26
1 OOmM 106 08 1 13
0 50mM 101 79
0 25mM 106 42 1 29
Trypsin Inhibitor 1 00mg/ml 85 30 2108
0 50mg/ml 84 74 5 05
0 10mg/ml 84 87 5 71
0 05mg/ml 80 40 5 71
T a b l e  3 13 E f f e c t  o f  O t h e r  F u n c t i o n a l  R e a g e n t s  o n  DPPIV A ctivity
1 4 3
3 8 8 Effect of Metal Ions on DPPIV Activity
The effect of metal salts on purified DPPIV activity was mvestigated by incorporating the metal 
salts mto the fluonmetnc assay as outlined in section 2 10 8 The results are presented in TABLE 
3 14 MgS04 had the most detrimental effect on activity, with a loss of 22% activity, followed by 
mercuric sulphate All other metal salts had an insignificant effect on enzymatic activity
M e t a l  Su l p h a t e R e s i d u a l DPPIV St a n d a r d  E r r o r
A ctivity %
%
Control 100 00 ~8 5xl04
Zinc 112 25 4 OxlO-4
Manganese 105 82 5 lxlO-4
Sodium 105 62 6 9XKT4
Calcium 102 00 7 6x1c4
Cadmium 101 04 5 5x1 O'4
Nickel 97 74 5 6x10"
Cobalt 95 29 6 9x1 O'4
Copper 90 90 6 6x10"
Mercury 79 67 6 2x10"
Magnesium 77 74 2 1x10"
T a b l e  3 14 E f f e c t o f  M e t a l  Io n s  
3 8 9 Effect of General Salts on DPPIV
3 8 91 Effect of Ammonium Sulphate
3 8 91 1 Ammonium Sulphate effect in the substrate
Ammonium Sulphate effect on DPPIV when included m  the substrate was earned out as 
desenbed in section 2 10 9 11 FIGURE 3 8 9 1 1 illustrates the significant effect the salt has on 
substrate catalysis 300mM Ammonium Sulphate in the substrate resulted m  a 60% decrease in 
activity which is further inhibited to 80% at 1M
1 4 4
3 8 91 2 Ammonium Sulphate effect with the enzyme
The effect of Ammonium Sulphate when pre-incubated with punfied DPPIV was investigated as 
outlined in section 2 10 9 1 2 FIGURE 3 8 9 1 2 highlights the inhibitory effect the salt has on 
enzymatic activity where even at 200mM Ammonium Sulphate a 21% decrease in activity was 
observed This trend was continued sequentially to 50% enzymatic activity at 1M Ammonium 
Sulphate
3 8 9 2 Effect of NaCl on DPPIV Activity
3 8 9 21 Sodium Chloride effect in the substrate
The effect of NaCl mclusion in the Gly-Pro-MCA substrate was earned out as outlined m  section
2 10 9 2 1 It resulted in a significant decrease in punfied DPPIV activity, where at a 
concentration of 600mM NaCl the activity of DPPIV was inhibited by 45% while substrate 
catalysis was further inhibited by almost 60% at 1 molar sodium chlonde FIGURE 3 8 9 2 1 
shows the pattern observed
3 8 9 2 2 Sodium Chloride effect with the enzyme
The direct effect of NaCl pre-mcubation with punfied DPPIV was expenmented as desenbed in 
section 2 10 9 2 2 It resulted m  a significant decrease in punfied DPPIV activity, up to a 
concentration of 600mM NaCl at which point the activity of DPPIV was inhibited by 25% and 
then the enzymatic activity began to plateau This is shown in FIGURE 3 8 9 2 2
3 8 9 3 Effect of Potassium Chloride on DPPIV Activity
3 8 9 31 Potassium Chlonde effect with the enzyme
The effect of KC1 on DPPIV activity when pre-incubated was documented in section 2 10 9 3 A  
decrease in enzymatic activity was observed on mcreasing salt concentration with an eventual 
catalytic inhibition of 34% at 1M KC1 FIGURE 3 8 9 3 1 illustrates this effect
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F i g u r e  3 8 9.1 1.
Ammonium Sulphate concentration (mM)
F i g u r e 3 8.9 11 E f f e c t o f  A m m o n i u m  Su l p h a t e  o n  DPPIV w h e n  i n c l u d e d 
w i t h  t h e  s u b s t r a t e
Plot of fluorescent intensity versus ammonium sulphate concentration Activity is expressed 
as a percentage of the zero ammonium sulphate value
F i g u r e  3.8 9.1 2.
Ammonium Sulphate Concentration (mM)
F i g u r e 3.8 9.12. E f f e c t o f  A m m o n i u m  Su l p h a t e  o n  DPPIV a c t i v i t y w h e n  
p r e -i n c u b a t e d  w i t h  t h e  e n z y m e
Plot of fluorescent intensity versus ammonium sulphate concentration Activity is expressed 
as a percentage of the zero ammonium sulphate value
1 4 6
Sodium Chloride Concentration (mM)
F i g u r e 3 8 9 21 E f f e c t o f  So d i u m  C h l o r i d e  o n  DPPIV w h e n  i n c l u d e d in 
t h e  s u b s t r a t e .
Plot of fluorescent intensity versus sodium chloride concentration Activity is expressed as a 
percentage of the zero sodium chloride value
F i g u r e 3.8.9 2.2
Sodium Chloride Concentration (mM)
F i g u r e 3 8.9.2 2 E f f e c t o f  So d i u m  C h l o r i d e  o n  DPPIV w h e n  p r e -i n c u b a t e d 
w i t h  t h e  e n z y m e
Plot of fluorescent intensity versus sodium chloride concentration Activity is expressed as a 
percentage of the zero sodium chlonde value
1 4 7
F i g u r e  3  8 9 3 1
Potassium Chloride Concentration (mM)
Fi g u r e 3 8 9 3 1 E f f e c t o f  P o t a s s i u m  C h l o r i d e  o n  DPPIV w h e n  p r e ­
i n c u b a t e d  WITH THE ENZYME
Plot of fluorescent intensity versus potassium chloride concentration Activity is expressed as 
a percentage of the zero potassium chloride value
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3  8 10 Substrate Specificity
3 8 101 Ion-Pair Reverse Phase H P L C
The ability of purified DPPIV to hydrolyse a range of synthetic and bioactive peptides was 
mvestigated using lon-pair HPLC as outlined in section 2 10 10 1 TABLES 3 16 and 3 17 lists 
the peptides which were tested and whether or not cleavage was detected while Table 3 15 
indicates the sequences of some bio-active peptides that could be hydrolysed by DPPIV The 
cleavage of Casomorphin, CRP (201-206), Enterostatm, Neuropeptide Y  (1-24) and Substance P, 
can be seen in the chromatograms of absorbance versus retention time in FIGURES 3 8 10 1 1 to 
3 8 10 1 20 respectively
3 8 10 11 Inhibition of P-Casomorphin Hydrolysis
The ability of H-Ile-Pyrrohdide to inhibit DPPIV and prove that DPPIV is the enzyme 
responsible for p-Casomorphin hydrolysis was earned out as desenbed in section 2 10 10 1 1 
FIGURE 3 8 10 16 clearly illustrates the large, single p-Casomorphin peak and demonstrates the 
lack of peptide cleavage due to the specific inhibitor
Peptide N-Terminal Sequence Source
p-Casomorphin 
CRP (201-206) 
Enterostatm 
Neuropeptide Y  (1-24) 
Substance P
H-Tyr-Pro-Phe-Pro-Gly-Pro-Ile-OH 
H-Lys-Pro-GIn-Leu-Trp-Pro-OH 
H-Ala-Pro-Gly-Pro-Arg-OH 
H-Tyr-Pro-Ser-Lys-Pro-Asp-Asn- 
H-Arg-Pro-Lys-Pro-Gln-Gln-Phe-
Bovine
Human
Human/Rat
T a b l e  315 A m i n o  A cid Se q u e n c e s  o f  B io-Acti ve P eptides Sus c e p t i b l e t o  
DPPIV H y d r o l y s i s
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P eptide H y d r o l y s i s b y  DPPIV
Aßi ii No
Ap20 29 No
Aß 29-40 No
Angiotensin I No
(Arg8)-V  asopressin No
ß-Casomorphin Yes
Bradykinin No
CRP201 206 Yes
Enterostatin Yes
IGF! 3 Yes
L H R H No
Neuropeptide Y  (1-24) Yes
Neurotensin^ No
Substance P Yes
T R H No
T a b l e  316 H P L C  Su b s t r a t e  Specificity A nal y s i s o f  B io-Acti ve P eptides
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P ept ide h y i
Ala-Pro-Gly Yes
Asp-Pro-Gln-Phe-Tyr No
Glu-ProGlu-Thr No
Gly-Pro-Ala Yes
Gly-Pro-Arg Yes
GJy-Pro-Gly-Gly Yes
Gly-Pro-Hyp No
Gly-Pro-Pro No
Phe-Pro-Ala Yes
Tyr-Pro-Phe Yes
Z-Pro-Ala No
Z-Pro-Gly No
Z-Pro-Leu No
Z-Pro-Pro No
T a b l e  3 17. H P L C  Su b s t r a t e  Specificity A n al ysis o f  Sy n t h e t i c P eptides
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F i g u r e  3.8.9.I.
Minutes
Figure 3.8.9.I. HPLC C h r o m a t o g r a m  of P-Casomorphin Incubation with 
DPPIV
Plot of absorbance at 214nm (___) and absorbance at 280nm (___ ) versus time in minutes. The
graph shows the sequential hydrolysis of the peptide with the presence of Gly-Pro at 9.9 minutes.
F i g u r e 3.8.9.2.
Minutes
F i g u r e  3.8.9.2. H P L C  C h r o m a t o g r a m  o f  P - C a s o m o r p h i n  s t a n d a r d
Plot of absorbance at 214nm (___) and absorbance at 280nm (___) versus time in minutes.
152
F i g u r e  3.8.9.3.
Minutes
F i g u r e 3.8.9.3. H P L C  C h r o m a t o g r a m  o f  T y r -Pr o  s t a n d a r d
Plot of absorbance at 214nm (__ ) and absorbance at 280nm (__ ) versus time in minutes
F i g u r e 3.8.9.4.
Minutes
F i g u r e  3.8.9.4. H P L C  C h r o m a t o g r a m  o f  P h e -P r o  s t a n d a r d
Plot of absorbance at 2 1 4 n m  (___ ) and absorbance at 2 8 0 n m  (___ ) versus time in minutes
F i g u r e  3.8.9.S.
Minutes
F i g u r e  3.8.9.5. H P L C  C h r o m a t o g r a m  o f  G l y -Pr o  s t a n d a r d
Plot of absorbance at 214nm (__ ) and absorbance at 280nm (__ ) versus time in minutes.
F i g u r e  3.8.9.6.
Minutes
F i g u r e  3.8.9.6. HPLC C h r o m a t o g r a m  o f  P-Ca s o m o r p h i n  In c u b a t i o n  w i t h  Il e - 
P r o -Th i a z o l i d i d e
Plot of absorbance at 214nm ( ) and absorbance at 280nm (__ ) versus time in minutes. The
graph shows inhibition of peptide hydrolysis.
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F i g u r e  3.8.10.1.7.
Minutes
F i g u r e 3.8.10.1.7. H P L C  C h r o m a t o g r a m  o f  Su b s t a n c e  P In c u b a t i o n
Plot of absorbance at 214nm (__ ) and absorbance at 280nm (__ ) versus time in minutes. The
graph shows the two dipeptides that are cleaved off the bio-active peptide (See Table 3.15).
F i g u r e 3.8.10.1.8.
Minutes
F i g u r e  3.8.10.1.8. H P L C  C h r o m a t o g r a m  o f  S u b s t a n c e  P  s t a n d a r d
Plot of absorbance at 2 1 4 n m  (___ ) and absorbance at 2 8 0 n m  (___ ) versus time in minutes.
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F i g u r e  3.8.9.9.
Minutes
Figure 3.8.9.9. H P L C  C h r o m a t o g r a m  of Arg-Pro standard
Plot of absorbance at 214nm (__ ) and absorbance at 280nm (__ ) versus time in minutes
Figure 3.8.9.10.
Minutes
F i g u r e  3.8.9.10. H P L C  C h r o m a t o g r a m  o f  L y s - P r o  s t a n d a r d
Plot of absorbance at 2 1 4 n m  (___ ) and absorbance at 2 8 0 n m  (___ ) versus time in minutes.
Minutes
F i g u r e 3.8.9.11. H P L C  C h r o m a t o g r a m  o f  E n t e r o s t a t i n  In c u b a t i o n  w i t h  
DPPIV.
Plot of absorbance at 214nm (___) and absorbance at 280nm (___) versus time in minutes. The graph
illustrates the sequential of the pentapeptide.
Minutes
F i g u r e  3.8.9.12. H P L C  C h r o m a t o g r a m  o f  E n t e r o s t a t i n  s t a n d a r d
Plot of absorbance at 214nm ( ) and absorbance at 280nm ( ) versus time in minutes.
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m
AL
Minutes
Fi g u r e 3.8.9.13. H P L C  C h r o m a t o g r a m  o f  A l a -Pr o  s t a n d a r d
Plot of absorbance at 214nm ( ) and absorbance at 280nm ( ) versus time in minutes.
F i g u r e 3.8.9.14.
m
AL
Minutes
F i g u r e 3.8.9.14. H P L C  C h r o m a t o g r a m  o f  G l y -Pr o  s t a n d a r d
Plot of absorbance at 214nm ( ) and absorbance at 280nm ( ) versus time in minutes.
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F i g u r e  3.8.9.15.
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F i g u r e 3.8.9.15. H P L C  C h r o m a t o g r a m  o f  C R P  (201-206) In c u b a t i o n  w i t h  
DPPIV
Plot of absorbance at 214nm (__) and absorbance at 280nm (__) versus time in minutes. The
chromatogram shows the presence of a cleavage product at 16.767 minutes.
Minutes
F i g u r e  3.8.9.16. H P L C  C h r o m a t o g r a m  o f  C R P  (201-206) s t a n d a r d
Plot of absorbance at 214nm (___) and absorbance at 280nm (__ ) versus time in minutes.
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F i g u r e  3.8.9.17.
Minutes
F i g u r e 3.8.9.17. H P L C  C h r o m a t o g r a m  o f  L ys-Pr o  s t a n d a r d
Plot of absorbance at 214nm ( ) and absorbance at 280nm (__) versus time in minutes.
1 6 0
F ig u r e  3 .8 .9 .1 8 .
Minutes
F igure 3.8.9.18. H P L C  C hrom atog ram  o f  N europeptide Y (1-24) Incubation  
w ith  D PPIV
Plot of absorbance at 214nm (__) and absorbance at 280nm (__ ) versus time in minutes. The figure
illustrates the presence of the dipeptide Tyr-Pro at 16.683 minutes.
Figure 3.8.9.19.
Minutes
F igure 3.8.9.19. H P L C  C h ro m atog ram  o f  N europeptide Y (1-24) s ta n d a rd
Plot of absorbance at 214nm ( ) and absorbance at 280nm ( ) versus time in minutes.
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F ig u r e  3 .8 .9 .2 0 .
Minutes
Figure 3.8.9.20. H P L C  C hrom atog ram  o f  T y r-P ro  s ta n d a rd
Plot of absorbance at 214nm ( ) and absorbance at 280nm ( ) versus time in minutes.
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3 8 10 2 K inetic  A nalysis
3 8 10 2 I KM Determinations for Gly-Pro-MCA
The Km values for the reaction o f DPPIV on Gly-Pro-MCA were determined experimentally as 
described in section 2101021 KMand Vmax values were determined using Michaelis-Menten, 
Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf analysis as described in section 6 4 1 TABLE 
3 18 lists the Km and Vmax values deduced using these models FIGURES 3 8 102 1 1 to 
3 8 10 2 1 4 illustrate Michaelis-Menten, Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf 
plots
Model Km
fjM
V max
Fluorescent
units
Michaelis-Menten (MM) 40 142
Lineweaver-Burk (LB) 33 85 150 4
Eadie-Hofstee (EH) 34 65 151 02
Hanes-Woolf (HW) 45 143 2
Average 38 4 146 7
Table 3 18. Kinetic Analysis of DPPIV using Gly-Pro-MCA
3 8 10 2 2 Km Determinations for Lys-Pro-MCA
The Km values for the reaction o f DPPIV on Lys-Pro-MCA were determined experimentally as 
described in section 2101022 KM and Vmax values were determined using Michaelis-Menten, 
Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf analysis as described in section 6 4 1 TABLE 
3 19 lists the Km and Vmax values deduced using these models FIGURES 3 8 10 2 2 1 to 
3 8 10 2 2 4 illustrate Michaelis-Menten, Lineweaver-Burk, Eadie-Hofstee and Hanes-Woolf 
plots
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Model Km
/jM
V m a X
Fluorescent
units
Michaehs-Menten (MM) 95 710
Lineweaver-Burk (LB) 103 9 880 8
Eadie-Hofstee (EH) 106 7 891 8
Hanes-Woolf (HW) 105 881 6
Average 102 65 8411
Table 3 19 K inetic Analysis of DPPIV using Lys-Pro-MCA
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F i g u r e  3 .8 .1 0  2 .1 .1
Gly-Pro-MCA Concentration (|iM)
Figure 3 8 10.2 1 2
l/Gly-Pro-MCA Concentration
Figures 3810 211 and3810 2 1 2 K m Determination of DPPIV on Gly-Pro-MCA
FIGURE 3 8 10 2 1 1 represents the Michaehs-Menton plot (fluorescent intensity versus 
substrate concentration) FIGURE 3 8 10 2 1 2 is a Linc-Weaver Burk plot (1/fluorescent 
intensity versus 1/substrate concentration)
165
Fluorescent Intensity/Gly-Pro-MCA Concentration (fiM-1)
Figure 3.8.10 4.
Gly-Pro-MCA Concentration (jiM)
Figures 3 8 10 213  AND 3 810 214  K m  DETERMINATION OF DPPIV ON Gly-Pro-MCA
FIGURE 3 8 10 2 1 3 represents the Eadie-Hofstee plot (fluorescent intensity versus fluorescent 
intensity/substrate concentration) FIGURE 3 8 10 2 1 4 is a Hanes-Woolf plot (substrate 
concentration/fluorescent intensity versus substrate concentration)
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F i g u r e  3  8 .10  2  2 1
Lys-Pro-MCA Concentration (|jM)
Figure 3 8.10.2.2.2.
1/Lys-Pro-MCA Concentration 
Figures 3 810 2 2 1 AND3810222 Km Determinations of DPPIV on Lys-Pro-MCA
F i g u r e  3 8 10 2 2 1 represents the Michaehs-Menton plot (fluorescent intensity versus
substrate concentration) FIGURE 3 8 10 2 2 2 is a Lme-Weaver Burk plot (1/fluorescent
intensity versus 1/substrate concentration)
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F i g u r e  3  8 10 2  2  3
Fluorescent Intensity/Substrate Concentration
Figure 3 8 10 2.2 4.
Lys-Pro-MCA Concentration 
Figures 3 810 2 2 3 and 3 8 1 0  2 2 4 k m D eterm ination o f DPPiv on Lys-Pro-MCA
FIGURE 3 8 10 2 2 3 represents the Eadie-Hofstee plot (fluorescent intensity versus fluorescent
intensity/substrate concentration) FIGURE 3 8 1 0 2 2 4  is a Hanes-Woolf plot (substrate
concentration/fluorescent intensity versus substrate concentration)
168
3 8 11 In h ib ito r Studies o f D PPIV
3 81 1 1 IC 5o Determination of Specific Inhibitors
The effect of specific peptidase inhibitors on DPPIV activity was determined (see section
2 10 11 1) Plots of enzyme activity versus inhibitor concentration were constructed and are 
shown in FIGURES 381111 - 3811 14 TABLE 3 20 summarises the IC50 values determined 
for DPPIV as described m section 6 5
3 8 112 K[ Determination of Specific Inhibitors
The effect of the inclusion of various specific inhibitors on the kinetic interaction between DPPIV 
enzyme activity and Gly-Pro-MCA was determined as described in section 2 10 11 2 A KM 
value was determined for DPPIV usmg the kinetic models described m section 3 8 10 2 1 Kapp 
values were graphically deduced for each inhibitor and subsequently a K, value was estimated as 
outlined in the appendix, section 642  The Kt values for DPPIV interactions studied are 
presented m TABLE 3 20 FIGURES 3 8 11 2 3 and 3 8 11 2 4 illustrates the competitive inhibition 
of DPPIV by Ue-Thiazolidide and Ile-Pyrrolidide respectively FIGURES 3 8 112 1 and 
3 8 11 2 2 shows competitive-non-competitive mixed inhibition by Diprotin A and Diprotin B
Inhibitor Mode IC50 K,
M M
Diprotin A Non-competitive 3 6x10 5 1 36x1 O'4
Diprotin B Non-competitive 5x10 5 1 4x1 O’4
H-Ile-Thiazohdide Competitive 7 5 xlO'7 3 7 xlO7
H-Ile-Pyrrohdide Competitive 1x10 6 75x107
T able  3 20 E ffe c t  o f  Specific In h ib ito rs  on D P PIV  A ctiv ity  
Concentrations as given in TABLE 2 16
3 8 113 K| Determinations for Proline-containing Peptides
The effect of the inclusion of vanous proline-containing peptides on the kinetic interaction 
between enzyme activities and Gly-Pro-MCA was determined as descnbed in section 2 10 11 3 
A Km value was determined for DPPIV usmg the kinetic models descnbed in section 3 8 10 2 1 
Kapp values were graphically deduced for each of the proline containing peptides and 
subsequently a K, value was estimated for each of the peptides tested (see appendix, section
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6 4 2) The nature of the inhibition was determined as outlined in section 64 3 The K, values 
for DPPIV interactions studied are presented in 3 21 FIGURE 381131 is a double reciprocal 
Lineweaver Burk plot which illustrates the competitive inhibition of DPPIV by p-Casomorphin 
In contrast, FIGURE 3 8 112 shows uncompetitive inhibition by Substance P via a Lineweaver 
Burk plot
Peptide Inhibition K ,
(M)
LB EH HW
ß-Casomorphin Competitive 9x10 5M 1 27x1 O^ M 1 lxlOiVt
Substance P Un-competitive 4 5x10"M 4 95x10^ 7 18x10^
T able  3.21 Kinetic Analysis o f DPPIV w ith  p ro lin e  Containing Peptides 
Assay concentrations of inhibitors as given in TABLE 2 17
Models used LB=Lineweaver-Burk, EH=Eadie Hofstee, HW=Hanes Woolf (see section 6 4 for 
calculations)
170
Diprotin A Concentration (M)
Diprotin B Concentration (M)
Figures 3 8 1 1 1 1  and 3 8 1112  Inhibitor Studies
Log plots of DPPIV activity versus inhibitor concentration Activity is expressed as a 
percentage of the no inhibitor value FIGURE 3 8 1111 illustrates potency of Diprotm A on 
enzyme activity FIGURE 3 8 1112 shows a similar effect of Diprotin B
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F i g u r e  3  8 1 1 1 3 .
Ile-Thiazolidide Concentration (M)
Ile-Pyrrolidide Concentration (M)
Figures 3.8 1 1 1 3 and 3.8 111.4 Inhibitor Studies
Log plots of DPPIV activity versus inhibitor concentration Activity is expressed as a 
percentage of the no inhibitor value FIGURE 3 8 1113 highlights the potency of Ile- 
Thiazolidide on enzyme activity Figure 3 8 11 14 also shows a strong specific effect of lie 
Pyyrolidide on DPPIV
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1/Gly-Pro-MCA concentration (|¿M_1)
F igure  3.8 1 1 2  2
l/Gly-pro-MCA Concentration (pM !)
F igures 3 8 1 1 2 1  and 3 8 1 1 2  2 K inetic  A nalysis o f  D P P IV  Specific In h ib ito rs
Lineweaver-Burk reciprocal plots of fluorescent intensity versus Gly-Pro-MCA concentration 
FIGURE 3 8 112 1 shows the mixed inhibition of Diprotin A (□) FIGURE 3 8 11 2 2 illustrates the 
Competitive-non-competitive inhibition of Dtprotin B at 2 5x10 5M (V) and 2 5x1 O^ M (A) Both 
were compared to no inhibition (•)
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F i g u r e  3  8 .1 1 .2  3
l/Gly-Pro-MCA Concentration (fxM"1)
Figure 3 8.11 2 4
l/Gly-Pro-MCA Concentration (jilvf1)
Figures 3 8.112 1 and 3 8 11.2 2. Kinetic Analysis of DPPIV Specific Inhibitors 
Lineweaver-Burk reciprocal plots of fluorescent intensity versus Gly-Pro-MCA concentration 
FIGURE 3 8 11 2 3 highlights the Competitive inhibition of Ile-Thiazolidide at 1x10 6M (V) and 
1x10 5M (A) FIGURE 3 8 11 2 2 also illustrates the Competitive inhibition of Ile-Pyrrolidide at 
lxlO^M (V) and 1x10 5M (A) Both were compared to no inhibition (•)
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F i g u r e  3 .8 1 1 .3 1
l/Gly-Pro-MCA Concentration (fiNT1)
Figure 3.8.11 3 2.
l/Gly-Pro-MCA Concentration (jiM-1)
Figures 3 8 112 1 and 3 8 112 2 Kinetic Analysis of Bio-Active Peptides
Lineweaver-Burk reciprocal plots of fluorescent intensity versus Gly-Pro-MCA concentration 
F ig u r e  3 8 113 1 highlights the Competitive inhibition of 3x1 O^ M P-Casomorphin (□) FIGURE 
3 8 11 3 2 illustrates the Uncompetitive inhibition of Substance P at 2x1 O^ M (A) Both were 
compared to no inhibition (•)
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4 . 0 . D i s c u s s io n
4.0. D iscu ssion
4 1 Fluorescence Spectrometry using 7-Amino-4-Methyl-Coumarin
This work primarily focused on the study of two prohne specific peptidases, namely PO and 
DPPIV from human saliva and bovine serum respectively The employment of high affinity 
substrates is essential for accurate detection of low levels of these enzymes m biological 
tissues The selection of substrates for the enzyme of interest has evolved over the years when 
the properties and functionality become clearer such as, Walter et a l, 1971 identifying PO 
using radiolabelled oxytocin Similarly, synthetic substrates have been specifically formulated 
for enzyme detection in recent years The some of the mam parameters ruling substrate 
selection are the specificity of the enzyme to the substrate and the chromophore employed 
Hopsu-Havu and Glenner, 1966 first reported DPPIV as glycylprohne naphthylamidase and 
many reports have utilised radiolabelled and spectrophotometnc substrates However 
fluonmetnc assays generally offer increased safety, sensitivity and specificity over 
colonmetnc, spectrophometnc and radiometric assays The high sensitivity from the 
wavelength difference between the exciting and fluorescence radiation results in minimal 
background, while the specificity is significantly increased due to a potentially unique 
excitation and emission spectra
The substrates used for PO and DPPIV detection were Z-Gly-Pro-MCA and Gly-Pro-MCA 
respectively These externally quenched fluonmetnc substrates both allow for peptide 
cleavage on the carboxyl side of the prohne residue liberating the fluorophore, MCA 
Excitation to a higher energy state occurs at 370nm due to constant absorption of 
electromagnetic radiation by MCA and requires a significant quantity of energy to create this 
state By the nature to fluorescence, the energised molecule returns to a lower state and results 
in a subsequent re-emission of radiation at 440nm The assay’s sensitivity can be increased by 
widening of the excitation and emission slit widths used This consequently broadens the 
bandwidth over which light is integrated For instance, at an emission wavelength of 440nm 
and a slit width of 5nm, the fluonmeter integrates light radiated from 437 5nm to 442 5nm, 
while if the slit width is increased to lOnm, light radiated from 435nm to 445nm is integrated 
Therefore, for samples of particularly low enzyme activity and hence low fluorescence, 
adaptation of the emission slit width ensures improved sensitivity However it is 
recommended to maintain the excitation slit width due to the high energy required to energise 
the MCA molecule This, in turn will increase the accuracy and reproducibility of all 
subsequent assays
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4 1 1  M C A  Standard Curves and the Inner Filter Effect
The excitation of the MCA molecule at 370nm and subsequent emission at 440nm is a very 
specific and well documented phenomenon However the selection of these wavelengths was 
mvestigated as described in section 2 2 3 and the subsequent scans reported m section 3 1 1 
FIGURES 3 15 and 3 1 6 clearly demonstrate the fluorescent intensity peak heights at both 
370nm for the excitation scan and 440nm for the emission scan It is worth noting that a 
significant trend was observed during these experiments On a number of occasions, the scan 
reported an excitation maximum at 340nm with the maximum emission wavelength 
remaining at 440nm Preliminary analysis was undertaken by utilising these wavelengths 
when analysing enzymatic activity The notable difference observed was that the fluorescent 
intensity of all fractions was significantly higher but no significant difference existed between 
blanks and active triplicates This illustrates the presence of contaminating compounds that 
may fluoresce at 340nm and 440nm greater than MCA does at 370nm, 440nm Therefore the 
fluonmeter searches for fluorescence maximum with is not attributed to free MCA and 
returns inaccurate optimised wavelengths Therefore the selection of 370nm as the excitation 
wavelength and 440nm as the emission wavelength agrees with other reports when MCA is 
employed as the fluorophore (Gilmartin and O’Cuinn, 1999)
Other similar or almost identical disadvantages in fluonmetnc assays are called quenching 
and the inner filter effect Both effects lead to an apparent alteration in fluorescent intensity 
and hence can be problematic where quantitation of fluorescence is important Quenching 
involves the removal of energy from a molecule in the excited state by another molecule, the 
most common form (collisional impunty quenching) is due to the collision of molecules This 
type of quenching may be attnbuted to the presence of heavy metals or dissolved oxygen in 
samples The inner filter effect is a result of an overlap of the excitation or emission band of 
the fluorescing sample with the absorption band of a contaminating compound These 
phenomena inevitably result in inaccurate false positives and negatives such as the inaccurate 
MCA wavelength scans
To ascertain the extent of this effect and attempt to alleviate the problem, free MCA standard 
curves were constructed as outlined in section 2 2 1 and recorded as reported in section 3 1 A 
notable difference in fluorescence detection was observed when biological samples were 
added FIGURES 3 13 and 3 14 demonstrate the effect buffered saliva and bovine serum can 
have on fluorescence and what is perceived as free MCA fluorescent intensity units Both 
samples contnbute to the inner filter effect with serum responsible for a significant 19% 
filtenng A notable decrease in filtenng once punfication commenced Similarly although 
buffered saliva did cause some filtenng, none of the post column fractions contnbuted to any
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inner filter effect This emphasises the importance of accounting for this effect, especially 
with coloured or turbid crude samples when quantifying the enzymatic activity present This 
accountability is even more important when accurately, ascertaining purification performance 
and effectiveness
It is worth noting too that, m addition to biological samples such as serum, many other 
compounds contribute to the inner filter effect These mcluded metal salts, functional 
reagents, inhibitors and even buffers Therefore it was necessary to account for these effects 
dunng any characterisation studies to ascertain the effect the compound is having on the 
enzyme and not the fluorescence of the substrate
4 2 Protein Determination
The enzymatic detection method employed is of significant importance and leads to much 
variability depending on the enzyme and the biological source However the accurate 
quantification of the total protein of a sample is of equal importance As already described, 
correct enzyme activity is required for purification assessment Similarly, this assessment can 
not be achieved without the knowledge to the total protein content Many protein 
determination techniques and reagents have evolved, each having their own advantages and 
disadvantages dependmg on the assay required The most non-specific, inexpensive method 
utilises ultraviolet spectrometry at 280nm This method exploits the ability of the aromatic 
ammo acids, tyrosme and tryptophan, to absorb at 280nm Therefore the assay will only be 
efficient when these amino acids are present m abundance One must question the inaccuracy 
created from the analysis of proteins with an unusually high proportion of these amino acids 
The assay is inaccurate unless the extinction coefficient of the protein is known, which is 
solely dependent on the precise amino acid composition which is not usually known 
Similarly the assay has many interferents that absorb at the same wavelength, giving an 
unusually high absorbance These include compounds that contain punne and pyrimidine 
rings such as nucleic acids and nucleotides which is abundant in many biological samples 
(Dunn, 1989)
In contrast, the Biuret assay has little dependence on ammo acid composition and has no 
interference from free amino acids This is due to the bmding of copper ions to the peptide 
chain, nitrogen of proteins and producing a purple colour with a maximum absorbance at 
560nm in alkaline conditions This assay is utilised when the protein content is in the region 
of 2-10mg/ml, however at protein concentrations lower than this, the assay proves insensitive 
Thus this method was only employed for crude protem samples Nonetheless this technique
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showed a notable reduction in interference substances, was linear up to lOmg/ml and requires 
less protein sample in comparison to the 280nm UV absorbancy method
The BCA assay combines the Biuret reaction of the reduction of Cu2+ by protein to Cu1+, with 
the highly sensitive and selective colorimetric detection of the cuprous cation (CuI+) by 
bicinchommc acid or BCA (FIGURE 4 1)
1 Protein (peptide bonds) + Cu2"- QH ► tetradentate-Cu1+ complex
2 Cu1+ + 2 Bicinchommc Acid (BCA) — ► BCA-Cu1+ complex (purple coloured)
Figure 41. BCA-Protein reaction Scheme
The BCA assay is generally lmear up to 2mg/ml, however its linearity is significantly 
increased when the protem content is reduced to 1 2mg/ml or below (FIGURE 3 2 2) The 
BCA reagent is very sensitive and has few interfering compounds In addition, the BCA 
assay’s adaptability is proven by simply adjusting the assay temperature and protem 
concentrations less than 100|j,g/ml can be detected, as outlined in section 2 3 5 to produce the 
enhanced BCA assay
The Coomassie® Plus Protem assay has a similar linearity to the standard BCA assay of up to 
2mg/ml The Coomassie molecule binds to protem in an acidic medium causing a colour 
change from green/brown to blue which maximally absorbs at 595nm The mam advantage 
for utilising this assay m comparison to the BCA method was its compatibility with the thiol 
reducing agent DTT For all charactensation of human salivary PO, DTT was essential to 
maintain enzyme activity However its presence at even 5mM interfered significantly with the 
accuracy of the BCA reagent Therefore any protem profiles of post-column PO was earned 
out usmg the Coomassie Plus protem reagent Nonetheless, when protein quantification was 
required, dialysis of the sample was employed and then subsequent BCA assay analysis This 
was a result of the reduced hneanty of the Coomassie reagent and the batch to batch vanation 
of the results generated
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Method and Range Interferents Comments
A280 Nucleic acids and nucleotides Insensitive, affected by ammo
(0 05-2mg/ml) acid composition, rapid and
inexpensive
Biuret Ammonia, sucrose, glycerol Low sensitivity, unaffected by
(l-10mg/ml) ammo acid composition, few
mterferents
BCA Thiol reagents, salts, protease Very sensitive, reproducible
(0 02-1 2mg/ml) inhibitors, sugars
Coomassie Plus Detergents, DTT >5mM Moderate sensitivity, batch-batch
(0 25-2mg/ml) variation
Table 4 1 Comparison of Protein Determination Assays
The mterferents listed are an indication and depend on the compounds concentration Despite 
the disadvantage of the mterferents, their effects can be compensated by the inclusion of an 
appropnate blank
4.3 Enzyme Assays
Enzyme assays employed for both PO and DPPIV were fluonmetnc, with MCA the released 
fluorophore being detected The linear relationship between fluorescence and MCA 
concentration allowed for subsequent accurate quantification of enzyme activity (see 
appendix, section 6 2)
Yoshimoto et a l, (1979) classified Z-Gly-Pro-MCA as a specific substrate for PO Smce then 
many researchers have utilised this substrate when trying to ascertain the influence of PO in 
biological systems However the existence of a second Z-Gly-Pro-MCA cleaving activity has 
been reported by this laboratory (Cunningham and O’Connor, 1997b) This activity proved 
unique to PO by its insensitivity to Z-Pro-Prohnal, a specific PO inhibitor and was therefore 
termed ZIP Similarly the relative ineffectiveness of the thiol reducing agent, on ZIP showed 
another significant difference to PO Initial studies on salivary PO proved that the enzyme had 
an obvious dependence on DTT for enzyme stability and was included in all buffers and 
substrates when analysing the peptidase More importantly 1x10 5M Z-Pro-Prolinal 
completely inhibited the enzyme even when buffered saliva was analysed Thus this would 
suggest that the Z-Gly-Pro-MCA cleaving activity observed is solely attributed to Prolyl 
Oligopeptidase and Z-Pro-Prohnal Insensitive Peptidase (ZIP) is not present Therefore the 
optimised assay conditions employed is descnbed in section 2 4 1
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The selection of Gly-Pro-MCA for Dipeptidyl Peptidase IV analysis was comparatively less 
complicated The use of the dipeptide, Gly-Pro- is widely reported and is subsequently 
deemed a specific DPPIV substrate when attached to a chromophore and mild basic 
conditions are employed The choice of chromophore vanes for many researchers however 
the supenonty of fluonmetry has already been established The choice of fluorophore utilised 
is somewhat more straightforward with 7-amino-4-methyl-coumarin (MCA) being a very 
common selection, which is in tandem with many other recent reports (Ohkubo et a l, 1994, 
Gilmartin and O'Cuinn, 1999) DPPIV does not show a preference for thiol reducing agents 
such as DTT nor does it require metals nor co-factors for activity In addition, the enzyme has 
little requirement for the metal chelator, EDTA Nevertheless, EDTA was often included in 
the substrate and running buffers when high salt concentrations were involved
Both enzyme assays were highly sensitive, rapid and quantifiable Another important 
parameter to account for is that the magnitude and charactenstics of inner filter effects 
strongly rely on the sample-cell geometry The use of a cuvette-based assay ensures 
perpendicular geometry between the sample and the incident beam The fluorescence emitted 
is collected along an axis at nght angles to the excitation beam This is the preferred 
geometnc onentation for fluonmetnc assays as it avoids the effects of scattered and 
transmitted excitation, which can lead to inaccuracies (FIGURE 4 2)
The aforementioned assay conditions were also employed for microplate use as descnbed in 
sections 2 4 2 and 2 4 4 This method was utilised for rapid identification of post-column 
fractions The preferential perpendicular geometry is not obeyed but uses front surface 
geometry, the fluorescent signal is collected and measured through the illuminated surface 
(see FIG 4 2) This arrangement increased inner filter effects and light scattenng thus 
reducing the assays sensitivity Despite these factors, the microplate assay proved invaluable 
for non-quantification of both enzyme activities and was commonly utilised It allowed for 
the use of less sample, substrate and acid than that of the cuvette assay and was subsequently 
quicker Once activity could be identified the assay was repeated employing the perpendicular 
geometry for accurate quantification
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440nm  A  370nm
Figure 4.2. Sample-Cell Geometry
MCA (•) absorbs electromagnetic radiation at 370nm ( —*►) and emits fluorescence at 440nm ( ) .
A: Cuvette-based assay - Fluorescence is emitted along an axis at 90° to the excitation beam - Perpendicular geometry. 
B: Microtitre plate assay - Fluorescence is emitted along the same axis as the excitation beam - Front surface geometry.
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4 4 Purification
The purification of a protein incorporated a number of specialised techniques which exploit 
certain physiochemical and biological characteristics of the protein of interest It would be 
considered that the purification of a protein is generally not the end-pomt but a means to cany 
out further studies As a consequence the maintenance of stability of the target protein is of 
vital importance The nature of the further studies will dictate the necessary purity, activity 
and quantity of the protein These parameters play a considerable role in the selection of the 
purification tools utilised and the extent to which they are implemented
4 4 1. Purification of Human Salivary Prolyl Ohgopeptidase
The purification of salivary PO was, from the outset, observed as potentially straightforward 
The bovine brain and serum sources of PO contained a stable, functional protein It was 
acknowledged that serum protein levels are often proportionally replicated in saliva without 
the large quantity of contaminating protem Therefore it was expected that a significant 
reduction in chromatographic techniques would be required to purify the salivary protein in 
comparison to its serum counterpart
4 4 1 1  Saliva Preparation
Saliva was collected and prepared as outlined in section 2 5 1 Batch to batch variation was 
significant for PO levels, even though the time of collection was regulated Eating habits had 
a big influence on the enzyme levels as they seemed to be proportional to the quantity of 
saliva produced For instance, PO levels appeared to be particularly low just after food intake 
but rose steadily hours after The immediate buffering of the saliva was of great importance in 
maintaining enzyme activity and allowing for reproducible results
4 4 12 Ammonium Sulphate Precipitation
The salt fractionation of saliva was earned in an attempt to begin the punfication process but 
also concentrate PO activity The technique operates according to the hydrophobic nature of 
the surface of the protem Hydrophobic groups, by their very nature, predominate m the 
intenor of the protein When salt is added to the system, water surrounding the hydrophobic 
groups solvates the salt ions and as the salt concentration increases water is removed from 
around the protem, eventually exposing the hydrophobic patches Aggregation then results 
from the hydrophobic patches from one protem interacting with another Proteins with more 
hydrophobic patches will then aggregate quicker than those with few patches This
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phenomenon is the basis upon which proteins can be sequentially salted out and thus 
separated from other proteins
FIGURES 3 3 11 and 3 3 12 highlight the success of the technique Generally the removal of 
enzyme activity from the supernatants results in subsequent increase in the corresponding 
pellets Despite the impressive quantity of activity observed m the pellets in comparison to the 
supernatants, it should be acknowledged that volume is not taken into account All 
experiments involved salt addition to 10ml of buffered saliva while the pellets were re­
suspended in 5ml of buffer Nevertheless a considerable concentration of PO activity occurs 
and there is also a notable reduction in protem content generating a two-fold purification step 
(Table 3 2) However the table shows a 2 5-fold reduction m activity which may be attributed 
to many factors Accordmg to Hams and Angel, 1989, 80% Ammonium Sulphate in 10ml of 
solution requires 5 23g of solid salt to be added This is the equivalent of almost 4 Molar, 
which may easily have a detrimental effect on enzyme activity Similarly, the addition of this 
quantity of this salt may cause localised unhomogenous decreases in pH, which may not be 
favourable for activity As outlined in section 2 5 2 the method requires 1 hour of constant 
stirring at 4°C followed by a 45 minute centrifugation step both of which contnbute 
significantly to the shear stress applied to the enzyme and may lead to protein instability In 
addition the exposure of the enzyme’s hydrophobic patches may cause protem unfolding and 
subsequent partial denaturation
4 413  Phenyl Sepharose Hydrophobic Interaction Chromatography
Like ammonium sulphate salt precipitation, hydrophobic interaction chromatography (HIC) 
exploits the presence of hydrophobic patches that can exist on the surface of a protein This is 
due to the side chains of non-polar ammo acids such as alanine, tryptophan and 
phenylalanine The number and size of these patches vanes for each protein and therefore can 
be used as a punfication tool due to the specific interactions that result A hydrophilic shell 
generally surrounds a hydrophobic core of the protein This shell can be removed by salt to 
expose the patches and enforce binding to a non-ionic group such as phenyl
Post 80% ammonium sulphate precipitation PO proved ideal for subsequent application to a 
Phenyl Sepharose column as the enzyme’s hydrophobic patches are already exposed and 
dialysis was not required The chromatographic method was earned out also desenbed in 
section 2 5 3 Figure 3 3 2 1 illustrates the elution profile obtained from the HIC column 
where specific binding of PO separated the enzyme from most other contaminating proteins 
The enzyme was eluted using an isocratic step, however a linear gradient was also employed 
This step did not separate any more of the protein from the enzyme and appear to dilute the
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PO elute peak Therefore the isocratic step was preferred However as TABLE 3 2 illustrates 
that despite a two-fold reduction m protein content, there is a considerable 4 6-fold decrease 
in enzymatic activity This reduced the purification factor to 0 9, which is undesirable It is 
worth noting that when purifying from a source of low protein, the purification factor can 
never be that high This is a result of the influence of protein content on the generation of the 
specific activity It is common to lose some enzyme activity during the course of a 
purification but this should be outweighed by the greater reduction m protein which would 
subsequently generate an increased specific activity factor and a greater purification factor 
When the protein level is low from the outset this occurrence is near impossible
4 414  Q-Sepharose Fast Flow Anion Exchange Chromatography
Proteins carry positive and negative charges on their surfaces, due mainly to the side chains of 
acidic and basic amino acids The net charge on a protein depends on the relative numbers of 
positive and negative charged groups, which vanes with pH The pH at which a protein has an 
equal number of positive and negative charged groups is called the isoelectnc point (pi) This 
point is often used to charactense a particular protein and similarly this property can also be 
used to punfy proteins Ion exchange of proteins involves their adsorption to charged groups 
followed by their elution with a buffer of higher lomc strength
Q-Sepharose is a anion exchanger which is frequently employed to separate proteins of pFs 
less than 7 Although the precise pi of salivary PO was unknown, bovine serum and brain PO 
had an isoelectnc pomt in the range 4 5-5 0, which is common for most mammalian proteases 
Therefore this technique was selected to specifically bmd and punfy the enzyme FIGURE 
3 3 3 1 illustrates the successful binding to the resin Its appears that almost all contaminating 
protein was eliminated in the run-through peak The linear gradient was selected as it did not 
lead to peak tailing and may have eluted other proteins undetected by the Coomassie protein 
method The punfication table shows another reduction (11-fold) in activity compared to the 
previous phenyl sepharose column while the protein content decrease was only 1 3-fold This 
inevitably generated an extremely low overall punfication factor
It would seem that bmding of this peptidase to any resin results in denaturation None of the 
chromatographies employed exposed the enzyme’s active site and should not have resulted in 
such a decrease in total activity During the punfication process the enzyme was subject to 
more disabling properties due to surrounding protein being removed However despite this 
low factor, if activity could be maintained to allow for subsequent analysis then the 
purification protocol would be acceptable
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4 4 1 5  Alternative Chromatographies for PO Purification
After the Phenyl Sepharose step PO activity was moderately high but not sufficiently pure 
This sample was subjected to a number of resms and techniques m an attempt to purify the 
protein but maintain activity
DEAE is a weak anion exchanger that separates similarly to the protocol outlined for QAE 
Sepharose m section 4 4 13 FIGURE 3 3 4 1 highlights the inability of the resm to separate 
the enzyme from contaminating protein Although an isocratic step is reported, the linear 
gradient did not improve protein separation but diluted the enzyme further As a consequence 
of the resin’s ability to bind too much protein the efficient separation of enzyme from 
contaminating protem was restricted to the elution step which proved difficult
Benzamidme is a senne protease inhibitor often used to classify classical, trypsin-like senne 
proteases When the molecule is immobilised onto Sepharose 6B, it potentially creates a very 
specific purification tool FIGURE 3 3 4 2 illustrates the effective binding and eluting of the 
enzyme from the resm Similarly the separation from other proteins was successful, however 
the subsequent analysis of the enzyme showed significantly lowered activity This could be 
due to the senne active site binding necessary for this method to work This obviously has a 
considerable effect on biological activity and maintenance of protein folding Nevertheless the 
enzyme was unfortunately too inactive to analyse when the method was employed
4 4 2 Purification Bovine Serum Dipeptidyl Peptidase IV  
4 4 21 Serum Preparation
A large volume of punfied enzyme was required for optimisation of the punfication protocol, 
necessitating a conespondingly large amount of starting matenal Therefore, a reliable, 
commercially available, inexpensive source that was high in DPPIV activity was essential 
Bovine serum fulfilled these requirements and was thus selected as an ideal source for the 
punfication of DPPIV Serum was prepared as outlined in section 2 6 1 by centnfugation of 
the non-clotted portion of bovine whole blood generating a large volume of bovine serum
4 4 2 2 Phenyl Sepharose Hydrophobic Interaction Chromatography
The inclusion of this resin may seem confusing when FIGURE 3 4 2 1 is observed This is 
because the protem of interest does not bind to the column but ‘runs through’, which is 
normally not favourable Although the complete binding of DPPIV to Phenyl Sepharose could 
be achieved with 1 5M ammonium sulphate, the main function of this resin was to initially
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separate Gly-Pro-MCA degrading activity from Z-Gly-Pro-MCA activity (PO) Both enzymes 
evolve from the same senne protease family (S9) and have many shared properties This 
includes the ability to hydrolyse identical peptides but at different cleavage sites As a 
consequence, it was imperative to separate these activities which proved near impossible 
when Phenyl Sepharose was not employed A small amount of the Gly-Pro-MCA degrading 
activity seems to bind which initially posed the question of a DPPIV isoform which would be 
in tandem with other reports from serum (Duke-Cohan et a l , 1995 and Shibuya-Saruta et a l , 
1996) However punfication and initial analysis of this peak did not suggest any difference to 
the unbound peak The protem separation profile shows significant contaminate protein 
binding in comparison to the run-through This may be somewhat deceiving It seems that 
when either the Biuret assay or the BCA assay was used, inaccurate protem measurements 
were sometimes reported The Biuret assay often proved too insensitive to protein content 
and/or the presence of ammonium sulphate may have interfered with the assay even though 
the salt concentration was below the specified compatible concentration Similarly the BCA 
assay was significantly affected by the salt content when it too was below the specified 
compatible concentration Dialysis of the fractions increased the recorded protem absorbances 
but was rarely utilised as it was detnmental to enzyme activity Either way a 186-fold 
reduction in protem resulted from this step, which aided the 48 1-fold increase in punty 
However a significant decrease in activity was also observed This is surpnsmg as the enzyme 
does not even bind to the resm but it was discovered that the high ionic effect of ammonium 
sulphate was considerably degrading for DPPIV activity This caused the loss of enzyme 
recovery to 26 3%
4 4 2 3 S-300 HR Gel Filtration Chromatography
All proteins have a charactenstic molecular weight based on the number of ammo acids, their 
size and conformation or folding of the protem Size exclusion chromatography is a very 
popular non-binding technique employed in protein punfication The resin is composed of 
pores of a predefined size When a mixture of diffenng molecular weights is applied to the 
resin the small sized molecules become retarded as they enter the pore beads In contrast, 
large molecules move through the column at a quicker rate As a consequence the rate of 
movement is directly proportional to the size of the molecule and it is on this basis that 
considerable protein separation can occur
The S-300 resin has the capacity to retard up to 1,500 kDa sized globular proteins Although 
the molecular size of DPPIV was unknown it was initially assumed that it was less than 1,500 
kDa Therefore Figure 3 4 3 1 clearly demonstrates the successful profile where the enzyme 
appeared to be separated from most of the contaminating protein The second protein peak is
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somewhat unusual but proves that there are a number of similar sized proteins present with 
DPPIV but are smaller This non-binding column was effective m reducing the total protem 
content to sub mg level However there is also a 2 6-fold decrease in activity compared to 
post-phenyl sepharose which led to a very low percentage yield of 9 9% Thus is seems that 
the conformation of the S-300 resm is degrading to DPPIV activity where shear and frictional 
stress from entering the resin’s pores may partially unfold the enzyme and reduce it’s 
functionality
4 4 2 4 POROS Anion Exchange Chromatography
The POROS 50 HQ is a strong anion exchanger and can challenge the protein’s pi property 
even more than a weak anion exchanger If binding can be achieved then increased 
purification can be obtained mainly due to the differing extent of protem binding The resm 
will be behave similarly to weak anion exchangers by immediately eliminating unbound 
proteins with high pi’s but also proteins with mildly low pi’s that can not bind strongly to the 
resin However over the elution process a linear gradient is important as finite differences in 
protein surface charges can be exploited FIGURE 3 4 4 1 demonstrates the obvious separation 
of bound protem from unbound In addition, there is expected if not immediately detectable 
protein separation over the sodium chloride positive linear salt gradient There is noticeable 
protein peak, coinciding with the sharp activity peak This suggests that this protein peak is 
mainly attributed to DPPIV This is also reflected in the Purification table 3 3 whereby the 
first binding resm reduced the protein content 11 5-fold compared to post-S300 DPPIV This 
is in tandem a smaller decrease in activity, which resulted in a significant increase in purity 
(250 5-fold)
4 4 2 5 G100 Gel Filtration Chromatography
Initially the G100 column was included solely to desalt the post-Anion Exchange sample as 
sodium chloride is detrimental to DPPIV activity This resm restricts any molecules smaller 
than 100 kDa in a manner already described in section 4 4 2 3 The initial molecular weight 
determination of DPPIV along with its behaviour on the S300 resm suggested that the enzyme 
would not enter any of the resin’s pores and elute very quickly Similarly, due to the use of 
the S300 column it was assumed all molecules sized 100 kDa or smaller would have been 
separated prior to use of this last column Protem analysis of the fractions showed no peaks 
but the assays sensitivity may be in question here Nevertheless FIGURE 3 4 5 1 clearly 
illustrates the removal of salt from the post-anion exchange preparation with an expected 
sharp DPPIV activity peak However TABLE 3 3 suggests an interesting phenomenon The 
reduction in total protem was not expected to be in the region of almost 6-fold, nor was such 
an unfortunate decrease in enzyme activity (5 7-fold) The frictional effects enforced on the
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enzyme should have been minimal but is appears that even when the protem is not retarded by 
the resm conventionally, the movement of the protem around the beads is sufficiently harsh 
on activity especially when very little other stabilising proteins surround it The reduction in 
protein is confusing but may suggest the possible presence of smaller proteins that may attach 
temporarily to the enzyme over the punfication protocol but is forced to separate during G100 
chromatography As a consequence, slight mcrease in punty is observed
It should be acknowledged that for the generation of the punfication table, both enzyme 
activity and protem had to be accurately quantified This involved the removal of mterfenng 
compounds mainly salt by dialysis This process undermined the importance of the 
punfication table For instance, the total activity of 49 5 units for post anion exchange has 
been applied to three columns but also had to be dialysed twice Dialysis also appeared to be 
detnmental to enzyme activity, proportional to protem levels This has a considerable effect 
on reducing the quantified enzyme activity as well as the punfication factors Therefore it is 
presumed that the ‘purified enzyme’ is considerably more that 257 times purer than that m 
serum
4 4 2 6 Alternative DPPIV Chromatography
Many reports have documented DPPIV as having a glycoprotein region Similarly FIGURE
3 8 2 indicates that bovine serum DPPIV is glycosylated Therefore the relative specificity of 
Lectin Chromatography was utilised Concanavalin-A Sepharose was prepared and earned 
out as outlined in section 2 6 5 1 Figure 3 4 6 1 shows the separation of contaminating 
protem from DPPIV activity but considerable peak tailing resulted It appeared that the 
enzyme bound very strongly to the column and was very difficult to remove The 
recommended elutant was 0 2-0 3M Methyl-mannoside or Methylglucoside However even 
when these concentrations were increased to 1 Molar the enzyme did not elute efficiently As 
a consequence the enzyme proved unstable after Con-A Sepharose This is understandable as 
the glycosylation region appears to be quite near the catalytic active site (see CD26 diagram) 
Therefore binding of the enzyme to lectm chromatographic columns would most occur deep 
within the protein’s structure, which could compromise it’s folding and ultimate functionality
4 5 Determination of Enzyme Purity
The concept of the term punty in relation to proteins is not always straightforward A pure 
protem would imply that the punfied sample contains, in addition to water and buffer ions, 
only one population of molecules all with identical covalent and three-dimensional structures 
This is often an unattainable and unnecessary goal In addition, it is very near impossible to 
prove a protein’s complete punty For the purpose of these studies, punty was assumed if the
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sample was shown not to contain any species which would interfere with the experiments for 
which PO or DPPIV was intended This was achieved using sodium dodecyl sulphate 
polyacrylamide gel electrophoresis (SDS PAGE) and fluonmetry-based analysis
4 5 1 SDS Polyacrylamide Gel Electrophoresis
FIGURE 3 5 11 represents a gelcode stained SDS PAGE gel completed usmg the protocol 
outlined m section 2 7 1 A number of protein bands are observed for both buffered saliva and 
post salt cut samples (lanes 5 and 4 respectively) Once column chromatography is 
undertaken, almost all of these contaminating proteins seem to be eliminated The figure 
shows very little difference between the post-phenyl sepharose or post-amon exchange 
samples This is understandable as there is only a slight reduction in protein after the last 
column The mobility of the protein m the gel also allowed for accurate molecular weight 
determinations of the ‘purified enzyme’
FIGURE 3 5 12 represents a gelcode stained SDS PAGE gel completed usmg the protocol 
outlined m section 2 7 1 Like PO gel analysis, numerous protein bands were observed in the 
crude protein samples In particular, even a dilution of crude serum had too much protein 
present to separate mto sharp individual bands Despite the initial perception that post-amon 
exchange DPPIV was pure, the gel suggests the elimination of a protein, approximately 150 
kDa m the post-GlOO sample It is probable that the G100 Gel Filtration resin was successful 
in retaining this protein and separatmg it from DPPIV No other protein bands were observed 
in the G100 sample, so it was assumed that the enzyme was pure
4 5 2. Fluonm etnc Substrate Analysis
Post anion exchange PO was incubated with other fluonmetnc substrates as outlined in 
section 2 7 2 , in attempt to ascertain the presence of other contaminating peptidases (TABLE 
2 6) TABLE 3 5 lists the substrates that were hydrolysed and unfortunately it appears that 
post-amon exchange PO is far from pure Most of the activities were quite low but may 
contnbute to inaccurate charactensation studies The presence of the aminopeptidases is 
significant, especially Prolme Aminopeptidase Due to the unique structure of the prolme 
ammo acid, the PO substrate, Z-Gly-Pro-MCA, becomes considerably more specific to the 
enzyme However if the Gly-Pro bond was cleaved then MCA could be released by Prolme 
Aminopeptidase and what is perceived as PO activity would then be inaccurate Both Gly- 
Pro-MCA and Z-Phe-Arg-MCA degrading activities were comparatively very high Their 
contaminating influence would be observed most in specific inhibitor studies The active site 
of these peptidases could be very similar to that of PO Therefore calculated IGso’s and K, s
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would be significantly inaccurate In addition, substrate specificity studies would also be 
compromised by the presence of these peptidases, whereby hydrolysis may not attribute to the 
influence of just one enzyme As a consequence, it would appear that the SDS PAGE gel 
observed is inaccurate The gel does not suggest the presence of any other proteins but 
fluonmetnc analysis does Therefore the sensitivity of the gel electrophoresis is not sufficient 
to detect low levels of proteins that may hydrolyse other substrates It is worth noting that the 
stability of some of the substrates could be questioned The difference between the blanks and 
the active triplicates is sufficient to suggest that a similar difference in stability could occur 
The substrate may remain protected from auto-catalysis at an acid pH (blanks), whereby the 
substrate could be destabilised at neutral pH at 37°C during the 60 minute incubation 
(triplicates) If this was the case, then the fluorescent intensities could be considerably lower 
if taken into account and substrate hydrolysis could be negligible
Like PO, purified DPPIV was incubated with other fluonmetnc substrates Unlike PO, the 
results make for more favourable reading All contaminating fluonmetnc substrates remained 
mtact, which conelates well with the gel observed High activity was recorded for both Gly- 
Pro-MCA and Lys-Pro-MCA, both of which are DPPIV substrates Lower activity was seen 
from Lys-Ala-MCA analysis, which is a DPPII substrate However DPPII can not hydrolyse 
this substrate at pH’s other than acidic Similarly the secondary affinity of DPPIV for Lys- 
Ala-MCA is well documented (Ohkubo et a l , 1994 and Gilmartin and O’Cuinn, 1999) 
Therefore it is assumed that further charactensation studies could be undertaken whereby the 
expenments results would be attnbuted to the DPPIV enzyme alone
4 6 Assay Development
4 6.1 Substrate Solvent Studies 
4 6 1 1  Substrate Solvent Determination for PO
The substrate employed for the detection of PO activity, Z-Gly-Pro-MCA, is water insoluble, 
so the addition of a non-aqueous organic solvent was essential for solubilisation The majonty 
of enzymes, which function in natural hydrophobic environments, did not evolve to function 
in non-aqueous environments and so the use of organic solvents is never favoured It has been 
hypothesised that although water remains essential for catalysis, an enzyme molecule in 
aqueous solution becomes fully hydrated when surrounded by a few layers of water (Gorman 
and Dordick, 1992) Therefore, bulk water, other than tightly bound structural water, is not 
crucial for catalytic activity and replacement of the remaimng water with an organic solvent 
should be possible without adversely affecting the enzyme In fact, aqueous-organic solvent
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mixtures may resemble the natural cellular environment more closely than pure aqueous 
media The enhanced catalytic activity in aqueous-organic solvent may reflect the optimum 
exploitation of catalytic activity inherent in the natural structural design of the enzyme 
molecule
A non-aqueous solvent was sought which proved optimal for both substrate solubility and 
enzyme activity Z-Gly-Pro-MCA was prepared in a range of organic solvents and assayed 
with ‘purified PO’ as described in section 2 8 1 FIGURE 3 6 11 compares the effect on PO 
activity of MeOH, EtOH, DMF and DXN as substrate solvent to that of DMSO, the 
previously favoured solvent Both alcohols increased enzyme activity but only slightly 
Nevertheless methanol contributed most to PO activity with a 22% mcrease This, coupled to 
its effective solubilisation properties, resulted in MeOH being selected as the optimal solvent 
for Z-Gly-Pro-MCA preparation
4 6 1 2  Substrate Solvent Studies of DPPIV
Although the substrate utilised for DPPIV detection, Gly-Pro-MCA is water-soluble and has 
no requirement for non-aqueous solvents, the potential of elevated catalysis in an organic- 
aqueous environment was mvestigated Like PO, FIGURE 3 6 12 demonstrates the effect on 
DPPIV activity of EtOH, DMSO and DMF as substrate solvents, compared to MeOH It is 
obvious how much of an effect ethanol has on substrate hydrolysis with a 2 7-fold mcrease 
Surprisingly, methanol seemed to be the least favoured substrate and the large vanation 
between both alcohols is significant
Generally short chain aliphatics cause a lower degree of denaturation than solvents such as 
butanol (Hams, 1989), and this may explain why PO activity was least affected by the 
presence of MeOH in the substrate Organic solvents effect both the denaturation and catalytic 
activity of enzymes, but not necessanly m a parallel manner Aliphatic solvents (EtOH and 
MeOH) show only moderate effect on activity denaturation and loss of catalysis DMF on the 
other hand, is a strong denaturant which also reduces catalytic activity, while dioxane does 
not induce denaturation but does diminish catalytic power The difference between the effect 
of methanol compared to ethanol on DPPIV activity suggests that the ethyl alcohol has a 
specific effect on the enzyme It is possible that the enzyme could be partially unfolded, 
exposing the active site and allowing for easier access of the substrate It has also been 
suggested that the pH of a buffer and MeOH or EtOH mixture is more likely to remain at the 
pH value of the added buffer component, than in mixtures composed of DXN, DMSO, DMF 
and acetomtnle This may offer another explanation as to why optimal enzyme activity was 
observed using MeOH or EtOH as the substrate solvent for PO and DPPIV respectively
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Once EtOH had been selected as the optimal solvent for DPPIV substrate preparation, the 
concentration at which it was most effective was then determined Experiments were earned 
out according to section 2 8 2 in which the concentration of EtOH used in Gly-Pro-MCA 
preparation was vaned Enzyme activity increased slightly at 4% of the solvent (FIGURE 
3 6 3 ) but eventually decreased when the ethanol concentration was mcreased further 
Although the 10% increase in enzyme activity was notable it was deemed too low to warrant 
change in the substrate and potentially high enough to interfere with the effect of other 
compounds Therefore as a consequence of the substrate’s solubility without the influence of 
any solvent, 1% EtOH was decided as an acceptable concentration to aid enzyme activity
4 6 2. Linearity Studies
A typical progress curve for an enzyme-catalysed reaction is presented m FIGURE 4 6 The 
time course is initially linear but the rate of product formation starts to decline after prolonged 
incubation This departure from lmeanty may be due to a number of factors, most frequently, 
substrate depletion, enzyme or substrate instability, products inhibiting the reaction, or a 
change in assay conditions It can be deduced from this that enzyme activity should only be 
quantified at a point where these factors are known not to be an issue This point is known as 
the initial velocity of the reaction and can be calculated by drawing a tangent through the 
ongin to the linear part of the progression curve as shown in FIGURE 4 6 Using a continuous 
assay system, this decrease in reaction velocity with respect to time is evident and generally 
due to substrate depletion
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Figure 4 3. typical Progress Curve of an Enzyme-catalysed Reaction
Plot of product formation versus time
The discontinuous assay can be treated in the same way However if slight deviation occurs, it 
may not be readily detected Therefore it is recommended that this assay be complimented by 
a continuous assay also
4 6 21 Linearity of PO
The discontinuous assay was carried out as described in section 2 8 3 1 with the overall time 
decided 60 minutes as this was the time limit used for all standard assays FIGURE 3 6 4 1 1 
clearly illustrates the linearity of the assay even if the rate of MCA release is quite low With 
a regression coefficient of 0 996, it may be assumed that the PO enzyme is stable enough over 
the 60 minutes to maintain hydrolysis and this assay time can be followed Similarly, the 
continuous assay is linear over the same time frame using the protocol outlined in section
2 8 3 2 This involved the adaptation of the fluonmeter attached to the waterbath, providing a 
warmed cuvette The graph is not shown as it proved difficult to convert the ‘time-drive5 file 
to one that could be imported and graphed
4 6 2 2 Linearity of DPPIV
The discontinuous assay was carried initially and generally shows that DPPIV is linear over 
60 minutes However there was some speculation over the actual 60 minute activity value If 
this was an anomaly or was not mcluded then the trend of the graph previous to this suggests 
rate slow down possibly due to substrate depletion or enzyme instability In contrast, if the 50 
minute value was excluded, the assay would appear to have greater linearity Either way the 
continuous assay was required to further confirm the enzyme’s linearity over time FIGURE
3 6 4 2 1 shows the obvious direct linearity of DPPIV, not only over 60 minutes but also over 
120 minutes (7200 seconds) This allowed for longer analysis if required and proved that the 
enzyme is stable and fully active over a wide time frame and that the assay is saturated with 
sufficient substrate over the selected time This was vitally important if accurate enzyme 
activity quantification could be carried out for purification factor determination and general 
characterisation studies (See appendix section 6 3)
Another parameter to be considered in the quantification of DPPTV, is the linearity of the 
assay with respect to enzyme concentration FIGURE 3 6 5 demonstrates that fluorescent 
intensity increases linearly and proportionally with increasing enzyme concentration 
Therefore the enzyme hydrolysed at the same rate depending on the quantity of enzyme 
present
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4 6 3. Optimum Assay Temperature
The effect of assay temperature on purified DPPIV activity was investigated as outlined in 
section 2 8 5 Samples were allowed to reach thermal equilibrium by pre-incubation for 15 
minutes at the appropriate temperature prior to assaying This ensured that the observed 
activity genuinely reflected the activity of the peptidase at the temperature under 
investigation A typical bell-shape curve was not observed as FIGURE 3 6 6 illustrates The 
rapid mcrease in fluorescent intensities observed in assays performed at temperatures greater 
than 37°C, reached a peak at the final temperature recorded, 60°C It was expected that the 
fluorescent intensity values may mcrease even further if the temperature was increased 
accordingly Although it is initially encouraging to suggest that DPPIV is thermostable to at 
least 60°C, it is more likely that the stability of the substrate has a significant part to play m 
these results The blanks recorded for each temperature increase also rose steadily suggesting 
that even without enzyme influence, MCA is still being released possibly due to the gradual 
thermal degradation of the substrate It is most likely that the substrate is partially destabilised 
by the high temperatures, the extent of which is directly proportional to the temperature but 
enzyme hydrolysis still occurs Although most reports document the assay temperature as 
ambient or physiological temperature, the enzyme is reputed to be very thermostable 
(Yoshimoto et a l, 1978) Despite the reports of DPPIV’s thermostability, and the result of this 
expenment, it was deemed that accuracy and reproducibility could be maintained if the assay 
was kept at the physiological temperature of 37°C
4 6 4 Effect of D T T  and E D T A  on Enzyme Activity 
4 6 41 Effect of DTT and EDTA on PO
Numerous reports have shown PO to be substantially activated by dithiothreitol or DTT 
(Walter, 1976, Orlowski et a l, 1979, Kalwant and Porter, 1991) Cunningham and O’Connor, 
1998, reported a twelve-fold mcrease in PO activity in the presence of lOmM DTT Therefore 
the stability of PO and the optimum assay conditions warranted a thorough investigation into 
this thiol reducing agent Figure 3 6 6 1 clearly demonstrates the considerable influence 
DTT has on the enzyme’s activity A 3 3-fold mcrease in activity m the presence of 5mM 
DTT was seen to nse even further to 4 3-fold at 20mM It is generally accepted that this 
marked increase is due to the reduction of disulphide bridges (S-S) to thiol groups (SH +SH) 
by DTT This suggests the existence of a cysteine residue, situated near the active site, which 
when reduced increases the ability of PO to initiate a nucleophilic attack upon a bound 
substrate (Polgar, 1991) The results obtained suggest that PO, has a cysteine residue near its 
active site which in the presence of thiol-reducing agents, contributes to the activation and
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stability of enzyme activity Even though it is not immediately obvious, it was assumed that 
high concentrations of DTT could interfere with other characterisation studies, therefore the 
DTT concentration was maintained at 5mM m all substrates and purification running buffers 
As a result, the enzyme was constantly stored in a known quantity of thiol reducing agent
PO is not reported as a metallo-protease and the effect of the metal chelator, Ethylenediamine 
tetraacetate (EDTA) is minimal (Yoshimoto, et a l, 1987) Nevertheless many of compounds 
contain trace heavy metals that may have a detrimental effect on activity Therefore the 
enzyme was incubated with the substrate with differing concentrations of EDTA to ascertain 
its effect on the enzyme FIGURE 3 6 7 1 illustrates the compounds effect on PO activity 
Eventhough quite a small concentration was used, EDTA eventually had a detrimental effect 
This suggests that the enzyme may have a metallo residue somewhere other than the active 
site However the 25% reduction in activity at 2mM may be attributed to partially blockmg 
the enzyme from attacking the substrate and not related to the enzyme itself Nonetheless, 
0 5mM EDTA was selected to be included in all substrates and buffers in the hope to maintain 
stability from heavy metal toxicity
4 6 4 2 Effect of DTT and EDTA on DPPIV
The schematic structure of DPPIV shows the presence of a cysteine rich domain close in 
proximity to the catalytic domain Therefore it could be assumed that cysteine residues may 
play a role m enzyme activity Thus the effect of DTT was of potential mterest However 
FIGURE 3 6 6 2 demonstrates the in-effect the thiol reducmg agent has on activity This may 
be understandable seeing as even though the cysteine and catalytic domains are very close to 
each other the active site is located near to the C-terminal side and further away from the 
cysteine residues than initially expected It is possible too that the folding of the protein does 
not allow for adequate thiol reduction by DTT This result correlates well with other reports 
of minimal DTT effects on DPPIV activity (De Meester et a l , 1992 and Shibuya-Saruta et a l, 
1996) Therefore it was not deemed necessary to include DTT m any of the buffers or 
substrate
Like DTT effects, EDTA is reported to have a minor effect on enzyme activity Nevertheless 
heavy metal effects may destabilise the enzyme, therefore the level of compatibility was
rinvestigated as outlmed in section 2 8 7 2 FIGURE 3 6 7 2 demonstrates the slight enhancing 
effect the metal chelator has on enzyme activity An mcrease of 50% at 8mM EDTA was 
surprising but may be attributed to the removal of metals that may have co-existed in the 
substrate It is possible that these metals destabilise the substrate, making easier for enzymatic 
hydrolysis However it is notable that the enzyme received increased activity Therefore 5mM
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EDTA was included in all of the running buffers employed during purification but was not 
deemed necessary for substrate inclusion as that concentration may influence the effect of 
other compounds that are tested and the effect observed may not be attributed to the enzyme 
alone
4 7 S ta b il i ty  S tudies o f  PO  
4 7 1 Thermostability of PO
Once a protein is released from its native environment, it will be subject to many inactivating 
conditions Normally the pH of the native state is maintained at 6 5-7 5, the protein content is 
high (lOOmg/ml) and the reducing potential is considerable (Hams, 1989) Upon disruption 
into the buffer, the protein concentration is automatically reduced and the protein experiences 
an oxidising environment as well as acidification Extremes in pH, temperature and organic 
solvents are the principal causes of denaturation Correct buffer selection can minimise effect 
of pH extremes while exposure to organic solvents is often insignificant However 
temperature effects are a lot more prevalent If a protem is exposed to an oxidising 
environment, then temperature extremes may not be necessary to destabilise it
4 7 1 1  Effect of 37°C Pre-incubation on PO activity
The inherent instability of salivary PO was very apparent and methods to try to stabilise 
enzymatic activity were undertaken The assay utilised to monitor PO activity involved the 
incubation at 37°C for 60 minutes Although it was established that activity was linear over 
the hour, the question was posed, how stable is the enzyme in these conditions and can they 
be improved upon Therefore the behaviour of PO was mvestigated as outlined in section 
2 9 1 The effect of pre-incubation time was observed and FIGURE 3 7 1 demonstrates the 
dramatic decrease in activity over time This effect can be acknowledged by the 25% loss of 
PO only after 15 minutes of pre-incubation This decrease continued steady to an almost 80% 
loss after 4 hours It is worth noting that as well as a 15 minute pre-incubation, the enzyme 
was also subjected to another 60 minutes at the same temperature for analysis Nevertheless 
the activity loss is very significant Although it is very unlikely that the enzyme would need to 
be pre-mcubated for anytime longer than 30 mmutes, the enzyme is considerably 
compromised and the results obtained from such a study would have to be analysed carefully
It is obvious that the enzyme is very unstable under these conditions, therefore stabilising 
agents were employed Although it may seem as a contradiction, the addition of protease-free 
BSA to a purified sample can often stabilise the protein of interest As a consequence, the
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previous study was also earned out m tandem with both 1% and 10% BSA added to the 
enzyme sample Very similar trends are observed for both BSA additions compared to the 
untreated sample However the decrease in activity is considerably reduced when protein was 
added The difference is quite alarming when after 90 minutes, 46% of PO activity was lost in 
the presence of 10% BSA, 60% was lost from the 1% sample while 67% was lost in the 
untreated sample The treated punfied samples were not continued after 90 minutes as the rate 
of activity loss was still sufficiently high to observe inevitable instability of the enzyme
4 7 1 2  Effect of -20°C  storage conditions on PO activity
Punfied and post column samples were stored in a frozen state when not in use The freeze- 
thaw process is known to be quite harsh on activity whereby the acid and conjugate basic 
species of buffers may have different freezing points That inevitably leads to sudden rapid 
change in the pH of the solution, which could cause irreversible protein degradation As well 
as the freeze-thaw process the stability of PO over time at these conditions was evaluated The 
thermostabilising effect of BSA was again incorporated with 1% also included and compared 
to the untreated sample FIGURE 3 7 2 1 clearly shows a common trend between when the 
BSA is included and when not Both observe decreases in activity over the first three days, 
which seem to plateau off for the following 28 days 30% activity was lost from the no BSA 
sample while 1% inclusion reduced the loss considerably to only 9% This would suggest that 
as well as aiding the enzyme dunng the thawing process BSA may also keep the enzyme 
protected dunng the frozen state It is assumed that a certain amount of enzymatic loss should 
be expected from all samples with such a low protein content Therefore it was suggested to 
include 1% BSA when the punfied PO enzyme was stored
As a consequence of the punfied PO sample behaviour under frozen conditions, the question 
was posed whether the punfication has an irreversible, detnmental effect on activity or if the 
protein is unstable to begin with Therefore buffered saliva PO was investigated as it was 
assumed that in this environment, the protein would most stable The same study was 
incorporated as previous with 20% glycerol also included for a companson effect FIGURE 
3 7 2 1 demonstrates the surpnsing result Protein degradation in untreated buffered saliva 
appears greater than in the punfied sample mentioned previously Enzymatic loss was in the 
region of 35% after 3 days to 58% after 5 days It was hoped that glycerol would minimise the 
effects of freeze-thawing by possibly keeping the protein in a c semi-frozen’ state Although is 
appeared to reduce the enzyme activity loss it still could not save a 32% loss after 5 days It is 
worth noting that a general reduction in PO activity was observed when glycerol was added, 
suggesting that it may have restncted the enzyme mobility somewhat It is also possible that 
the buffer capacity of buffered saliva is restncted due to the presence of oxidants Similarly it
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is assumed that buffered saliva contains a number of proteases that may not be favourable to 
PO activity The removal of these proteases and other contaminating proteins seem to allow 
for more reproducible results and decreased instability
Therefore the results mdicate an inherent instability of the enzyme despite the best efforts of 
stabilising agents It possible that the enzyme may be secreted in saliva without an N-terminal 
precursor or signalling peptide as part of its structure that is present in other mammalian PO 
species, and which maintains stability (Chevailler et a l , 1992) This may cause the inevitable 
self destruction of the enzyme before it reaches the acidic medium of the stomach Thus it is 
expected that the half life of salivary PO is extremely short while its ultimate physiological 
function still remains elusive However the presence of neuropeptides in saliva may suggest a 
specific, evolutionary role (Dawidson et a l, 1997)
4 8. C h a ra c te r is a t io n  
4 8 1 Relative M olecular Mass Determinations
The anionic detergent sodium dodecyl sulphate (SDS) readily binds to proteins in a ratio of 
14 1, effectively masking the intrinsic charge of the polypeptide chains by coating the protein 
with a negative charge (Dunn, 1989) The net charge per unit mass becomes approximately 
constant, therefore separation of SDS-treated proteins is effectively based on molecular 
weight alone
48 11 SDS PAGE of PO
SDS polyacrylamide gel electrophoresis (PAGE) was employed in the estimation of the 
molecular mass of purified PO as outlined in section 2 10 1 2 A 10%v/v gel was prepared 
since the molecular weight was expected to be in the range 15-200kDa FIGURE 3 5 11 
represents the image of the PO gelcode stained gel Measurement of the molecular weight 
marker Rf values allowed for the construction of standard curves (FIGURE 3 8 11 1) Using 
these curves, molecular masses of PO were determined to be 78,860Da (gelcode stain) and 
82,870Da (blue stain) The interaction of SDS with proteins causes the irreversible 
denaturation of the 3-dimensional structure and proteins are thus broken down into individual 
polypeptide chains (monomers) Therefore SDS-PAGE yields no insight into the native 
molecular mass of a protein and so a second method for the determination of molecular mass 
is regularly performed However this was not employed for PO as all reports show the 
enzyme to be a monomer, therefore the determined molecular weight from SDS-PAGE is also 
the enzyme’s native molecular weight
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4 8 1 2  SDS PAGE and Size Exclusion Chromatography of DPPIV
SDS-PAGE was also utilised for DPPIV molecular weight determination The same method 
was followed as that of PO Although the enzyme has been reported larger than 200kDa, a 
10%v/v gel was still employed as the enzyme’s monomeric weight was assumed to be 
considerably less FIGURE 3 5 12 illustrates the gelcode stained gel of DPPIV post-column 
fractions and molecular weight markers The Rf value could be determined as described in 
section 3 8 11 FIGURE 3 8 112 allowed for the estimation of the enzyme’s monomeric 
molecular weight which was 67,140Da from the blue stain and 74,340Da for the gelcode 
stain As most reports of DPPIV’s molecular weight or structure are of a dimenc or tnmeric 
enzyme, a second method was employed to ascertain the native molecular weight
Size-exclusion chromatography (SEC) is frequently employed as a non-denaturing technique 
for molecular mass estimation Separation is based on the hydrodynamic volume of a protein 
or simply its size, larger proteins eluting faster than smaller ones that mteract with the pores 
of the column Two SEC columns were run as described m section 2 10 1 1, namely a low 
pressure Sephacryl S-300 column and also a medium pressure HiPrep Sephacryl S-300 
prepacked column FIGURES 3 8 12 1 and 3 8 1 2 2 represent the standard curves of log 
molecular weight versus elution volume/void volume for each resin Molecular masses of 
276,00 and 328,000Da were estimated from these graphs for S-300 and HiPrep S-300 
sephacryl resins respectively Based on these results, it was assumed that the estimated 67kDa 
and 74kDa SDS PAGE bands corresponded to the mass of a subunit of the peptidase It was 
deduced, due to the presence of a smgle band following PAGE analysis that DPPIV possibly 
exists as a tetramer of four subunits of equal or similar molecular weight and indicative 
molecular weights are reported in TABLE 3 7 Combination of SDS PAGE and SEC for the 
determination of molecular weight, compensated for the inadequacies of each technique and 
so an average molecular weight of 292,5OODa can be confidently postulated for the enzyme
4.8 2. Glycosylation Estimation of D P P IV
Many specialised cells secrete proteins produced by the rough endoplasmic reticulum Most 
of these secretory proteins are glycoproteins The carbohydrate side chains of glycoproteins 
are attached covalently during or after synthesis of the polypeptide chain In some 
glycoproteins, the carbohydrate side chain is attached enzymatically to asparagine residues, in 
others senne or threonine residues (Lehmnger, 1982) The schematic structure of DPPIV 
shows a large glycosylation domain spanning almost 250 amino acids in the extracellular 
portion of the protease (De Meester, et a l , 1999) This domam is located in the N-terminal as 
contains eight potential glycosylation sites These sites account for the difference in molecular
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mass between the predicted polypeptide and the actual mature protein Although the sites are 
situated near the transmembrane domain of membrane-bound DPPIV, it is not part of it so 
would also be expected to be part of the soluble protein’s structure
This experiment was earned out in tandem with punty determination studies and/or molecular 
weight estimations as the test could be utilised on SDS-PAGE gels but simply stained 
differently (TABLE 2 6) FIGURE 3 8 2 illustrates the presence of a glycoprotein m the post- 
G100 sample The mobility of the pink band coincided with a gelcode stained SDS-PAGE 
gel, indicating that the band is monomeric DPPIV The gel further confirms the assumption 
that DPPIV is composed of similar sized subunits, with the presence of one band
4 8 3 Overnight Thermostability of D P P IV
Although the stability of DPPIV, has already been established at vanous temperatures, it was 
of interest to ascertain for what range of time the activity was stable for In addition, any 
substrate specificity studies were recommended to be earned out over a 24 hour penod at 
physiological temperature Therefore it was deemed necessary to evaluate if the enzyme was 
capable of remaining active over this time frame FIGURE 3 8 3 1 demonstrates the stability of 
DPPIV at 37°C over time Even though the same substrate batch was used for analyses, there 
still was some fluctuation in the enzyme's activity However this is expected and does not 
unduly inform of any significant physiochemical property of the enzyme This study simply 
confirms the possibility of utilising 24 hour mcubations, if required
4 8 4. pH Effects
4 8 41 pH Effects on PO
The effects of pH on PO stability and activity was performed Section 2 10 4 1 desenbes how 
the pH range over which the Z-Gly-Pro-MCA degrading peptidase remained stable was 
examined This was achieved by pre-incubation at a range of pH values followed by assaying 
with substrate prepared in buffer at pH 7 4 Citrate, phosphate, Tns and glycme buffer 
systems (pKa values 4 76, 7 20, 8 06 and 9 78 respectively) were chosen to reflect a range of 
pKa values, since buffering capacity is maximal at the pKa FIGURE 3 8 4 1 represents the 
bell-shaped inactivation curve constructed for PO The enzyme showed a preference for 
neutral with a noticeable preference for potassium phosphate, pH 7 4, the buffer that had been 
used dunng all analyses The enzyme was, not surpnsingly, almost inactivated at low pH 
This suggests that salivary PO does not have two forms that behave differently depending on
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the pH that has been already reported (Polgar, 1991) Nevertheless the buffer selection was 
accurate for optimising enzymatic activity
4 8 4 2 pH Effect on DPPIV
Like PO, the effect of pH on DPPIV activity was investigated Citrate, phosphate, Hepes and 
glycine buffer systems (pKa values 4 76, 7 20, 7 48 and 9 78 respectively) were utilised 
FIGURE 3 8 4 2 demonstrates an un-classical bell-shaped curve with neutral pH generally 
being preferred The highest enzyme activity was noticed in the phosphate buffer at pH 7 0 
however the overall activities were considerably low so the margin of error is increased The 
complete loss of activity at pH 9 0 to 10 5 is surprising seeing as DPPIV is reported to have a 
pH optimum at mild basic pH’s However it is very possible that the effect is due to the type 
of buffer used, l e glycine and not a pH effect
The second study on the pH effects on DPPIV is termed ‘pH Inactivation’ and is expected to 
give a better insight into the optimal buffer and pH required for activity As well as pre- 
mcubation of the enzyme in the different buffer species and at different pHs, the substrate is 
also made up in the respective buffer FIGURE 3 8 4 3 demonstrates some unusual behaviour 
The effect of the individual buffers plays a more important part than before and suggests a 
general tendency for weak acidic pH in either citrate or phosphate buffer The previous loss of 
activity at the high pH range is not observed, therefore a similar trend between both studies 
can not be drawn Nevertheless the phosphate buffer at weak basic pH appeared to be the 
optimal buffer conditions to use However the zwitteromc ‘Good’ buffer Hepes was selected 
despite its increased cost as the buffer of choice This selection was made mainly due to the 
perceived auto-catalysis of the Gly-Pro-MCA substrate in phosphate buffer It is unlikely that 
phosphate is the cause of this auto-catalysis but Hepes significantly reduced non-enzymatic 
substrate breakdown
It is important to establish the significance or possible insignificance of these results The 
objective of the studies was to ascertain the direct effect of pH on enzyme activity This can 
only be achieved by altering the pH of a buffer species as far as it’s buffering capacity allows 
(usually 1 0 pH unit either side of the designated pKa) Therefore the buffer species has to the 
changed also This creates two different variables and their effects can not be separated Thus 
the decrease in activity from one buffer to the next may not be due to a change in pH but a 
change in buffer This problem can be somewhat minimised if overlapping pHs are allowed 
but this may not always be the case The buffer itself can have a specific effect on enzymatic 
activity, often regardless of pH For instance, phosphate inhibits many kinases and 
dehydrogenases as well as enzymes with phosphate esters as substrates (Blanchard, 1984)
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Therefore a certain amount of reserved judgement should be kept in mind when analysing 
these results
4 8 5 Isoelectric Point Determination (D PPIV)
Chromatofocusing was employed in the determination of the isoelectric point (pi) of DPPIV 
It differs from ion exchange in that the anion exchange matnx, pre-adjusted to a given pH, has 
distinct buffering properties that allows the creation of a pH gradient on the column rather 
than outside it Chromatofocusing can be employed as either an isoelectric focusing or 
purification technique Section 2 10 5 I outlines the conditions at which a PBE 94 resin was 
run Bmding of DPPIV was achieved at the initial pH of 7 8 and eluted during a pH gradient 
between pH 5 2 and 5 3 (FIGURE 3 8 5 1 ) This implies that in this range DPPIV had no net 
charge and therefore is a good indication of its pi
Chromatofocusing could have been applied in the purification protocol, but the low working 
pH range was not optimal for DPPIV activity, as well as the enzyme dilution that can occur 
Coupled to this, polybuffer can be difficult to remove, requiring a further step such as 
ammonium sulphate precipitation, size-exclusion or affinity chromatography As a 
consequence, chromatofocusing has not been widely reported in the purification of DPPIV
In order to confirm the pi deduced using chromatofocusing, vertical isoelectric focusing (IEF) 
was performed which is based on the following theory In the presence of an electric field and 
pH gradient, charged proteins migrate towards the anode or cathode until they reach their 
isoelectric point at which they have no charge and hence cannot further migrate Vertical IEF 
systems are becoming more common due to their simplicity and there is no need for a 
separate IEF system as PAGE electrophoresis equipment can be employed The relatively 
large pore size of agarose made it an ideal matnx for the large MW DPPIV FIGURES 3 8 5 2 
and 3 8 5 3 represent an image of the blue stained gel and the standard curve constructed as 
descnbed in section 2 10 5 2 respectively The isoelectnc point of DPPIV was estimated to 
be 4 71 usmg this technique This value does not correlate well with the chromatographic 
estimate of 5 2-5 3 but due to the supenor resolving capabilities of IEF, the pi of DPPIV was 
concluded to be 4 71 This is acceptable as the chromatofocusing technique involved 
manually measuring the pH of each individual 3ml fraction It is assume that of the 3 ml, 
DPPIV constitutes a small fraction but the pH measurement is for the entire 3ml The pi 
estimation correlates well with the enzyme’s behaviour on anion exchange resms as well as 
the literature (De Meester et al, 1992)
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Source Assay Temp 
°c
M onomeric MW 
kDa
F memngosepticum 45 75
Lamb kidney ND 115
Human placenta 37 120
Human lymphocytes ND ND
Porcine seminal plasma 37 115
Human serum 37 100
Ostrich kidney 45 133
Guinea-pig bram 37 93
T a b le  4 2 D P P IV  Physiochem ical P ro p e r tie s  
ND means not determined
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N ative M W  Optimum p i C a ta ly t ic  R efe ren ce :
k D a  pH In h ib tion
160 7 4 - 7 8 95 DFP Yohimoto and Tsuru, 1982
230 7 8 49 DFP Yoshimoto and Walter, 1977
200 8 0 3 - 4 DFP Puschel et a l , 1982
264 8 7 50 DFP De Meester et a l, 1992
300 80 6 85 DFP Ohkubo et a l , 1994
250 85 ND DFP Shibuya-Saruta et a l , 1996
270 80 47 PMSF Wagner et a l , 1999
194 78 ND p-CMB Gilmartin and O’Cumn, 1999
NEM
4.8 5 Catalytic Classification and Effect of Other Functional Reagents
Sensitivity to specific active-site-directed inhibitors coupled to ammo acid sequence analysis 
is frequently investigated to determine the catalytic class of an enzyme In this study a 
number of serine, metallo- and cysteine protease inhibitors were incubated with purified 
DPPIV to establish inhibition effects Cysteine protease activators and some non-specific 
inhibitors were also examined as detailed in sections 2 10 6 and 2 10 7
TABLE 3 9 lists the Senne Protease inhibitors and their percentage effect on DPPIV 
Surprisingly even though the enzyme is generally classified as a senne protease (Yoshimoto 
and Walter, 1977 and Iwaki-Egawa et al, 1998), none of the inhibitors had a significant effect 
on activity This may be explained by the belief that DPPIV is not a classical senne protease 
(Rawlings and Barrett, 1991), so could be more resistant to senne protease inhibitors that may 
normally be potent to general senne proteases, such as, trypsin etc Alternatively the active 
site senne is the target for these studies and inaccessibility by stenc hindrance may prevent 
any inhibition This may explain the minimal inhibition observed due to PMSF, the classical 
senne protease inhibitor, which correlates with the literature (Shibuya-Saruta et a l, 1996 and 
De Meester et a1, 1992) These possibilities ultimately could have been answered with the 
availability of the potent senne inhibitor, Dnsopropyl Fluorophosphate (DFP), which is the 
standard reagent used However the hazardous nature of the compound suggested otherwise
An interesting set of results came from the inhibitory effect of metallo-protease inhibitors on 
DPPIV activity The phenanthrolines had a particular potent effect on activity with 20mM 
4,7-phenanthrolme decreasing DPPIV activity by 46% (TABLE 3 10) This may warrant the 
possible classification of a metalloprotease or the fact that a metallo residue is located near 
the catalytic site and is necessary for activity However the effect of the metal chelators does 
not indicate any significant reduction in activity compared to the phenanthrolines If a metallo 
residue was present, it would be assumed that at least one of the chelators would have been 
more potent than observed Therefore this suggests that there may be more structural 
similanty between DPPIV and 4,7-phenanthrolme The latter compound consists of an 
aromatic nng, which may interact with the hydrophobic patches on the surface of the enzyme 
and reduce its activity somewhat This effect has also been observed in serum PO, which is 
classified as a senne protease (Cunningham and O'Connor, 1998)
The structure of DPPIV outlines a cysteine nch region located next to the catalytic domain 
(De Meester et al, 1999) Therefore it is possible that cysteine protease inhibitors and 
activators could ascertain their influence in substrate catalysis both positively and negatively 
TABLE 3 11 shows that 10mM N-ethyl maleimide (NEM) had a 47% inhibitory effect on
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DPPIV activity, while other inhibitors were insignificant. Similarly the cysteine protease 
activator, mercaptoethanol increased DPPIV activity by 25% at lOmM (TABLE 3.12). This 
suggests that the cysteine rich region near the catalytic site has some influence on enzyme 
activity. It is possible that the cysteine residue do not contribute to the catalytic process but 
aids the protease’s functionality. Despite this possibility, the standard thiol reducing agent, 
DTT did not aid activity at all. However that could be due to the differences in how both 
compounds reduce the thiol groups.
The effect of general functional reagents was explored on DPPIV. These reagents were 
expected to have a non-specific effect on activity by possibly partially binding to enzyme. 
None of the reagents had any significant effect on the activity of the enzyme however the 
effect of Trypsin Inhibitor is potentially interesting. Although the inhibitory effect of the 
reagent does not reach above 20%, it is possible that this could be due to binding to one of the 
catalytic triad residues. Trypsin is also a serine protease but the arrangement of the catalytic 
triad is different to that of DPPIV. However non-specific binding may occur, but is 
insufficient to make a mechanistic evaluation on the enzyme.
As a consequence of these results, no definite conclusions can made on the catalytic 
classification of DPPIV. It is likely that the protease has a serine in its catalytic domain but is 
not inhibited by any of the serine protease inhibitors. It was initially thought that a metallo 
residue was located near the enzyme’s active site that influences catalysis, however further 
evaluation may suggest otherwise. It can be assumed that cysteine residues are positioned 
near the active site but do not play a major role in substrate hydrolysis.
4.8.6. Effect of Metal Ions on DPPIV Activity
The effect of metal ions was investigated as described in section 2.10.8. To avoid any dual 
variable effects, all salts had the same counter-ion, sulphate, included in the controls and all 
active reactions. This ensured that the effect observed was due solely to the presence of the 
metal ion. Table 3.14 demonstrates the general ineffectiveness of the metals. The most 
significant effect was observed in both mercuiy and magnesium with a 20% and a 22% 
decrease in activity. The mercuric effect may be explained by the preparation technique that 
was required. Table 2.12 illustrates that mercuric sulphate required initial dissolution in 1 
Molar HC1 and then brought to volume by buffer. Although the pH was observed at 7.5, it is 
questionable the effect that this quantity of acid could have on the enzyme. Another 
possibility is that heavy metal cations such as mercury are known to react with histidine and 
tryptophan residues in proteins and polypeptides (Volkin and Klibanov, 1990). As DPPIV is 
classified as a serine protease, histidine forms part of the catalytic triad, therefore inhibitory
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effects from mercury are most likely However their effects are not as potent as that 
previously reported where almost complete inhibition is achieved (Puschel et a l, 1982 and De 
Meester et a l , 1992)
4 8.8 Effect of Salts on D P P IV  Activity
During the purification of DPPIV, high concentrations of salt were often required, such as 
500mM NaCl to elute the enzyme from the ion exchange column Analysis of post column 
fractions seemed to illustrate a decrease in enzyme activity As a consequence of the lack of 
knowledge whether the salt effects were directed at the enzyme or at the substrate, it 
warranted a study of a number of salts and their effect on the substrate and the enzyme
Ammonium sulphate, sodium chloride and potassium chlonde was pre-incubated with Gly- 
Pro-MCA and purified DPPIV and the effect measured as outlined in section 2 10 9 FIGURE 
3 8 9 1 1 illustrates the considerable effect ammonium sulphate has on DPPIV activity when 
included in the substrate Enzyme activity seemed to preserved up to lOOmM, but the enzyme 
activity was significantly reduced with an 80% decrease at 1M ammonium sulphate FIGURE 
3 8 9 1 2 shows a similar effect when the salt was pre-mcubated with the enzyme A steady 
decline in enzymatic activity was observed to a maximum inhibition of 50% at 1M salt, 
however the salt concentrations listed are prepared in the required sample volume which is 4 
times less than that m the substrate Therefore if a direct comparison was to be made between 
both studies the equivalent 1M salt concentration when in the enzyme is 250mM when added 
to the substrate Thus the salt effects were very similar regardless what mode of analysis was 
used which is significantly lowered DPPIV activity A common occurrence with ammonium 
sulphate is that it can lower the pH of the buffer However this was not a problem in Hepes 
buffer as the zwitteromc buffer maintained its buffering capacity Nonetheless the salt seemed 
to be capable of specific interaction with the enzyme
The same study was mvestigated with sodium chlonde in both the substrate and with the 
enzyme FIGURE 3 8 9 2 1 illustrates a considerable reduction in activity on increasing salt 
concentration The salt did not appear to affect as potently as that observed for ammonium 
sulphate but with a 59% decrease in DPPIV activity, it obvious that sodium chlonde is having 
a unique effect on the enzyme This is confirmed when the salt is added to the enzyme before 
addition to the substrate FIGURE 3 8 9 2 2 highlights the potency of the salt on activity but 
when the volume factor is taken into account it shows that 250mM sodium chlonde, 
comparative reaction concentration, reduces activity by 30%, 10% more than that observed 
when the salt was added to the substrate Although sodium chlonde does not affect buffer pH 
capacity it must have a significant influence on the ionic interactions of enzyme-substrate
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catalysis In attempt to ascertain a substitute for the sodium chlonde inclusion in relevant 
punfication buffers, potassium chlonde was mvestigated FIGURE 3 8 9 3 1 demonstrates the 
almost identical effect that this salt also has on the enzyme It is assumed that both sodium 
and potassium chlonde act m a similar way m reducing enzyme activity
These results are surpnsmg, not necessary for the effect the salts have on activity but the 
extent of the degradation Timasheff and Arakawa, 1990 report that sodium chlonde and 
especially ammonium sulphate are good protein stabilising agents by increasing surface 
tension They also enhance the formation of water clusters around the protein, which causes a 
loss of total free energy This ‘preferential hydration’ causes the protein to become more 
compact and therefore more stable However they do acknowledge that there is potential 
complications due to the charged state of salts possibly interacting electrostatically with 
charged sites on protems This was explored by Polgar, 1995, when it was discovered that 
sodium chlonde destabilised Prolyl Ohgopeptidase by a mechanism opposing ‘preferential 
hydration’ He proposes that the salt may penetrate the zone of preferential hydration and bind 
to the enzyme at specific sites This binding could weaken electrostatic forces that stabilise 
the protein’s conformation Therefore it seems most likely that a similar phenomenon occurs 
in this study It is not clear whether this destabilisation effect can be predicted due to some 
common conformation between protein, however it is important to be able to counteract the 
sensitivity that the enzyme has to increased ionic strength environments
4 8 9. Substrate Specificity
The specificity of DPPIV for particular substrates is potentially the most important study that 
can undertaken to ultimately understand the functionality of the enzyme It has not been 
established what the natural substrate of DPPIV is, in vivo, which has lead to much 
expenmentation Similarly the role the enzyme plays in protein degradation has many 
possibilities with the subsequent loss in the protein’s physiological effect However the 
cleavage of a dipeptide from a peptide often may activate the peptide or at least result in 
vaned receptor binding and physiological effects
The excellent resolving power of reverse phase high performance liquid chromatography (RP 
HPLC) has resulted in it becoming the predominant HPLC technique for peptide separation 
In this study lon-pair RP HPLC was used to detect cleavage products following incubation of 
peptides with punfied enzyme A silica based analytical column containing octadecyl ligands 
(Cig) was employed as the non-polar stationary phase The polar mobile phase of water and 
MeOH contained the hydrophobic lon-painng reagent tnfluoroacetic acid (TFA) In the pH 
range dictated by the stability of the Cj8 column, basic amino acids and the terminal amino
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group are fully ionised It has been suggested that TFA complexes with basic residues that 
are positively charged and this interaction tends to increase the affinity of the peptide for the 
column and also results in unique differences in chromatography Thus, lon-pair RP HPLC 
was chosen as the optimum analytical tool for this substrate specificity investigation
A range of synthetic peptides were examined and the results are presented m TABLE 3 17 As 
described in section 1 5 7 , the general preferences and restrictions for DPPIV activity is that 
the enzyme prefers bulky, hydrophobic residues but dislikes acidic groups m the P2 position, 
prefers prohne in the PI position and can not cleave peptides with proline or hydroxproline in 
the PT position It was decided to maintain prohne in the PI position and thus vary the ammo 
acids m the other position as well as the length of the peptides The majority of the peptides 
analysed were tnpeptides and a common trend was observed Peptides with N- 
benzyloxycarbonyl (Z) at the P2 position were not cleaved This is understandable as DPPIV 
can not cleave peptides when their ammo terminus is blocked Gly-Pro-Hyp or Gly-Pro-Pro 
were also uncJeaved due to the residues at position P1 ’ Phe-Pro-Ala was hydrolysed due to 
the hydrophobic nature of phenylalanine and the small size alanine at the PI’ position The 
most unexpected peptide cleaved was Tyr-Pro-Phe The neutral, hydrophilic tyrosine residue 
is not favoured at that position while the bulky phenylalanine does not allow complete ease of 
access to the proline residue This would explain the relatively small peak obtained as the rate 
was hydrolysis may have been restricted
Table 3 16 lists the bioactive peptides that were examined and whether hydrolysis was 
achieved or not It appears that bovine serum DPPIV does not have significant affinity to 
alanine when in position P1 as none of the amyloid p-proteins were hydrolysed This could 
also be attributed to the size of the peptides analysed Either way it would seem that the 
enzyme does not have any influence in Alzheimer’s disease
The first bioactive peptide to be cleaved was the opioid, P-Casomorphin Opioids are 
polypeptides that influence nerve transmission in certain parts of the bram They are called as 
such because they bind to specific receptors that bind opiate drugs such as morphine 
Therefore they may be regarded as the brams own ‘pain killers’ (Lehnmger, 1982) FIGURE 
3 8 10 1 1 illustrates the chromatogram of the incubation of the peptide with the enzyme and 
shows multiple peaks The sequence of Casomorphin (TABLE 3 15) has a prohne residue at 
every second position of the seven amino acid peptide Therefore it is a perfect candidate for 
DPPIV sequential hydrolysis The peak at 9 9 minutes of FIGURE 3 8 10 1 1, suggests the 
presence of the Gly-Pro dipeptide (FIGURE 3 8 10 15) This dipeptide could not be produced
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unless the Tyr-Pro and then the Phe-Pro bonds were cleaved indicating complete hydrolysis 
It is possible that the tyrosine residue could restrict hydrolysis due to the enzyme’s dislike for 
hydrophilic residues at the P2 position As a consequence, the cleavage of the Tyr-Pro 
dipeptide could be the rate-1 uniting step Therefore DPPIV plays a role m reducing pain 
prevention when in the bram The serum enzyme could hydrolyse the peptide, which would 
subsequently pass the blood-bram barrier and have a physiological effect This hydrolysis 
correlates with the literature (Mentlein, 1999), however the difference between the bovine 
peptide and that from human is that the latter does not have a second proline residue at the 
fourth position and therefore only one point cleavage could ever be achieved by DPPIV 
Nevertheless the hydrolysis of the final Gly-Pro dipeptide has been reported as difficult or 
unattainable (Gilmartin and O’Cuinn, 1999) The peptide’s cleavage was confirmed as due 
solely to DPPIV by its inhibition when Ile-Pyrrohdide a specific DPPIV inhibitor, was added 
FIGURE 3 8 10 1 6 clearly illustrates the removal of the multiple peaks with a mam peak 
eluted at a retention time of 18 90, which represents the intact Casomorphin peak Two small 
peaks do appear and the peak at 16 783 correlates with the Phe-Pro dipeptide (FIGURE 
3 8 10 14) However this dipeptide could not be produced unless the Tyr-Pro dipeptide was 
cleaved first Therefore is probable that this peak is due to the presence of the inhibitor
Enterostatm is a five ammo acid peptide with two proline residues at every second position 
The peptide is released from the N-terminus of the pancreatic procohpase in the intestine and 
they act as specific satiety signals for fat intake FIGURE 3 8 10 1 11 demonstrates the 
peptide’s incubation with DPPIV and two cleavage peaks were observed which seemed to 
correlate with free Ala-Pro and Gly-Pro dipeptides (FIGURES 3 8 10 113 and 38 10 1 14) 
Therefore DPPIV could have an influence in obesity and fat intake The pentapeptide is a 
perfect candidate for DPPIV hydrolysis due to the initial hydrophobic nature of the alanine 
residue, followed by Gly-Pro-Arg which DPPIV would also be expected to cleave
Substance P is a neuropeptide from the tachykinin family These peptides all have 10 or 11 
residues with a common -FXGLM-NH2 ending They elicit a wide range of responses from 
neurons, smooth muscle and cells of the immune system which are similar to bradykimn and 
serotonin The peptide has many implications, some of which include its release dunng 
headache and migrane (Fuller, 1996) and scratching and biting behaviour when induced by 
intrathecal administration (Roman, 1995) Substance P Receptor binding results in specific 
physiological effects while the peptide’s analogues have different effects Therefore the 
potential of hydrolysis by DPPIV was investigated FIGURE 3 8 10 1 7 illustrates the 
generation of two dipeptide peaks of Arg-Pro, and Lys-Pro, which would be expected due to 
the ability of DPPIV to hydrolyse peptides with basic residues in the P2 position The
210
remaining cleaved peptide may be hydrolysed further by other peptidases or could remain 
intact and be of physiological importance Whatever pathway occurs, it is obvious that DPPIV 
contributes to this process (Harada, 1997)
Neuropeptide Y is widely distributed in central and peripheral neurons The peptide is
involved in food intake and anxiolysis with a significant role as a co-released transmitter
(Roman, 1995) FIGURE 3 8 10 1 18 shows the chromatogram of the Neuropeptide Y 
analogue (1-24) mcubation with DPPIV and the graph illustrates a cleavage product at a 
retention time of 16 683 This could be the dipeptide Tyr-Pro, which would correlate with 
FIGURE 3 8 10 1 20 or may be the corresponding 22 ammo acid peptide Either way the 
hydrolysis of Neuropeptide Y by DPPIV is very likely indicating the wide substrate 
specificity of the enzyme and it’s broad functionality It should be noted that it may be
unlikely that DPPIV could hydrolyse the native 36 ammo acid peptide However
Neuropeptide Y contains a proline-nch N-termmal sequence that would confer considerable 
resistance to the peptides degradation Therefore it is possible that DPPIV could play a major 
role in the hydrolysis of Neuropeptide Ys if the relevant prolme containing ammo dipeptide 
was exposed (Mentlein et a l , 1993)
Michaelis Menton constants (KM) were determined for purified DPPIV activity as described 
in sections 2 10 10 2 1 and 2 10 10 2 2 using Gly-Pro-MCA and Lys-Pro-MCA respectively 
Four kinetic models were applied to the data, namely the Michaelis-Menten, Lineweaver- 
Burk, Eadie-Hofstee and Hanes-Woolf models Section 6 3 details how each model utilised 
the data to produce a KM value for the two substrates TABLES 3 18 and 3 19 presents the 
calculated constants It is obvious that the enzyme had a high affinity for Gly-Pro-MCA, since 
an average constant of 34 8jxM was obtained DPPIV appeared to have a lower affinity for 
Lys-Pro-MCA showing an average KM of 103(iiM However the Vmax constants obtained in 
both studies are considerably different With an average Vmax of 841 fluorescent units from 
Lys-Pro-MCA hydrolysis, the question may be asked whether the latter substrate would be 
better employed as the standard substrate for DPPIV Although a higher concentration of 
substrate would be required to maintain saturation, a higher fluorescent signal could be 
achieved This would correlate well with the preference of DPPIV for basic residues (lysine) 
than hydrophilic residues (glycine) at position P2 However it was decided that this substrate 
could be used in addition to Gly-Pro-MCA, especially when the enzyme activity was quite 
low but the latter substrate was maintained as the characterisation substrate as it may have 
greater specificity, accuracy and reproducibility The KM determined was lower than that 
reported from other sources (Puschel et a l , 1982, Shibuya-Saruta et a l , 1996 and Wagner et
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a l , 1999) However the difference m the chromophore utilised for these studies may also 
influence the kinetics of the enzyme
4 8 10 Inhibitor Studies
The m vivo effect of DPPIV is hard to elucidate but it’s potential generated from m vitro 
studies is widespread One method to investigate the enzymes physiological effect in the body 
is the use of specific inhibitors However the requirement for biocompatibihty of these 
compounds has prohibited the introduction of some inhibitors into biological systems (De 
Meester et a l, 1997) In general, specific inhibitors are synthesised to bind to the enzyme’s 
active site Thus it can be speculated that good DPPIV substrates could also be adapted to 
become effective specific inhibitors and substrate specificity criteria could be applied to both
Diprotm A (Ile-Pro-Ile) and B (Val-Pro-Leu) have been synthesised as specific DPPIV 
inhibitors but could also be regarded as good substrates With isoleucine and valine at 
position P2, the ammo acids hydrophobicity is preferred by DPPIV and should compete with 
the substrate for hydrolysis, creatmg a potent inhibitor The effect of these compounds were 
investigated as described in section 2 10 11 1 FIGURES 3 8 1111 and 3 8 1112 show 
similar potency from both inhibitors resulting in complete inhibition of DPPIV Although 
Diprotm A appeared to be most potent in inhibitory capacity, it is possible that both 
compounds behave in a similar fashion with IC5o’s of 1x10 5M and 5x10 5M for Diprotm A 
and B respectively (TABLE 3 20) This correlates well with the literature (Ohkubo et a l, 1994 
and Gilmartin and O’Cuinn, 1999) even though the IC5o values were not estimated The mode 
of inhibition was also determined as outlined in section 2 10 11 2 Lmeweaver-Burk plots 
were constructed and FIGURES 3 8 112 1 and 3 8 11 2 2 demonstrate the similar profiles 
obtained for both inhibitors The curves all intersect above the negative portion of the y-axis 
suggesting that both inhibit by competitive-non-competitive mixed inhibition (see appendix 
section 6 4 3) This is slightly surprising as the structures of both compounds are very similar 
to the substrate and simple competitive inhibition was expected The inhibition constants, K, 
were determined from these graphs as described in section 6 4 2 and were estimated as 
1 36xlO^M and 1 93x1 O^ M for Diprotm A and B respectively
An identical study was earned out on another two similar inhibitors, Ile-Thiazohdide and Ile- 
Pyrrolidide Both have been reported as specific DPPIV inhibitors, which could prove an 
important tool in elucidating the structure and function of the proteolytic enzyme (Stockel- 
Maschek et a l , 2000) The inhibitory studies earned out demonstrate the potency of the 
inhibitors to DPPIV activity as FIGURES 3 8 1113 and 3 8 1114 allow an IC50 estimation to 
be made Ile-Thiazohdide appeared to be very potent to DPPIV activity with an IC50 of
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7 5x10 7M while the corresponding value for Ile-Pyrrohdide was 6x10 5M (TABLE 3 20) 
However the graphs obtained were considerably different to that of the Diprotins The 
enzyme seemed to resist inhibition to a saturation point where the inhibitor concentration is 
such that reduction in activity is inevitable This activity reduction occurs very quickly and 
complete is inhibition is achieved at a lower inhibitor concentration The mode of this 
inhibition was still unknown so both compounds were subjected to kinetic analysis and 
Lmeweaver-Burk plots were constructed as outlined m section 2 10 11 2 FIGURES 3 8 112 3 
and 3 8 11 2 4 clearly indicate the intersecting lines on the positive intercept of the y-axis 
This is typical of competitive inhibition where the inhibitor competes with the substrate for 
the active site of the enzyme The structures of both Thiazohdide and Pyrrolidide are almost 
identical, the only exception being the presence of a sulphur atom in the five membered ring 
of Thiazohdide Thus it is expected that the mode of inhibition should be similar or the same 
Despite the latter compound producing a very low IC5o value compared to Ile-Pyrrohdide, a 
less potent K, was observed TABLE 3 19 lists 3 7x10 7M and 7 5x10 7M as the inhibition 
constants of Ile-Thiazohdide and Ile-Pyrrohdide respectively Although this correlates with 
reports of similar inhibition constants, Ile-Thiazohdide was seen to be the more potent 
(Stockel-Maschek et a l , 2000)
The hydrolysis of some bioactive peptides by DPPIV has been successfully shown by HPLC 
These peptides contain the proline residue and as a consequence of DPPIV cleavage it is 
possible that the peptides could also inhibit DPPIV’s activity on the standard substrate, Gly- 
Pro-MCA The effect of □-Casomorphin and Substance P was investigated as described in 
section 2 10 113 and the kinetic models were applied to generate the corresponding 
Michealis-Menton constant, KM and the velocity maximum, Vmax Depending on the 
inhibition obtained, the inhibition constant could be estimated FIGURES 3 8 113 1 and 
3 8 11 3 2 demonstrate Lmeweaver-Burk plots for Casomorphin and Substance P 
respectively It is clear that the two plots are very different with Casomorphin possibly 
inhibiting competitively The Substance P plot is a clear example of Uncompetitive inhibition 
with the presence of two parallel lines Casomorphin appeared to be the more potent inhibitor 
of the two peptides with an average K, of 1 lxlO^M, while Substance P inhibited DPPIV with 
an inhibitory constant of 5 5x10^M (TABLE 3 21) The difference m the mode of inhibition is 
potentially interesting as both peptides have a similar sequence with the second and fourth 
amino acid occupied by a proline residue It is probable that sequential cleavage of the 
peptides is not required to inhibit the enzyme, however the size and the ammo acid positions 
may play a major role in the mode of inhibition obtained There still is much speculation 
about whether a substrate can be classified as an inhibitor and if an inhibitor is hydrolysed can 
it be regarded as a substrate For all inhibitor studies earned out during this project, if a
213
decrease m the apparent rate of hydrolysis was observed then the compound was classified as 
an inhibitor Similarly if all enzyme activity was eliminated by a specific compound then 
active site binding would be likely and the enzyme could be deemed as specifically inhibited
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6.0 . A p p e n d ic e s
6 o A pp e n d ic e s
6 1 E r r o r  B a r s
Error bars on all graphs represent the standard error of the mean o f triplicate fluorescence or 
absorbance values The standard error (SE) of mean is defined as
SE = of
Where
a  is the standard deviation î e Vvariance (variance is (a2 + b2+ c2)/3, where a, b and c are the 
triplicate values)
n is the number o f repeat values measured (three m these studies)
6 2 E n z y m e  Q u a n t it a t io n
One umt o f  enzyme activity is defined as the amount o f enzyme which releases 1 nanomole MCA 
per minute at 37°C
Derivation
Let MCA released = X\iM
= Ajxmoles/Litre
(assay uses 400^L MCA, IOOjiL enzyme)
= X x  103 x 0 4 jumoles/min/100jaL 
60
= X x  103x 0 4  x10+3 nanomoles/min/lOOjiL 
60
= X x 0 4  nanomoles/minute/10 0 |iL 
60
24 0
= X x  4 nanomoles/minute/1000jaL 
60
= X x  4 nanomoles/minute/mL 
60
= X  nanomolcs/mm/mL 
15
But
lunit o f activity is defined as amount o f enzyme which releases 1 nanomole MCA/mrn,
Therefore
= X  umts/ml 
15
And
MCA released (X) is also defined as fluorescent intensity observed/slope of the appropnate MCA 
standard curve, so
Umt/mL
Therefore
Unit of activity =  Fluorescent Intensity
Slope of filtered standard curve x 15
= Fluorescent Intensity 
Slope o f filtered standard curve x 15
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Total activity (unit) Units o f enzyme activity, calculated from fluorescent intensity as described 
in section 6 2
Total protein (mg) mg/mL protein estimated from appropriate BSA standard curve (using Biuret 
or BCA assays) x volume o f sample in mL
Specific Activity (unit/mg) Total activity/total protem
Purification factor Specific activity of sample/specific activity o f starting sample (saliva or 
serum)
Yield (%) (Total activity o f sample/total activity of starting sample (serum)) x 100
6  3  P u r i f i c a t i o n  T a b l e  C a l c u l a t i o n s
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6  4  K i n e t i c  A n a l y s i s
6 4 1 K m Determinations
The Michaelis constant (KM) is defined as the dissociation equilibrium constant for the enzyme- 
substrate complex It may be measured by the analysis o f initial velocities at a series of substrate 
concentrations and one concentration o f enzyme The data points can then be fitted to a number o f  
models as outlmed below
Michaelis-Menten -  Plot of fluorescent intensity versus substrate concentration 
Km is the substrate concentration at half the maximum fluorescent intensity
Lineweaver-Burk - Plot of 1/fluorescent intensity versus 1/substrate concentration 
The intercept o f the line at the x-axis is given as -1/KM and the Y-Axis intercept represents 1/Vmax
Eadie-Hofstee -  Plot o f fluorescent intensity versus fluorescent intensity/substrate concentration 
The slope is given as -KM and the Y-Axis intercept represents Vmax
Hanes-Woolf - Plot o f substrate concentration/fluorescent intensity versus substrate concentration 
The intercept at the X-Axis is given as -KM and the slope represents 1/Vmax
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6.4 2 K, Determinations
K„ the inhibition constant, is defined as the constant o f dissociation o f inhibitor from a reversibly 
bound enzyme-inhibitor complex for competitive inhibition
K =  Km x I
Kapp" Km
Where
K, is the inhibition constant
K m is  the Michaehs constant with no inhibitor present 
I is the inhibitor concentration
Kapp is the apparent Michaehs constant and is taken to be the ‘new KM’ observed when a reversible 
inhibitor is incorporated into the assay Kapp is measured as for KM (described in section 6 4 1 )
When the inhibition is not competitive, the inhibition constant can be calculated as follows,
K,= Vappmax x I
V ™ -  V app,max v max 
Where
K, is the inhibition constant
Vmax is the maximum velocity with no inhibitor present 
I is the inhibitor concentration
V appmax is the apparent maximum velocity and is taken to be the ‘new V max’ observed when an 
Un-competitive or Non-competitive inhibitor is incorporated into the assay
6 4 3 Types of Reversible Inhibition
Reversible inhibition involves noncovalent forces that bmd inhibitors to enzymes The following
are the common forms o f reversible inhibition
E- enzyme
I-inhibitor
S-substrate
P-product
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Competitive inhibition mvolves binding o f the enzyme to the inhibitor forming an enzymc- 
mhibitor complex The inhibitor competes with the substrate for the enzyme active site
E + S < - >  ES E + P
+
I
l ' K t
El
With competitive inhibition, the slope o f the Lmeweaver-Burk plot increases as does the KM 
Competitive inhibition is recognisable when plots intersect at a common point o f intersection on the 
positive y-axis
Uncompetitive inhibition occurs when the inhibitor binds to the enzyme-substrate complex, 
binding to a site other than the substrate binding site
E + S < - >  E S - »  E + P
+
I
$*■
ESI
This type of inhibition is identified by the presence o f parallel lines in the Lmeweaver-Burk plot 
Km decreases but slope values remain the same
Non-competitive inhibition mvolves the random binding of inhibitor to either enzyme or enzyme- 
substrate complex
E + S < ~ >  ES E + P
+ +
I I
t*. t*.
El + S ++ ESI
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Non-competitive inhibition may be identified by lines intersecting on the negative portion of the y- 
axis Km remains the same but Vmax decreases
Mixed inhibition occurs when inhibitor binds unequally to enzyme or enzyme-substrate complex 
Vmax decreases and KM may increase or decrease Non-competitive-uncompetitive mixed inhibition 
is evident when the type of inhibition lies between the two types and is identified by lines 
mtersectmg below the negative portion o f the y-axis Competitive-non-competitive inhibition is 
recognisable by lmes mtersectmg above the negative portion of the y-axis
6 5 IC5o Determinations
The IC50 is defined as the concentration at which an enzyme is half inhibited It can be calculated 
graphically from a plot o f enzyme activity versus inhibitor concentration, by locating 50% activity 
on the y-axis and calculating the corresponding concentration on the x-axis
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